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Previous studies have reported altered glutamate (Glu) concentrations in the 
blood and brain of individuals with autism spectrum disorder (ASD) compared 
to neurotypical controls (NC), but the direction (increased or decreased) of 
metabolite differences is still unclear. Moreover, the relationship between Glu 
and both brain function and clinical manifestations of the disorder require 
further investigation. Within this study, we investigated metabolite 
concentrations within the dorsal anterior cingulate cortex (dACC), a brain 
region functionally associated with inhibitory executive control tasks and also 
part of the salience network. 
There were 19 participants with ASD and 20 NCs between the ages of 23 
and 58 years who participated in this study. A study clinician administered 
the Autism Diagnostic Observation Schedule (ADOS) to individuals with ASD 
to further confirm their diagnosis. In addition, all participants in this study 
completed assessments of general intelligence and attention, which included 
an inhibitory executive control task. Researchers also acquired in vivo single-
voxel proton magnetic resonance spectroscopy (1H-MRS) in the dACC to 
quantify both Glu and combined Glu and glutamine (Glx) concentrations. We 
hypothesised that these metabolite concentrations would be altered 
(decreased or increased) in adult participants with ASD compared to NCs 
and would correlate with inhibitory performance and ASD severity in 
individuals with ASD. Participants also underwent a resting-state functional 
magnetic resonance imaging (fMRI) scan to assess the relationship between 
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functional connectivity and Glu and Glx concentrations. We also 
hypothesised that there would be an altered relationship between local Glu 
and Glx concentrations and seed-based functional connectivity in adults with 
ASD compared to NCs. 
There were no significant group differences in Glu or Glx concentrations 
between individuals with ASD and NCs. Furthermore, we did not find any 
relationship between metabolite concentrations and either inhibitory 
performance or clinical symptoms of the disorder. This evidence suggests 
that increased or decreased Glu and Glx concentrations were not a core 
marker of altered brain function in the dACC in this group of adult individuals 
with ASD. When individuals taking psychotropic medications were excluded 
from the analysis, there was a significant interaction between age and group 
for Glx concentrations. This evidence weakly suggests disease-specific 
variations in Glx concentrations over the lifespan of an individual with ASD. 
Nevertheless, this result did not survive correction for multiple comparisons 
and requires further replication.   
In our final experiment, we reported that Glu concentrations were negatively 
correlated with right and left dACC seed-based resting-state functional 
connectivity to the left medial temporal lobe only in individuals with ASD. We 
also reported an interaction between groups in the association between Glx 
concentrations and both left and right dACC functional connectivity to other 
salience network regions including the insular cortex. This evidence suggests 
that local Glu and Glx concentrations were incongruent with long-distance 
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functional connectivity in individuals with ASD. This analysis was largely 
exploratory, but further investigation and replication of these relationships 
may further explain the pathophysiology of the disorder as well as provide a 





Glutamate (Glu) is the primary chemical messenger used by brain cells 
(neurones) to stimulate or excite other neurones. Glutamate is necessary for 
normal brain functions, such as learning and memory, but must also be 
tightly controlled in the brain, because too much or too little can harm brain 
cells. Following release from a neurone, Glu not immediately taken up by 
neurones is converted to glutamine (Gln) to prevent overstimulation of brain 
cells and later converted back into Glu in the neurone for further chemical 
signalling. 
Autism spectrum disorder (ASD) is a developmental brain disorder 
associated with social-communication difficulties and repetitive and restricted 
behaviours or interests. The severity and clinical presentation of symptoms 
vary widely among individuals diagnosed with the disorder. The cause of the 
disorder is still unclear. Researchers have reported altered Glu and 
combined Glu and Gln (Glx) concentrations in the brains of people with ASD, 
but this research is at an early stage. 
We compared Glu and Glx concentrations in adults with ASD to healthy 
control (HC) participants. Furthermore, to better understand how Glu was 
associated with the disorder, we also investigated the relationships between 
Glu and Glx and both behaviour and brain function in individuals with ASD 
compared with HCs. 
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All participants completed tests of intelligence and attention. Individuals with 
ASD were also assessed for core symptoms of the disorder. Finally, all 
persons in our study participated in brain scans which were used to measure 
Glu and Glx concentrations and functional connectivity, thought to reflect 
patterns of synchronisation or communication across the brain. 
We did not find group differences in Glu or Glx concentrations in adults with 
ASD compared to HCs. Also, we did not find any association between Glu or 
Glx concentrations and symptoms of the disorder or behaviour, suggesting 
that increased or decreased Glu concentrations were not a clear marker of 
individuals with ASD compared to HCs. 
For participants free of antidepressant and anticonvulsant medications, we 
reported a greater reduction in Glx concentrations with age in individuals with 
ASD compared to NCs. This evidence weakly suggested that Glx 
concentrations differ depending on the age of the adult with ASD. 
Nevertheless, this result requires further replication in a larger sample of 
participants with ASD. 
We also reported that increased local Glx concentrations were associated 
with reduced functional connectivity in individuals with ASD but increased 
functional connectivity in HCs, suggesting an inconsistency between local 
function and long-distance brain synchronisation in individuals with ASD. 
In conclusion, we did not report group differences in Glx or Glu 
concentrations. Nevertheless, this research suggested that Glx 
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concentrations might vary across the lifespan and have an altered 
relationship to functional connectivity in individuals with ASD compared to 
HCs. Future research into these relationships may assist in developing 




Table of Abbreviations 
 
ACC  Anterior cingulate cortex 
ADI-R  Autism Diagnostic Interview-Revised 
ADOS  Autism Diagnostic Observation Schedule-Generic Module 4 
ADOS-G Combined social and communication scores on ADOS 
AMPA  α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
ANT  Attentional Network Test 
ANCOVA Analysis of covariance 
APA  American Psychiatric Association 
ART  Artefact Detection Toolbox 
ASD  Autism spectrum disorder 
BA  Brodmann area 
BOLD  Blood oxygen level dependent 
CBF  Cerebral blood flow 
Cho  Choline containing compounds 
cm3  Cubic centimetre 
Cre  Creatine plus phosphocreatine 
CRIC  Clinical Research Imaging Centre 
CRLB  Cramér-Rao lower bounds 
CSF  Cerebral spinal fluid 
dACC  Dorsal anterior cingulate cortex 
DLPFC Dorsolateral prefrontal cortex 
DSM-IV Diagnostic and Statistical Manual of Mental Disorders 4th  
   Edition 
DSM-V Diagnostic and Statistical Manual of Mental Disorders 5th  
   Edition 
EPI  Echo-planner imaging 
ER  Error Rate 
FDR  False discovery rate 
fMRI  Functional magnetic resonance imaging 
FXS  Fragile X syndrome 
GABA  Gamma-Aminobutyric acid 
GGC  Glutamate to glutamine cycle 
Gln  Glutamine 
Glu  Glutamate 
Glu/Cre Glu concentrations relative to creatine plus phosphocreatine 
   concentrations 
Glx  Glutamate and glutamine 
GM  Grey matter 
HC  Healthy control 
HR  Hemodynamic response 
IQ  Intelligence quotient 
LCModel Linear Combination Model 
LOC  Lateral occipital cortex 
LTD  Long-term depression 
LTP  Long-term potentiation 
xv 
 
M  Mean 
MATLAB Matrix laboratory 
mI  Myo-inositol 
Mm  Millimoles per litre of brain tissue 
MNI  Montreal Neurological Institute coordinates 
MPFC  Medial prefrontal cortex 
MP-RAGE Three-dimension magnetization prepared rapid   
   gradient-echo 
MRI  Magnetic resonance imaging 
ms  milliseconds 
1H-MRS Hydrogen proton magnetic resonance spectroscopy 
MRS  Magnetic resonance spectroscopy 
MRUI  Magnetic resonance user interface 
NAA  N-acetyl-aspartate 
NAAG  N-acetyl-aspartyl-glutamate 
NC  Neurotypical control 
NMDA N-methyl-D-aspartate 
PEPSI Proton echo-planar spectroscopic imaging 
PET  Positron emission tomography 
PMF  Psychotropic medication free 
ppm  parts per million 
pACC  Pregenual anterior cingulate cortex 
PRESS Point resolved spectroscopy sequence 
RF  Radio frequency 
ROI  Region of interest 
RT  Response time 
SD  Standard deviation 
SNR  Signal to noise ratio 
SPECT Single-photon emission computed tomography 
STEAM Stimulated echo acquisition mode 
SPM  Statistical Parametric Mapping 
T  Tesla 
tDCS  Transcranial direct current stimulation 
TE  Echo time 
VLPFC Ventrolateral prefrontal cortex 
VOI  Volume of interest 
WASI  Wechsler Abbreviated Scale of Intelligence 








1 GLUTAMATE, BEHAVIOUR AND BRAIN FUNCTION ............................. 1 
1.1 INTRODUCTION ............................................................................... 2 
1.2 AUTISM SPECTRUM DISORDER .................................................... 3 
1.2.1 Clinical Diagnostic Criteria ...................................................... 3 
1.2.2 Executive Control and Inhibition .............................................. 5 
1.2.3 Prevalence .............................................................................. 7 
1.2.4 Aetiology ................................................................................. 8 
1.2.5 Treatment ............................................................................. 11 
1.3 GLUTAMATE FUNCTION IN THE BRAIN....................................... 11 
1.3.1 Glutamate Receptor Signalling ............................................. 12 
1.3.2 Neuronal Plasticity ................................................................ 12 
1.3.3 Glutamate to Glutamine Cycle .............................................. 14 
1.3.4 Development ........................................................................ 15 
1.3.5 Excitotoxicity ......................................................................... 16 
1.4 EVIDENCE OF ALTERED GLUTAMATE CONCENTRATIONS ...... 17 
1.4.1 Blood .................................................................................... 17 
1.4.2 Brain ..................................................................................... 18 
1.5 GLUTAMATE CONCENTRATIONS AND BEHAVIOR .................... 26 
1.5.1 Autism Spectrum Disorder .................................................... 26 
1.5.2 Neurotypical Controls ........................................................... 27 
1.6 GLUTAMATE CONCENTRATIONS AND FUNCTIONAL 
 CONNECTIVITY ............................................................................. 28 
1.6.1 Introduction to Functional Connectivity ................................. 29 
1.6.2 Association between Glutamate Concentrations and BOLD 
Response in Neurotypical Controls ....................................... 33 
1.6.3 Manipulation of Glutamate Concentration and Association with 
Functional Connectivity in Neurotypical Controls .................. 34 
1.7 DORSAL ANTERIOR CINGULATE CORTEX ................................. 35 
1.7.1 Location ................................................................................ 35 
1.7.2 Function ................................................................................ 36 
1.7.3 Conflict Effect Task ............................................................... 38 
1.7.4 Functional Association with the Conflict Effect Task ............. 41 
1.7.5 Functional Connectivity ......................................................... 41 
xvii 
 
1.8 DORSAL ANTERIOR CINGULATE CORTEX IN AUTISM 
SPECTRUM DISORDER ......................................................................... 48 
1.8.1 Altered Function.................................................................... 48 
1.8.2 Altered Function and Functional Connectivity During Inhibition 
Tasks .................................................................................... 49 
1.8.3 Altered Function During the Flanker Conflict Task ................ 51 
1.9 GENERAL SUMMARY, HYPOTHESISE AND OVERVIEW ............ 52 
2 GENERAL METHODOLOGY .................................................................. 55 
2.1 INTRODUCTION ............................................................................. 56 
2.2 ATTENTIONAL NETWORK TEST .................................................. 57 
2.2.1 Advantages ........................................................................... 59 
2.2.2 Disadvantages ...................................................................... 59 
2.3 MAGNETIC RESONANCE IMAGING ............................................. 60 
2.3.1 Basic Principles .................................................................... 60 
2.3.2 Advantages ........................................................................... 60 
2.3.3 Disadvantages ...................................................................... 61 
2.4 MAGNETIC RESONANCE IMAGING SEQUENCES ...................... 62 
2.4.1 Structural Magnetic Resonance Imaging .............................. 62 
2.4.2 Functional Magnetic Resonance Imaging ............................. 62 
2.4.3 Proton Magnetic Resonance Spectroscopy .......................... 63 
2.4.4 Technical Considerations of Proton Magnetic Resonance 
Spectroscopy ........................................................................ 65 
2.5 METABOLITES ............................................................................... 74 
2.5.1 Glutamate and Combined Glutamate and Glutamine ............ 74 
2.5.2 N-Acetyl-Aspartate ................................................................ 74 
2.5.3 N-acetyl-aspartyl-glutamate .................................................. 75 
2.5.4 Quantifying N-Acetyl-Aspartate and N-Acetyl-Aspartyl-
Glutamate ............................................................................. 75 
2.5.5 Creatine and Phosphocreatine.............................................. 76 
2.5.6 Choline Containing Compounds ........................................... 76 
2.5.7 Myo-inositol .......................................................................... 77 
2.6 METHODS ...................................................................................... 78 
2.6.1 Study Population................................................................... 78 
2.6.2 Ethical Consent..................................................................... 81 
2.6.3 Assessment Procedure ......................................................... 82 
2.6.4 Background Clinical and Demographic Information............... 82 
xviii 
 
2.6.5 Clinical Assessment .............................................................. 83 
2.6.6 Neuropsychiatric Assessments ............................................. 84 
2.6.7 Magnetic Resonance Imaging Acquisition ............................ 92 
2.6.8 Magnetic Resonance Imaging Parameters ........................... 93 
2.7 DEMOGRAPHIC CHARECTORISTICS .......................................... 95 
2.7.1 Age ....................................................................................... 96 
2.7.2 Intelligence ........................................................................... 96 
2.7.3 Education.............................................................................. 97 
2.7.4 Employment Status ............................................................... 97 
2.7.5 Autism Diagnostic Observation Schedule ............................. 98 
2.8 CONCLUSION ................................................................................ 99 
3 METABOLITE CONCENTRATIONS ..................................................... 100 
3.1 INTRODUCTION ........................................................................... 101 
3.2 METHODS .................................................................................... 103 
3.2.1 Participants ......................................................................... 103 
3.2.2 Demographic, Clinical and Psychometric Data Collection ... 104 
3.2.3 Magnetic Resonance Imaging Data Collection .................... 104 
3.2.4 Neuroimaging Data Processing .......................................... 105 
3.2.5 Statistical Analysis .............................................................. 107 
3.3 RESULTS ..................................................................................... 110 
3.3.1 Example of Spectra Output ................................................. 110 
3.3.2 Basic Demographic Group Comparisons ............................ 112 
3.3.3 Correlation Between Metabolite Concentrations and Autism 
Diagnostic Observation Schedule ....................................... 112 
3.3.4 Group Comparisons of Cramér-Rao Lower Bounds Standard 
Deviation Values ................................................................. 113 
3.3.5 Group Comparisons In Grey Matter, White Matter and 
Cerebral Spinal Fluid Percentages in Reconstructed Voxel 115 
3.3.6 Correlation Between Metabolite Concentrations and Age and 
Intelligence ......................................................................... 117 
3.3.7 Group Comparisons in Metabolite Concentrations .............. 118 
3.3.8 Post-Hoc Correlations Between Metabolite Concentrations by 
Group ................................................................................. 122 
3.3.9 Post-Hoc Group Comparisons in Metabolite Concentrations In 
Psychotropic Medication Free Participants Only ................. 123 
3.4 DISCUSSION ................................................................................ 125 
xix 
 
3.4.1 Glutamate ........................................................................... 125 
3.4.2 Glutamate and Glutamine Concentrations .......................... 127 
3.4.3 N-Acetyl-Aspartate and N-Acetyl-Aspartyl-Glutamate ......... 128 
3.5 CONCLUSION .............................................................................. 129 
4 ATTENTIONAL NETWORK TEST ........................................................ 131 
4.1 INTRODUCTION ........................................................................... 132 
4.2 METHODS .................................................................................... 134 
4.2.1 Study Populations ............................................................... 134 
4.2.2 Demographic, Clinical and Psychometric Data Collection ... 135 
4.2.3 Attentional Network Test ..................................................... 135 
4.2.4 Magnetic Resonance Imaging Acquisition .......................... 136 
4.2.5 Neuroimaging Data Processing .......................................... 136 
4.2.6 Statistical Analysis .............................................................. 136 
4.3 RESULTS ..................................................................................... 139 
4.3.1 Basic Demographic Group Comparisons ............................ 139 
4.3.2 Attentional Network Test ..................................................... 140 
4.4 DISCUSSION ................................................................................ 152 
4.4.1 Main Effects Attentional Network Test ................................ 153 
4.4.2 Basic Demographic Characteristics and the Attentional 
Network Test ...................................................................... 154 
4.4.3 Group Differences on the Attentional Network Test ............ 154 
4.4.4 Correlation between Conflict Effect and Communication Score 
in Participants with Autism Spectrum Disorder .................... 157 
4.4.5 Correlation between Conflict Effect and Metabolite 
Concentrations ................................................................... 158 
4.5 CONCLUSION .............................................................................. 158 
5 RESTING-STATE FUNCTIONAL CONNECTIVITY .............................. 159 
5.1 INTRODUCTION ........................................................................... 160 
5.2 METHODS .................................................................................... 162 
5.2.1 Study Populations ......................................................................... 162 
5.2.2 Demographic, Clinical and Psychometric Data Acquisition . 163 
5.2.3 Demographic, Clinical and Psychometric Data ................... 164 
5.2.4 Magnetic Resonance Imaging Acquisition .......................... 164 
5.2.5 Magnetic Resonance Imaging Parameters ......................... 164 
5.2.6 Imaging Preprocessing ....................................................... 164 
xx 
 
5.2.7 Modified Whole Brain Mask ................................................ 167 
5.2.8 Seed Regions ..................................................................... 168 
5.2.9 Statistical Analysis .............................................................. 168 
5.3 RESULTS ..................................................................................... 170 
5.3.1 Age and Intelligence ........................................................... 171 
5.3.2 Group Comparison Movement Outlier Scans ...................... 171 
5.3.3 Functional Connectivity Within Groups ............................... 172 
5.3.4 Functional Connectivity Between Groups ........................... 181 
5.3.5 Functional Connectivity and Associations ........................... 182 
5.4 DISCUSSION ................................................................................ 198 
5.4.1 Functional Connectivity Within and Between Groups .......... 199 
5.4.2 Functional Connectivity Association with Metabolite 
Concentrations ................................................................... 202 
5.4.3 Functional Connectivity Association with Conflict Effect 
Performance ....................................................................... 207 
5.5 CONCLUSION .............................................................................. 209 
6 GENERAL DISCUSSION ...................................................................... 211 
6.1 INTRODUCTION ........................................................................... 212 
6.2 SUMMARY OF MAIN FINDINGS .................................................. 213 
6.3 IMPLICATIONS OF PRESENT RESEARCH ................................. 214 
6.4 STRENGTHS ................................................................................ 217 
6.5 LIMITATIONS ............................................................................... 218 
6.6 SUGGESTIONS FOR FUTURE STUDIES .................................... 219 
6.7 CONCLUSION .............................................................................. 221 














Autism spectrum disorder (ASD) is a lifelong neurodevelopmental disorder. 
Symptoms include both social communication deficits and repetitive and 
stereotyped behaviours 1. In 2014, researchers estimated that ASD costs 
more than £32 billion in treatment, support services and productivity loss in 
the United Kingdom. This disorder also comes with a huge emotional burden 
for both individuals with ASD and their caregivers 2,3. Therefore, there is a 
great need to investigate and understand the pathophysiology of this disorder 
to develop improved treatment and support for individuals diagnosed with 
ASD. 
The overall objective of this research was to investigate glutamate (Glu) and 
its relationship to behaviour and brain function in individuals with ASD. In this 
chapter, we lay the foundation for later analyses. We firstly discuss the 
clinical characteristics of ASD (chapter 1.2). We then briefly present the 
theory of executive dysfunction in ASD and introduce inhibitory behaviour, a 
focus within this thesis (chapter 1.2.2). We conclude this section by 
discussing the prevalence, aetiology and current treatment for ASD (chapter 
1.2.3, 1.2.4 and 1.2.5 respectively). Next, the role of both Glu and glutamine 
(Gln) in the brain is discussed (chapter 1.3). Following this, a summary of the 
evidence of altered Glu and Glx concentrations in individuals with ASD 
compared with neurotypical controls (NC) is presented (chapter 1.4). Next, 
evidence that Glu and Glx have a relationship to behaviour (chapter 1.5) and 
brain function is further discussed (chapter 1.6). The final section of this 
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chapter discusses the primary brain region investigated, the dorsal anterior 
cingulate cortex (dACC) in NCs (chapter 1.7) and individuals with ASD (1.8). 
1.2 AUTISM SPECTRUM DISORDER 
1.2.1 Clinical Diagnostic Criteria 
Autism spectrum disorder is considered a lifelong neurodevelopmental 
disorder 4,5. Clinicians base diagnosis of the disorder on the presence of 
social communication deficits and stereotyped or repetitive behaviours or 
interests which result in substantial impairment in social, professional or other 
critical areas of life. A diagnosis of ASD can only be given when behavioural 
symptoms are not better explained by other intellectual or developmental 
disabilities 1,6. The early behavioural symptoms of this disorder are typically 
observed in the first three years of life. Nevertheless, a definite diagnosis in 
early development can be challenging as social or communicative deficits 
may not be fully evident until greater social demands are placed upon an 
individual in adolescence and adulthood. Additionally, some individuals learn 
strategies to mask ASD behaviours 6. 
The current American Psychiatric Association’s (APA) Diagnostic and 
Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) combines the 
Diagnostic and Statistical Manual of Mental Disorders 4th, Fourth Edition 
(DSM-IV) diagnostic categories of autistic disorder, Asperger syndrome and 
pervasive developmental disorder into one category of ASD. In the DSM-V, a 
diagnosis of ASD is given in accordance with the level of severity to indicate 
the amount of support an individual requires 1,6. For greater clarity, we 
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present the exact DSM-V diagnostic criteria below which lists typical 
behaviours and symptoms of the disorder 6: 
A. Persistent deficits in social communication and social interaction across multiple 
contexts, as manifested by the following, currently or by history (examples are 
illustrative, not exhaustive; see text): 
1. Deficits in social-emotional reciprocity, ranging, for example, from abnormal social 
approach and failure of normal back-and-forth conversation; to reduced sharing of 
interests, emotions, or affect; to failure to initiate or respond to social interactions. 
2. Deficits in nonverbal communicative behaviors used for social interaction, ranging, 
for example, from poorly integrated verbal and nonverbal communication; to 
abnormalities in eye contact and body language or deficits in understanding and 
use of gestures; to a total lack of facial expressions and nonverbal 
communication. 
3. Deficits in developing, maintaining, and understand relationships, ranging, for 
example, from difficulties adjusting behavior to suit various social contexts; to 
difficulties in sharing imaginative play or in making friends; to absence of interest 
in peers. 
Specify current severity: 
Severity is based on social communication impairments and restricted, 
repetitive patterns of behavior. 
B. Restricted, repetitive patterns of behavior, interests, or activities, as manifested by at 
least two of the following, currently or by history (examples are illustrative, not 
exhaustive; see text): 
1. Stereotyped or repetitive motor movements, use of objects, or speech (e.g., 
simple motor stereotypes, lining up toys or flipping objects, echolalia, idiosyncratic 
phrases). 
2. Insistence on sameness, inflexible adherence to routines, or ritualized patterns of 
verbal or nonverbal behavior (e.g., extreme distress at small changes, difficulties 
with transitions, rigid thinking patterns, greeting rituals, need to take same route or 
eat same food every day). 
3. Highly restricted, fixated interests that are abnormal in intensity or focus (e.g., 
strong attachment to or preoccupation with unusual objects, excessively 
circumscribed or perseverative interests). 
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4. Hyper- or hyporeactivity to sensory input or unusual interest in sensory aspects of 
the environment (e.g. apparent indifference to pain/temperature, adverse 
response to specific sounds or textures, excessive smelling or touching of objects, 
visual fascination with lights or movement). 
Specify current severity: 
Severity is based on social communication impairments and restricted, 
repetitive patterns of behavior. 
C. Symptoms must be present in the early developmental period (but may not become 
fully manifest until social demands exceed limited capacities, or may be masked by 
learned strategies in later life). 
D. Symptoms cause clinically significant impairment in social, occupational, or other 
important areas of current functioning. 
E. These disturbances are not better explained by intellectual disability (intellectual 
developmental disorder) or global developmental delay. Intellectual disability and 
autism spectrum disorder frequently co-occur; to make comorbid diagnoses of autism 
spectrum disorder and intellectual disability, social communication should be below 
that expected for general developmental level  
Note: Individuals with a well-established DSM-IV diagnosis of autistic disorder, 
Asperger’s disorder, or pervasive developmental disorder not otherwise specified 
should be given the diagnosis of autism spectrum disorder. Individuals who have 
marked deficits in social communication, but whose symptoms do not otherwise meet 
criteria for autism spectrum disorder, should be evaluated for social (pragmatic) 
communication disorder. 
 
1.2.2 Executive Control and Inhibition  
Executive control, often used interchangeably with executive function or 
cognitive control 7, is defined as the adaptive influence of cognitive processes 
to coordinate external sensory stimuli, environmental conditions, prior 
learning and internal state, to influence behaviour and achieve an internally 
desired goal. Executive control is critical to human adaptability during 
unfamiliar, multi-dimensional tasks 8–12. Typically, tasks which initiate 
executive control require greater initiation of an effortful cognitive response 
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7,13. Executive control is a broad construct which includes inhibition, 
behaviour regulation, working memory and mental planning. Executive 
control performance has been associated with academic achievement 14,15, 
improved health 16–18, life satisfaction 19 and long-term accomplishments in 
NCs 20, suggesting that it is important for both success and happiness in life.  
Many research groups have reported that participants with ASD have 
reduced performance on executive controls tasks 21–35 including flexibility 
21,36,37, inhibition 26,38,39 and planning tasks 22.  Executive control has also 
been linked with severity of other autistic symptoms. For example, response 
inhibition and cognitive flexibility were associated with the severity of 
repetitive movements in ASD 40–42. In addition, executive control skills were 
also correlated with social performance 41 and even independence in 
adulthood in individuals with ASD 43.  
This evidence has led to the executive dysfunction theory, a hypothesis that 
individuals with ASD have core executive control deficits compared to NCs 
31,44,45. Nevertheless, one problem with this theory is that executive control is 
an incredibly broad concept and associated with a diverse range of tasks and 
underlying brain regions 9. Several groups have reported a lack of 
performance differences on various executive control tasks in individuals with 
ASD compared to NCs 27,41,46,47, suggesting that executive control deficit may 
not be pervasive within the disorder.   
Although we present the executive dysfunction theory of ASD for further 
context, a full investigation of executive control tasks in individuals with ASD 
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is well beyond the scope of this thesis. Instead, we focus on a specific 
inhibitory executive control task. Inhibition is defined as the control of 
automatic behaviour, with a more goal appropriate response to achieve an 
objective. Inhibition permits us to change our habits and learn new ways to 
react to our environment 7.  
Even within the domain of inhibition, ASD performance deficit varies 
depending on the type of inhibition task. There is little evidence that 
individuals with ASD have reduced performance on the Stroop task, a task 
which the participants must inhibit a prepotent response 27,41,46–49. In contrast, 
there has been evidence that individuals with ASD exhibit performance deficit 
when required to inhibit attention to irrelevant non-target stimuli during the 
flanker conflict effect task 26,27,50–55, a task in which a participant must indicate 
the direction of a target while inhibiting both attention and motor response to 
competing non-target stimuli 56. We discuss the flanker conflict task in much 
more detail within chapter 1.7.2 and 1.7.3.   
1.2.3 Prevalence 
In the 1960’s, the prevalencen of autism disorder was thought to be less than 
.05% 57. Over time, more research, heightened awareness and improved 
diagnostic tools have likely contributed to an increased diagnosis of ASD in 
the population 58–63. More recent studies suggest that around one in 100 
adults 64 and school-age children have a diagnosis of ASD in the United 
Kingdom 65 and estimates in the United States reported a similar prevalence 
66. Currently, four in five individuals with ASD are male 60,67,68. It is unclear if 
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being female offers some protection against the disorder 69–71 or if females 
are overlooked for diagnosis 71. 
1.2.4 Aetiology 
The precise cause of ASD is still unclear, but evidence suggests that an 
interplay between various genetic and environmental factors contribute to the 
disorder 72. 
1.2.4.1 Genetics 
Twin studies suggest a genetic influence in the disorder and have reported a 
higher concordance rate for a diagnosis of ASD between monozygotic twins 
(44 - 90%) compared to dizygotic twins (10 - 36%) 73–76. Nevertheless, only 
10% of all individuals with a diagnosis of ASD have a known monogenetic 
cause 66,68,77. 
One monogenetic disorder with closely overlapping autistic symptoms is 
fragile X syndrome (FXS) 78,79. Fragile X is a trinucleotide repeat genetic 
disorder in which the fragile X mental retardation 1 gene is silenced 78,79, 
leading to a reduction or complete lack of the fragile X mental retardation 
protein 80. Symptoms of the disorder also include physical abnormalities such 
as large ears, flat feet and an arched palate 81,82. Individuals with FXS also 
exhibit some behavioural symptoms which overlap with ASD, such as 
repetitive and stereotyped movements, heightened sensitivity to sensory 
stimuli 83 and social deficits 84,85. Studies have reported that one-third of the 
children with a diagnosis of FXS also met the criteria for ASD 86,87. 
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Outside of disorders such as FXS, geneticists have been less successful in 
identifying and replicating singular genetic contributions to the ASD. 
Typically, researchers have identified genetic contributions linked to only a 
rare minority of individuals with the disorder or which are also common in 
NCs 88. 
A lack of evidence for strong monogenetic contributors to this disorder has 
led geneticists to instead proposed that hundreds of genetic loci might 
interact to increase the risk of ASD 89–93. Furthermore, these genes might 
modify a shared biological pathway 92–100, such as genes which modify or 
interact with glutamatergic signalling 101. A 2014 genetic literature review 
reported that more than 50% of all the 249 genes which were known building 
blocks or moderators of Glu metabolism, transport, receptors and signalling 
also had at least one genetic linkage or association study linking it to 
individuals with ASD. Various genetic contributors to Glu signalling pathways 
may increase the likelihood of the development of ASD, although the 
separate effect size for each of these genetic contributions was small 101. 
1.2.4.2 Environment 
Environmental stressors are also likely contributors to ASD. Environmental 
variables which increase the risk of developing ASD include increased 
parental age 102, a heightened maternal immune response to infection during 
pregnancy 103,104, prenatal exposure to anti-epileptic medications 105 and 
oxygen deprivation at birth 102,106,107. As with genetic causes, it may be that 
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environmental stressors which increase risk all differentially impact an 
underlying biological pathway 101. 
1.2.4.3 Neurological Disorder 
Finally, although genetics and environmental variables likely initiate the 
development of ASD, the disorder impacts the brain, and this has been made 
evident through structural and functional neuroimaging studies 108,109. For 
example, structural magnetic resonance imaging (MRI) research has 
consistently reported early macrocephaly for young children with ASD 110–112 
providing further evidence that ASD is a neuro-developmental disorder. 
Functional magnetic resonance imaging (fMRI) evaluates relative changes in 
the BOLD signal in association with an experimental paradigm 113–115 and has 
been a valuable tool in highlighting focal areas of altered function in the brain 
of individuals with ASD compared to NCs 116–119. For example, a metanalysis 
of non-social fMRI tasks suggests that the dACC might be a core area of 
hypofunction in individuals with ASD compared to NCs 120,121. Evidence of 
altered function is further bolstered by post-mortem studies reporting altered 
neural architecture in individuals with ASD compared to NC. Within the 
anterior cingulate cortex (ACC), researchers have reported smaller neuronal 
size in layers I-III and V-VI of Brodmann area (BA) 24b and reduced cell 
density in layers V-VI of BA 24c in adults with ASD compared to age-





Given that the cause of ASD is still unknown, it is not surprising that there is 
no cure. Difficulties in identifying appropriate interventions include 
heterogeneity in symptoms of the disorder and the many potential genetic 
and environmental causes 123,124. 
Although researchers continue to develop new treatments for ASD 125, 
current clinical interventions primarily focus on reducing symptom severity 
and secondary comorbidities. Rigorous behavioural interventions 
implemented early in development offer some improvements in cognitive 
ability and adaptive behaviour for individuals with the disorder 126. Clinicians 
also typically prescribe antidepressants and antipsychotics to alleviate 
secondary symptoms such as anxiety, aggression or irritability 127–130. 
Nonetheless, greater clarification of the neurobiological origins of the disorder 
and improved methods to better classify heterogeneity in participants with 
ASD may assist in the development of better treatment options 123. 
1.3 GLUTAMATE FUNCTION IN THE BRAIN 
Within this section, the objective is to briefly summarise what Glu does within 
the brain and highlight potential mechanisms in which altered Glu 
concentrations can be detrimental. Glutamate has many roles in the brain 
131,132, but its primary role is as a neurotransmitter 132 (chapter 1.3.1) which 
also modulates neuronal plasticity (chapter 1.3.2). Extracellular 
concentrations of Glu within the brain are removed and regulated via the 
glutamate to glutamine cycle (GGC) (1.3.3). During development, the brain is 
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more sensitive to Glu (chapter 1.3.4), although neuronal insult and death can 
occur throughout life when extracellular Glu concentrations are not tightly 
controlled (chapter 1.3.5).  
1.3.1 Glutamate Receptor Signalling 
Glutamate is the primary excitatory neurotransmitter in the brain 133 and 
necessary for neuronal communication 134. Glutamate binds to ionotropic Glu 
receptors 135. Fast acting Glu ligand-gated ionotropic receptors include N-
methyl-D-aspartate (NMDA), α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA) 131,136 and kainate receptors 134,137. 
Ionotropic receptors contain an ion channel which, under the right conditions, 
open to allow ions entry into the cell leading to an increased likelihood of 
action potential 134,135. Signalling pathways association with NMDA receptors 
also influence the efficacy between the pre and post-neuronal synapse by 
altering the number of AMPA receptors in the post-synaptic membrane 138. 
Researchers have also demonstrated that kainate receptors can moderate 
excitability and synaptic transmission 137. 
Glutamate also binds to metabotropic receptors, which do not contain ion 
channels, but indirectly modify other receptor ion channels and signalling 
pathways 139–141. These receptors can also mediate neural efficacy, signalling 
and release 142–144. 
1.3.2 Neuronal Plasticity 
Glutamate receptor signalling can initiate a cascade of proteins which alter 
the synaptic plasticity or efficacy between two neurones. Long-term 
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potentiation (LTP) is an increase in responsiveness of the post-synaptic 
neurone to pre-synaptic signalling 145 and is a prominent biological 
explanation for learning and memory 146–149. Animal research of the 
hippocampus has formed the basis of our understanding of LTP 147, but 
similar mechanisms have been shown in the ACC 150–152. One of the most 
studied mechanisms of LTP is the increase in AMPA receptors in the post-
synaptic membrane leading to increased post-synaptic sensitivity to further 
Glu signalling 151,153–155. 
Nevertheless, LTP is associated with many other Glu receptors and 
signalling pathways. For example, pre-synaptic kainate receptors can 
moderate the likelihood of pre-synaptic excitation leading to increased Glu 
release in the pre-synaptic neurone 149,156. Later stages of LTP also impact 
gene transcription and protein production in the postsynaptic neurone 157,158. 
Changes in morphometry or quantity of dendritic spines 159–161, increased 
postsynaptic area 157 and intrinsic excitability of ion channels 162 are 
associated with later stages of LTP. 
In contrast, long-term depression (LTD) is associated with reduced efficacy 
between neurones 157. Typically, LTD occurs when the Glu signal does not 
sufficiently depolarise the postsynaptic neurone and is associated with brief 
or weak stimulation 163,164. In addition, group I metabotropic Glu receptors 
can moderate LTD and AMPA receptor endocytosis through complex protein 





Figure 1.1 Long-term Potentiation and Depression (Reproduced from Lüscher et al. 
(2014)). 
This model highlights the basic mechanisms of neuronal plasticity in association with the 
AMPA and NMDA receptors. Many other receptors and proteins modulate neuronal plasticity 
which are not included in this figure. On the left, LTD occurs in association with weak 
depolarisation of the post-synaptic neurone. A small amount of calcium enters the post-
synaptic neurone which further activates phosphates and results in endocytosis of the AMPA 
receptor. On the right, LTP is shown. Glutamate signalling leads to post-synaptic neurone 
depolarisation. Calmodulin-dependent kinase II (CaMKII) facilitates AMPA receptor 
phosphorylation and exocytosis. 
1.3.3 Glutamate to Glutamine Cycle 
As part of the GGC cycle, Glu transporters collect extracellular Glu that is not 
immediately taken up by pre-synaptic or post-synaptic neurones. Glutamate 
transporters shuttle Glu to astrocytes for further synthesis into Gln 169,170 thus 
limiting hyperexcitation in nearby neurones 171. Within astrocytes, ammonia is 
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added to Glu to produce Gln. Next, Gln is transferred to the neuron for further 
processing 170,172,173. Within a glutamatergic neuron, Gln can be metabolised 
back into Glu for further release into extracellular space. Ammonia is a bi-
product of Gln degradation 173 and must also be regulated within the neuron 
as it can have a deleterious impact on brain cells including inflammation or 
seizure 170,174. The processes associated with the GGC cycle utilise at least 
70% of glucose taken up by the brain 175,176. 
1.3.4 Development 
During development, Glu receptor signalling has been associated with many 
developmental processes including cell migration 177–179, dendritic growth 
180,181, neurogenesis 182 and cell survival 183,184. In postnatal rats, reducing 
Glu NMDA receptor expression was associated with increased apoptotic cell 
death 184, a less severe neurodegenerative process associated with gradual 
cell shrinkage and containment of cell contents from neighbouring neurones 
185. Researchers also demonstrated that genetic knockout of excitatory amino 
acid transporter 1 and vesicular Glu transporter 1, known to move Glu from 
the cytoplasm to the synapse for further release 186, resulted in widespread 
developmental abnormalities including altered neuronal migration and 
differentiation in the cortex, hippocampus and olfactory bulb of mice. This 
evidence suggests that altering Glu transport and likely increasing 
extracellular Glu concentrations lead to widespread morphological 
differences in the cortex as demonstrated in these knockout mice 187. 
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Furthermore, neurones may be more vulnerable to Glu insult during 
development. Compared to mature mice NMDA receptors in developing mice 
took in higher quantities of calcium 188 and were less easily blocked by 
magnesium 189,190, making these receptors more sensitive to Glu signalling. 
Although increased sensitivity allows for growth and organisation in the 
developing cortex, atypical alterations in Glu signalling can also result in 
greater damage to neurones 133,191. Administration of glutamate agonists 
caused increased neuronal death during early critical developmental periods, 
but this vulnerability diminished with age in mice 183,192. The relationship 
between cortical development and Glu neuro-signalling may be particularly 
relevant to ASD as symptoms become evident in early development 193,194. 
1.3.5 Excitotoxicity 
Excitotoxity is neuronal death and injury caused by excessive neuronal 
excitation and mitochondrial failure due to calcium build up in the cell 195,196. 
Increased extracellular Glu concentrations have been associated with 
excitotoxity 196–202. For example, acute ischemic events are associated with 
high extracellular concentrations of Glu. Excitotoxity results in Glu release 
from the cell membrane of the dying cell causing further death and 
inflammation to neighbouring neurones 185,203,204. Furthermore, blocking both 
ionotropic and metabotropic Glu receptors had a neuroprotective effect 
during an ischemic insult in rats 205,206. In conclusion, although Glu neuronal-
signalling is critical for neuronal plasticity and cortical development, 
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extracellular Glu concentrations must be tightly regulated to prevent both 
altered cortical development and excitotoxicity. 
1.4 EVIDENCE OF ALTERED GLUTAMATE 
CONCENTRATIONS 
Altered Glu concentrations may contribute to the pathophysiology of ASD 
194,207. Within this section, we present evidence of altered Glu concentrations 
in the blood (chapter 1.4.1) and brain (chapter 1.4.2) of individuals with ASD 
compared to NCs. 
1.4.1 Blood 
Separate investigations have reported increased Glu concentrations in blood 
serum and plasma in participants with ASD when compared to NCs 208–217. 
For example, Shinohe et al. (2006) reported increased Glu concentrations in 
serum of adult individuals with ASD compared to age-matched NCs 208. 
Investigators also reported a positive correlation between Glu concentrations 
and the severity of social symptoms as measured by the Autism Diagnostic 
Interview-Revised (ADI-R). The ADI-R is a diagnosis tool for individuals 
suspected of having ASD 
218
. This evidence suggests that increased Glu 
concentrations might result in increased severity of social symptoms in the 
disorder. Finally, another investigation reported that, unlike NCs, children 
with ASD did not exhibit an age-related decline in blood Glu concentrations 
215, further suggesting that Glu alterations might continue into adulthood in 
individuals with the disorder. 
In contrast to these results, other studies report no group differences in Glu 
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concentrations in the blood of individuals with ASD compared to NCs 219,220. 
Nevertheless, a recent metanalysis of all published studies of Glu 
concentrations in the blood concluded that, overall, there was evidence for 
increased Glu concentrations in the blood of individuals with ASD compared 
to NCs 211. 
Glutamate transporters can assist in the regulation of extracellular Glu 
concentrations by transporting Glu across the blood-brain barrier 221,222. In 
NCs, Glu concentrations in serum significantly correlated with concentrations 
in cerebral spinal fluid (CSF) 223,224. Furthermore, Hassan et al. (2013) 
reported a positive correlation between plasma and brain Glu concentrations. 
Glu concentrations were measured by proton magnetic resonance 
spectroscopy (1H-MRS) in several regions of the brain including the bilateral 
dACC and left frontal lobe in children with ASD compared to NCs 217. These 
studies suggested that Glu concentrations in the blood might be associated 
with Glu concentrations in the brain of individuals with this disorder. 
Unfortunately, we were unable to collect blood samples in this study. Future 
1H-MRS studies within the brain would strongly benefit from including the 
measurement of Glu concentrations in the blood for comparison to Glu 
measurement in the brain.   
1.4.2 Brain 
Proton magnetic resonance spectroscopy is a neuroimaging technique which 
researchers have used to quantify Glu or Glutamate and Glutamine (Glx) 
concentrations in the brain in vivo. Many researchers reported altered Glu or 
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Glx concentrations in the brain of individuals with ASD compared to NCs. 
Nevertheless, these studies have contradicted each other as some groups 
reported increased 217,225–232 while others reported decreased 233–238 or no 
group differences in Glu or Glx concentrations in individuals with ASD 
compared to NCs 239–246. We summarise all the published studies 
investigating Glu or Glx concentrations in adults with ASD in table 1.1. 
Participant characteristics, brain region investigated and 1H-MRS 
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Results and study characteristics (metabolite investigated, brain region investigated, cohort size, cohort age and cohort IQ (Wechsler Abbreviated Scale 
of Intelligence (WASI)) of 
1
H-MRS studies investigating Glu and Glx concentrations in individuals with ASD compared to NCs. All studies included 
investigated adult participants. All significant group differences (p > .05) are highlighted in bold.  
1 
Also reported Glx relative to Cre concentrations which was also not significantly different between groups 
2
 Actual significance not reported 
Abbreviations: AC, Auditory cortex; AHR, amygdala-hippocampal region; B, Bilateral; BG, basal ganglia; DLPFC, dorsolateral prefrontal cortex; dACC, 
dorsal anterior cingulate cortex; Glu, glutamate concentrations; Glx, glutamate and glutamine concentration; IPS, intraparietal sulcus; MPFC, medial 
prefrontal cortex; MPL, medial parietal lobe; NR, not reported; pACC, pregenual anterior cingulate cortex; PC, parietal cortex; PCC, posterior cingulate 




Glu and Glx concentrations vary throughout the brain. In NCs, researchers 
reported higher concentrations of Glu and Glx in GM compared to WM 248. In 
another study of NCs, investigators report higher Glu concentrations in the 
pregenual ACC (pACC) (Mean (M) = 11.48, Standard Deviation (SD) = 1.35 
Institutional Units) than in the cerebellum (M = 7.54, SD = .94 Institutional 
Units). The same study also reported significant reductions in Glu 
concentrations in the pACC but not left cerebellum for adults with ASD 
relative to NCs 237. Variations in Glu or Glx concentrations in individuals with 
ASD are likely region specific 247,249,250. Therefore, we focus on 1H-MRS 
studies of the ACC because this was one of the most investigated regions for 
Glu and Glx concentrations in individuals with ASD compared to NCs. 
Bejjani and colleagues reported increased Glx concentrations in the pACC in 
adolescents with ASD compared to neurotypical adolescents 225. This result 
was further supported by two studies reporting increased Glu concentrations 
in the pACC in adolescents with ASD compared to NCs 230,231. The study by 
Naaijen and colleagues was particularly interesting as it investigated a large 
group (NC = 53, ASD = 51) of adolescents 231. Finally, Hassan and 
colleagues reported an increase in Glu concentrations in the dACC, left 
striatum, cerebellum and frontal lobe in children with ASD ages 6 through 14 
compared to age-matched NCs 217. We will discuss the underlying 
methodology of MRS studies in more detail in chapter two, but the results of 
Hassan and colleagues require further replication as they reported Glu 
concentrations in the brain at 1.5 tesla (T). It is incredibly difficult to measure 
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Glu concentrations with a 1.5 T MRI scanner given the technical constraints 
of 1H-MRS 232,251. 
There were two further studies in children and adolescents which reported no 
difference between groups in Glu 241 and Glx 240 concentrations in the ACC 
240,241. Brix and colleagues investigated Glx concentrations in a very large 
voxel overlapping with both the dACC and pACC, while Cochran and 
colleagues investigated the pACC. Although there is some contradiction 
between studies, we know of no study reporting reduced Glu or Glx 
concentrations in children or adolescents with ASD compared to NCs in the 
ACC. 
It has been less clear if Glu ro Glx concentrations are altered in the ACC in 
adult participants with ASD compared to NCs because there are fewer 
studies. There have been four studies measuring Glu or Glx concentrations 
in the ACC in adults with ASD. Researchers have reported reduced Glu 237 
and Glx concentrations in the pACC in adults with ASD relative to NCs 233. In 
contrast, two other research groups reported no difference in Glx 
concentrations in the pACC 252 and dACC of individuals with ASD compared 
to NCs 245.  
The conflicting results from these studies warrant further investigation of Glu 
and Glx in the ACC of adults with ASD. There was some variability in 
participant characteristics which might have contributed to the variable 
results of these studies. Furthermore, it is unclear if altered concentrations 
are associated with altered brain function and behaviour in ASD. Clarifying 
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metabolite concentrations in adult participants with ASD will have 
implications for appropriate interventions throughout the lifespan of the 
disorder. 
1.5 GLUTAMATE CONCENTRATIONS AND BEHAVIOR 
To further clarify conflicting 1H-MRS results, we investigated the relationship 
between Glu concentrations and both clinical symptoms of ASD and 
behaviour. Published evidence that Glu or Glx concentrations are associated 
with behaviour in individuals with ASD (chapter 1.5.1) and NCs (chapter 
1.5.2) is discussed below. 
1.5.1 Autism Spectrum Disorder 
Again, Tebartz van Elst and colleagues reported a significant reduction in Glu 
and Glx concentrations in the pACC in individuals with ASD compared to 
NCs. Investigators also reported that increased Glu concentrations in 
individuals with ASD correlated with decreased empathy as measured with a 
self-report questionnaire, the Empathy Quotient 253. There was no significant 
relationship between these variables in NCs. The pACC has been associated 
with emotional tasks 254,255. Glutamate concentrations in the pACC might be 
associated with empathy in individuals with ASD within increased 
concentrations being associated greater deficit 237. Nevertheless, this was a 
self-report measure, and these relationships require replication in association 
with more direct of empathy. 
In contrast to this study, Libero et al. (2015) reported no significant 
correlation between dACC Glx or Glx/Cre concentrations and the Ritvo 
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Autism Asperger Diagnostic Scale-Revised, an assessment tool to highlight 
autistic traits and behaviours 256. This evidence suggests that Glx 
concentrations in the dACC did not relate to symptoms of the disorder. 
Another study in adolescents with ASD reported no significant relationship 
between intelligence or social behaviour and Glu concentrations in the pACC 
241. Unfortunately, most of the studies investigating Glu and Glx 
concentrations in the ACC did not assess the relationship between clinical 
symptoms or behaviours 217,225,230,233,239. Therefore, much more research is 
needed to investigate the relationship between Glu and Glx concentrations 
and behaviours or symptoms of individuals with ASD compared to NCs. 
1.5.2 Neurotypical Controls 
There has been evidence that Glu concentrations, specifically in the dACC, 
have a relationship to behavioural control in NCs. Studies have reported that 
increased Glu concentrations in the dACC were associated with increased 
self-reported impulsivity in both NCs and individuals with borderline 
personality disorder 257, suggesting that higher Glu concentrations in the 
dACC might be associated with reduced behavioural inhibition. Another 
group investigated performance on a delay discounting task in which 
decreased scores were a measure of increased impulsivity. Researchers 
reported that increased impulsivity correlated with increased dACC ratio of 
Glu to creatine plus phosphocreatine concentrations (Glu/Cre) in NCs 258. 
 Another study investigated if Glu concentrations would predict what type of 
information a participant would use when making a cognitive decision. During 
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this task, the overall objective was to obtain the highest reward with the least 
effort. When completing this cognitive reward task, participants could either 
rely on learned feedback information provided over the length of the task or 
solely utilise the available information on the screen for each trial when 
completing a cognitive reward task. Investigators reported that increased Glu 
concentration in the dACC was positively correlated with increased use of 
previously learned information to guide future behaviour during this task 259. 
These studies suggested that Glu concentrations in the dACC were 
associated with behavioural control in NCs. Given this evidence, we explored 
the relationship between dACC Glu concentrations and a cognitive inhibition 
task in both NCs and individuals with ASD. In comparison to broad symptoms 
of the disorder, we hypothesised that a more finely tuned and regionally 
specific behavioural performance task might more clearly index the 
association between Glu and Glx concentrations on behaviour. 
1.6 GLUTAMATE CONCENTRATIONS AND FUNCTIONAL 
CONNECTIVITY 
Next, the relationship between both Glu and Glx concentrations and 
functional connectivity is presented. Firstly, functional connectivity and 
resting-state functional connectivity is presented (chapter 1.6.1). Evidence 
that Glu and Glx concentrations have a relationship to functional connectivity 
in NCs (chapter 1.6.2 and 1.6.3) is then presented. The goal of this section is 
to present functional connectivity analysis and also provide a theoretical 
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basis for the investigation of the relationship between metabolite 
concentrations and functional connectivity. 
1.6.1 Introduction to Functional Connectivity 
Functional connectivity is a statistical method which measures the correlation 
or association in time-series between distant brain regions and is typically 
applied to fMRI data. By definition, functional connectivity analysis methods 
do not indicate a causal relationship between brain regions. Instead, 
functional connectivity maps patterns of BOLD activity which are thought to 
reflect neural activation patterns and organisation of the human brain 
116,118,260–263. Throughout this thesis, we define task-based fMRI as fMRI 
obtained in association with an externally defined task 264. 
In contrast to task-based fMRI, functional connectivity has often been applied 
to a resting-state fMRI sequence, a fMRI scan which is conducted in the 
absence of an externally defined paradigm 264. Resting-state functional 
connectivity analyses measure the statistical relationships in spontaneous 
low-frequency BOLD fluctuations, usually between 0.009 and 0.09 Hz 116–118. 
Several research groups have demonstrated that regions which were 
functionally associated with each other during a task-based fMRI analysis 
continued to exhibit low-frequency BOLD correlations even in the absence of 
a task 265. For example, in NCs, researchers have demonstrated that resting-
state seed-based functional connectivity from the left motor cortex was 
associated with sensory-motor brain regions previously associated with a 
task-based fMRI hand movement experiment 116. Researchers have also 
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demonstrated a relationship between altered resting-state fMRI and cognitive 
performance in neurological disorders such as ASD 266. 
1.6.1.1 Advantages of Resting-State Functional Magnetic Resonance 
Imaging 
One advantage of resting-state fMRI is its simplicity. Unlike task-based fMRI, 
resting-state fMRI is not constrained by a specific experimental paradigm. 
Given the high cost of MRI and the difficulty of getting a participant to feel 
compfortable inside an MRI scanner 118, resting-state fMRI data has opened 
doors for greater innovation in neuroimaging research by allowing more 
opportunities for data sharing and recycling 108,267. Nevertheless, not all 
resting-state MRI scans are the same. Great care should be taken to identify 
differences which can variably impact the BOLD response, such as variation 
in instructions (for example eye closed or open).268–270. 
Resting-state fMRI is also more practical for clinical groups because it does 
not require the participant to attend to a task while being inside an MRI 
scanner 271. It may be that symptoms of the disorder rather than reduced 
neurocognitive ability can confound both task performance and 
neurocognitive response. For example, there has been some evidence that 
individuals with ASD are less impacted by social motivation than NCs when 
completing a cognitive task. Social influences lead to group differences in 
task performance when there were no actual differences in ability between 
groups 272. Therefore, investigating brain function without having account for 
performance variability during a task can be much less complicated.  
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1.6.1.2 Disadvantages of Resting-State Functional Connectivity Analysis 
Nevertheless, resting-state fMRI has several methodological concerns which 
need to be considered when interpreting the data. Most critically, resting-
state fMRI data is more sensitive to contamination of non-neural artefacts like 
head movement 271,273 and respiration 274,275. Movement artefact can lead to 
signal change resulting in spurious group differences 276–278. 
Both during scanning and post-scan processing, we attempted to reduce 
non-neural artefacts as much as possible. Firstly, evidence suggests that 
preparing an individual for what to expect during an MRI scan can reduced 
head movement 276. Before scanning, we explained the scanning process in 
detail. Participants also listened to the sound and viewed pictures of an MRI 
scanner. During scanning, we stressed the importance of staying relaxed but 
also still.  
Prior to our MRI analysis, participants with excessive head movement were 
excluded from the analysis (greater than 20% of their resting-state fMRI 
scans being labelled as outliers) 276. Furthermore, we compared the number 
of identified outlier scans between groups to determine if motion artefacts 
might have variably impacted the data of individuals with ASD. Nevertheless, 
even with these precautions, we concede that movement is a considerable 
concern in resting-state fMRI data. 
1.6.1.3 Functional Connectivity Techniques 
Functional connectivity has been a promising method of investigating 
statistical correlations in time series across the brain, but neuroimaging 
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researchers have applied many different statistical techniques to map 
functional connectivity 263 which can impact the outcome of an analysis 118. 
A full overview of these methods is beyond the scope of this introduction. 
Instead, we present the two most common functional connectivity analysis 
methods: seed-based correlation and independent components functional 
connectivity analysis. The seed-based correlation analysis method 
investigates the temporal correlation between a seed and other voxels in a 
specified region in the brain. This method requires a prior hypothesis in 
regards to a seed region 263 and is used to identify brain clusters which 
correlated with the average BOLD time course of that seed 263,279–281. This 
technique is not designed to map functional connectivity across the entire 
brain but in relation to a specific seed region. The primary advantage of 
seed-based correlation analysis is its simple application and results 262,282. 
We applied seed-based  functional connectivity analysis because we wanted 
to investigate functional connectivity in association with the dACC only. 
In comparison, independent components analysis is a data-driven method 
which does not require a prior hypothesis in regards to a seed region. This 
statistical method is used to segregate and cluster a BOLD dataset into both 
independent neural networks and signal artefacts which are independent of 
each other based on temporal-spatial neural associations. Independent 
components analysis can investigate functional connectivity across the entire 
brain although the statistical technique is more technically complex compared 
to the seed-based correlation analysis method 283–285. 
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1.6.2 Association between Glutamate Concentrations and BOLD Response 
in Neurotypical Controls 
Studies have reported a relationship between Glu or Glx concentrations in a 
brain region and the BOLD response in closely associated brain regions in 
NCs 258,286–293, suggesting that Glu concentrations play a role in the strength 
of functional connectivity between brain regions 294. 
For example, one group reported that increased relative ratio of Glu to N-
acetyl-aspartate (NAA) concentrations in the medial prefrontal cortex 
(MPFC), as measured by 1H-MRS, was correlated with increased MPFC 
resting-state functional connectivity to the nucleus accumbens and 
dorsomedial thalamus in NCs 286. Another study reported that Glu 
concentrations in the dACC predicted the BOLD response in the retrosplenial 
cortex, basal ganglia, orbitofrontal cortex and inferior parietal lobe during an 
auditory inhibition task 288. This evidence suggests that Glu concentrations in 
the dACC/MPFC may modulate the BOLD response of other closely 
associated brain regions. 
Schmaal and colleagues (2012) reported a positive correlation between the 
Glu/Cre concentrations and impulsivity 258. Researchers also reported that 
increased Glu/Cre concentrations were correlated with increased dACC 
seed-based resting-state functional connectivity to the substantia nigra, 
posterior cingulate cortex and ventral tegmental area in NCs. This evidence 
further suggested that Glu concentrations mediated long-distance functional 




1.6.3 Manipulation of Glutamate Concentration and Association with 
Functional Connectivity in Neurotypical Controls 
In addition, there is some evidence that manipulating Glu or Glx 
concentrations with anodal or positively charged transcranial direct-current 
stimulation is associated with changes in functional connectivity 290,295–297. 
Anodal transcranial direct-current stimulation (tDCS) administers low current 
to the scalp to stimulate the brain 298. Researchers have reported changes in 
Glu or Glx concentrations following administration of tDCS to the motor 
cortex 299,300 and parietal lobe of NCs 290,301. 
Hunter and colleagues reported increased Glx concentrations in the right 
intraparietal sulcus but not the left hemisphere, as measured by 1H-MRS, 
following administration of tDCS to the right parietal cortex in NCs. At 
baseline, investigators applied independent components analysis to a 
resting-state fMRI scan and identified twelve separate brain networks. One of 
these networks was the salience network, a network of brain regions centred 
around insular cortex and dACC. As we explain in more detail later in this 
introduction (chapter 1.7.5.1), the salience network is a group of brain 
regions associated with integrating external and internal sensory information 
to guide behaviour 302. Following tDCS, investigators reported increased 
functional connectivity across several of the baseline networks including in 
the salience network 290. This evidence suggests that changes in Glx 
concentrations are associated with immediate changes to functional 
connectivity in NCs. In conclusion,  we have presented evidence that Glu or 
Glx concentrations are associated with both behaviour and functional 
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connectivity in NCs, but there has been no investigation of these 
relationships in individuals with ASD. 
1.7  DORSAL ANTERIOR CINGULATE CORTEX 
The dACC is a central part of executive control tasks in NCs 303,304 and is 
anatomically and functionally connected with frontal, paralimbic, limbic and 
motor brain regions 302,305–312. As the region of investigation with this study, 
we firstly provide an overview of the anatomical location of the dACC 
(chapter 1.7.1). We then discuss the dACC’s functional relationship to both 
EC tasks (chapter 1.7.2) and more specifically, the inhibitory flanker conflict 
task (1.7.3). Finally, we present previous evidence that the dACC is 
functionally connected with a diverse range of brain regions (chapter 1.7.3). 
1.7.1 Location 
The dorsal ACC (dACC) is located on the medial surface of the brain and is 
superior to the corpus callosum. It also overlaps with the cingulate gyrus and 
sulcus. The dACC is posterior to the genu of the corpus callosum and rostral 
to the anterior commissure 313,314 in the anterior portion of BA 32 and 24 




Figure 1.2 Location of the Dorsal Anterior Cingulate Cortex (Reproduced from 
Eisenberger et al. (2012)). 
The dACC is marked in red on the medial surface of the brain just above the corpus 
callosum. 
1.7.2 Function  
The dACC has consistently been associated with tasks which require 
increased executive control 254,255,255,303,313,316–318 and this may explain its 
association with a range of tasks involving cognition, movement and emotion 
314. For example, researchers have reported an increased functional 
response in the dACC in association with emotional conflict 319, inhibitory 
motor control 320, inhibitory resistance to distraction 26,304 and decision 
making 321,322; all slightly different tasks which require increased executive 
control. 
Even though the dACC is associated with executive control tasks, 
researchers still disagree about the precise function of the dACC 313,323. One 
prominent theory of dACC function is the conflict theory, which suggests that 
the dACC may elicit an increased functional response in association with 
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conflict 8,318,324. Conflict is defined as an impediment or interaction between 
separate information processing streams 8,325. The conflict hypothesis is 
supported by many neuroimaging studies reporting an increased functional 
response in the dACC in association with various types of conflict 303,318,325–
332. 
Nevertheless, the monitoring theory might more completely represent dACC 
function. According to this theory, the dACC functions in a supervisory role 
which initiates and adjusts the appropriate type and level of cognitive 
processing 303,316,329,333–335 to increase performance, reduce future conflict 
and limit performance error 8,254,325,329,336–340. According to the monitoring 
theory, the dACC tends to be most sensitive to conflict when it is new 
information relevant to an internal goal, rather than because the stimuli are 
conflicting 341. In other words, conflict is an indicator of task difficulty and the 
requirement for increased cognitive effort 313. The differences between the 
two theories are minor, but the monitoring theory better explains evidence of 
an increased dACC functional response to error 342–346 pain 347,348, social 
exclusion 
349,350
 or even reward 
351–353
. 
Researchers also postulate that the dACC may be associated with tasks 
which evaluate the cost versus benefit of initiating greater executive control 
313. Individuals typically engage in executive control processes only when 
they have sufficient motivation 354,355 and prefer to rely on habitual 
behaviours as a default 313,356,357. Given this subjective cost, executive control 
processes initiate the least effortful response 7,13 to achieve a goal 313,356–358. 
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Similarly, the dACC may also be associated with motivation to participate in a 
task. Researchers demonstrated that mice with dACC ablation had reduced 
motivation to participate in a visuospatial attention task to increase access to 
sugar 359, presumably because the animal is unable to determine the value of 
participating in the task. Direct neuronal recording in monkeys found that the 
dACC encoded values related to probability, payoff and cost manipulations 
during a task 321. Furthermore, direct stimulation of the dACC increased task 
perseverance in human epilepsy patients 360. Although our understanding of 
dACC associated function continues to evolve, we suggest that the dACC 
may function to determine the value of executive control in association with 
the personal cost, monitor the available information regarding a goal-related 
task and flexibly adapt executive control processes as appropriate to attain a 
goal 323. 
1.7.3 Conflict Effect Task 
We applied the Erikson flanker or conflict effect task, a inhibition to distraction 
task which measures a participant’s efficiency to inhibit attention and motor 
response to conflicting, non-goal related stimuli 26,338,358,361. 
Although there are many variations of this task, we briefly outline the basic 
design. The goal of the conflict effect is to correctly indicate the direction (left 
or right) the centre arrow is facing. Flankers are non-target arrows. During 
congruent conditions of this task, there is little distraction from flankers 
because flankers face the same direction as the target arrow (←←←←←). 
During incongruent conditions, contradictory, flankers surround and face the 
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opposite direction of the target arrow (←←→←←). The conflict effect is 
calculated by the increase in average response time (RT) and total error rate 
(ER) during the incongruent conditions minus the congruent conditions. The 
conflict effect measures the efficiency and accuracy which an individual 
resists distractions from non-target stimuli 26,304,361–363. 
During incongruent conditions, researchers have hypothesised that 
participants must increase executive control to contend with two competing 
stimulus information streams 56,364. Firstly, there is a quick perceptual 
evaluation which primes a motor response to the dominant visual stimuli. 
Next, a slower, more deliberate cognitive information stream appraises the 
target and, in the case of incongruent flankers, inhibits the incorrectly primed 
motor response. During the incongruent flanker conditions, the competing 
flankers dominate immediate visual processing and require inhibition of the 
early incorrect response 361. Investigators have shown that decreasing the 
distance between target and distractors 361 or increasing distractor contrast 
365 further reduces efficiency in NCs by increasing the dominance of the 
incongruent visual stimuli and requiring increased inhibition. 
Participants with ASD typically perform better than NCs on tasks which 
benefit from a local rather than global focus properties of visual stimuli 366–368. 
For example, compared to NCs, individuals with ASD are faster and have 
fewer errors on the embedded figures task, in which a participant must find a 
target concealed within a complex figure 369.  
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Nevertheless, the propensity for bottom-up visual processing is unlikely to 
benefit individuals with ASD during the flanker conflict task. There has been 
evidence that individual with ASD view flankers in a less integrated way 370 
and have difficulty filtering irrelevant visual stimuli 371,372. During variations of 
the conflict effect task, individuals with ASD have had greater performance 
impairments with the addition of distracting arrows 26,27,50,52,272,373.  
Nevertheless, some studies have not reported performance differences on 
the conflict effect task in individuals with ASD compared to NCs 35,54,374. It 
has been suggested that variability in ASD sample characteristics could 
contribute to conflicting results between some inhibition to distraction studies 
9,358. Some evidence suggests that comorbidities with attention deficit 
disorder might underlie reduced executive control performance in ASD 
groups 375,376. Additionally, a metanalysis of inhibition to distraction tasks, 
which included the conflict effect task, reported that varying intelligence 
quotients (IQ) between groups significantly contributed to performance 
differences in individuals with ASD compared to NCs 358. Furthermore, 
executive control has a prolonged developmental trajectory into late 
adolescence in NCs 318,377. Some evidence suggests that group differences 
in the conflict effect task might be associated with a delayed developmental 
trajectory rather than a lifelong deficit in inhibition 27,50. Therefore, within our 
investigation, we focused only on adult participants with normal IQ to 
determine if performance differences on the conflict effect task occur in 
adults individuals without intellectual deficits.  
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1.7.4 Functional Association with the Conflict Effect Task 
Studies have reported an increased BOLD response in the dACC during 
incongruent flanker conditions compared to congruent flanker conditions (see 
figure 1.3) in NCs 26,304. In addition to the dACC, researchers also report an 
increased BOLD response in other regions such as the thalamus and frontal 
lobe in association with incongruent flanker conditions 26,304. 
 
Figure 1.3 Increased Blood Oxygenated Level Dependent Response during Flanker 
Conflict Task in Neurotypical Controls (Reproduced from Fan et al. (2005)). 
The conflict network is a group of brain regions with an increased BOLD response in 
association with conflicting flanker arrows compared to congruent flanker arrow conditions. 
as part of the Attentional Network Test (ANT) in NCs. Regions showing increased activation 
include the dACC, thalamus, left superior frontal gyrus, bilateral inferior frontal gyrus, 
bilateral fusiform gyrus, cerebellar vermis and right middle frontal gyrus. 
1.7.5 Functional Connectivity 
Given the integrative role in executive control tasks, it is not surprising that 
the ACC is a densely connected and influential brain region anatomically and 
functionally linked with frontal, paralimbic, limbic and sensory-motor areas 
302,305–312. Therefore, a thorough comprehension of neurocognitive function 
and behaviour, particularly for such an interconnected region, requires 
42 
 
investigation of the interaction between brain regions associated with the 
dACC. 
1.7.5.1 Salience Network 
Seeley and colleagues (2007) applied seed-based functional connectivity 
analysis to a resting-state BOLD dataset 116–118. In this study, researchers 
investigated the functional connectivity between a seed region in the right 
anterior insular cortex and the rest of the brain in a group of NCs. Following 
analysis, researchers reported a network of brain regions which they referred 
to as the salience network. These results were further replicated in a second 
sample of NCs in which investigators applied independent components 
analysis to regions previously defined in the seed-to-voxel analysis. Both 
analyses identified a similar network of brain regions, centred around the 
insular cortex and dACC, but also including other paralimbic regions such as 
the paracingulate cortex and temporal pole. The paralimbic cortex, which 
also includes the insular cortex and dACC, rests between limbic and 
neocortical brain regions 378,379. Therefore, it was unsurprising that the 
salience network also included limbic or subcortical regions such as the 
thalamus, hypothalamus, ventral striatum/ pallidum area, periaqueductal grey 
and substantia nigra/ ventral tegmental area; and also neocortical regions, 
such as the superior temporal lobe, frontal pole, operculum cortex, pre-
supplementary and supplementary motor areas, ventrolateral and the 
dorsolateral prefrontal cortex (DLPFC) 302. 
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In the same year, another research group applied graph theory which defined 
a set of 39 predefined regions into functional connections using a resting-
state BOLD dataset in NCs. Investigators identified a more restricted network 
which included core salience network regions including the dACC, thalamus, 
anterior insula, frontal operculum and frontal pole 306. 
In yet another resting-state seed-based correlation analysis, researchers 
investigated functional connectivity between 16 separate seed regions in the 
ACC and the rest of the brain in NCs. Investigators reported that the left and 
right dACC (Montreal Neurological Institute coordinates  (MNI)  ±5, 19, 28) 
were functionally correlated with para-limbic regions such as the insular 
cortex; frontal lobe regions such as the ventrolateral prefrontal cortex 
(VLPFC), DLPFC and supplementary motor cortex; and limbic/subcortical 
region such as the thalamus 380. This study further supported the salience 
network in association with a seed in the dACC rather than in the insular 
cortex (figure 1.4). In the same study, investigators also reported a negative 
correlation between the dACC and regions in the parietal and occipital cortex 
(figure 1.4).  
As a first step in the analysis, researchers orthogonolised each of the 16 
ACC seed region’s time series to the other 15 seed regions in the ACC. The 
objective of the study was to identify the unique functional connectivity map 
associated with each seed region independent of the other ACC seed 
regions. It is possible that this orthogonalisation step undervalued functional 
connectivity for seed regions such as the dACC by removing shared variation 
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between seed regions 380. Nevertheless, this study does agree that the dACC 












Figure 1.4 Seed-Based Correlation Functional Connectivity Analysis of the Dorsal 
Anterior Cingulate in Neurotypical Controls (Reproduced from Margulies et al. (2007)). 
Seed-to-voxel functional connectivity maps associated with the dACC regions on the right 
(top images) and left (bottom images) in NCs. The dACC was positively correlated with other 
ACC, paralimbic, subcortical/limbic and frontal brain regions (red). Investigators reported a 
negative relationship between the dACC and parietal and occipital brain regions (blue). Seed 
region located at MNI ± 5, 19, 28. 
A further dACC seed-to-voxel analysis was used to compare younger (17 to 
25 years of age) and older NCs (51 years of age or greater). Again, 
researchers reported that the dACC was functionally correlated with the 
insular cortex, thalamus, superior temporal gyrus, primary motor cortex and 
superior frontal gyrus. In contrast to Margulies et al. (2007) 380, investigators 
reported a positive correlation with medial parietal lobe regions such as the 
inferior parietal lobule, precuneus and supramarginal gyrus (figure 1.5). 
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Researchers also reported that young adults had greater functional 
connectivity to the temporal parietal junction when compared to older adults 
381, suggesting that changes to functional connectivity might vary with age. 
 
Figure 1.5 Functional Connectivity Analysis of the Dorsal Anterior Cingulate in 
Younger and Older Neurotypical Controls (Reproduced from Cao et al. (2014) 
Functional connectivity maps associated with the dACC seed regions in neurotypical (left) 
young adults (17 to 25 years) and (right) older participants (51+ years). The dACC was 




Functional Connectivity to Paralimbic and Limbic Brain Regions and 
Relationship to Internal Experience 
Researchers have reported that dACC was functionally connected with other 
interoceptive, sensory and emotional regions such as the insular cortex, 
thalamus and amygdala 302,314,381. Researchers have suggested that these 
brain regions might represent the value of stimuli to the dACC for further 
cognitive vetting to determine the most appropriate type of behavioural 
response 313. 
The anterior insula is positioned between frontal, temporal and parietal lobes 
and functionally associated with tasks requiring interoceptive sensory and 
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emotional processing 382. Seeley and colleagues further reported that 
increased resting-state functional connectivity, as measured by independent 
components analysis, between the anterior insula and dACC correlated with 
higher self-reported prescan anxiety in NCs. This evidence suggests that 
greater functional connectivity between these regions was associated with 
increased conscious awareness of internal experience 302. 
In support of this hypothesis, Critchley et al. (2004) reported an increased 
BOLD response in salience network regions including the bilateral anterior 
insula and dACC when participants were asked to attend to their heartbeat. 
Interoceptive accuracy during this task also correlated with self-reported 
anxiety, depressive symptoms and negative affect 383. Moreover, a 
longitudinal study of individuals with anxiety disorder reported that increased 
resting-state functional connectivity between the dACC and anterior insula 
was associated with reductions in anxiety over time. Although this study did 
not include a control group, it suggested that increased functional 
connectivity between the dACC and anterior insula might serve to modify a 
heightened emotional response to stimuli 384. Tu et al. (2016) also 
investigated dACC seed-based resting-state functional connectivity. 
Researchers reported that when dACC functional connectivity increased to 
the right superior temporal gyrus and decreased to the right putamen and 
thalamus, there was an increase in social responsiveness scores in NCs 385. 
These studies suggest that functional connectivity between the dACC and 
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paralimbic and subcortical structures are associated with both interoceptive 
and emotional experience in NCs 302,386. 
Dorsal Anterior Cingulate Cortex Association with Cerebral Cortex and 
Relationship to Cognitive and Motor Response 
As we previously mentioned, the dACC is also functionally connected with 
neocortical regions such as the DLPFC and VLPFC 380,381. There has been 
limited evidence that functional connectivity between these regions might 
impact cognitive performance. Zhao and colleagues investigated participants 
with brain damage to measure nodal degree, an index of how well brain 
regions were functional connectivity with each other. Researchers reported 
that the nodal degree between the ACC and the rest of the brain was 
significantly associated with performance on general and modality-specific 
semantic cognitive tasks completed outside of the MRI scanner 
312
. In 
relationship to the conflict effect task, another study reported that functional 
connectivity between the left dACC and DLPFC was directly associated with 
conflict effect performance when completed in an MRI scanner in NCs 387. 
Finally, the dACC may also initiate a goal appropriate motor response which 
explains evidence of functional connectivity between the dACC and motor 
areas including the supplementary pre-motor area, a brain region functionally 
associated with movement planning 302,314,381. In support of the association 
between the dACC and motor cortex, anatomical investigation in non-human 
primates has identified portions of the anterior cingulate which directly project 
to motor/ premotor cortex and spinal cord 388–391. Other fMRI evidence in NCs 
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suggests that the effective connectivity, which measures the causal direction 
between brain regions, from the dACC to the supplementary motor area 
increases during a finger motor task compared to rest 392. Researchers have 
reported that lesion to the supplementary motor area and also ACC severely 
diminished voluntary movements in primates 393. These studies suggest that 
the dACC modulates the motor areas when movement is required. 
1.8 DORSAL ANTERIOR CINGULATE CORTEX IN AUTISM 
SPECTRUM DISORDER 
An increased functional response in the ACC has been associated with tasks 
which require greater executive control in NCs 26,334,394–397. In individuals with 
ASD, there has been evidence of altered brain function in the dACC (chapter 
1.8.1), suggesting that this region may be of interest in the disorder. We also 
present evidence of both altered function and functional connectivity of the 
dACC during inhibition tasks (chapter 1.8.2) and more specifically, the 
conflict effect task (chapter 1.8.3). 
1.8.1 Altered Function  
Several neuroimaging researchers have reported hypofunction of the dACC 
in association with individuals with ASD while at rest. Ohnishi and colleagues 
applied single-photon emission computed tomography (SPECT) to report 
reduced cerebral blood flow (CBF) in the left ACC in adolescents and young 
adults with ASD compared to NCs 398. A further arterial spin labelling study 




In adults, researchers applied positron emission tomography (PET) to report 
reduced glucose metabolism in the dACC during a verbal learning task in 
adults with ASD relative to NCs 400. Within the brain, there has been 
evidence that glucose metabolism is closely coupled to with Glu cycling 401–
403. A metanalysis of several cognitively-oriented but heterogeneous tasks 
suggested an overall hypoactivation of the dACC in individuals with ASD 
compared to NCs 404. Taken together, this evidence suggests hypofunction of 
the dACC in individuals with ASD both during cognitive tasks and at rest. 
Additionally, altered resting-state functional connectivity in association with 
the dACC in individuals with ASD may further predict an altered BOLD 
response when participating in an externally focused experimental task. 
Delmonte et al. (2013) reported increased resting-state functional 
connectivity between the dACC and striatum during a region-to-region seed-
based correlation analysis in individuals with ASD relative to NCs. Functional 
connectivity between the dACC and dorsal striatum was associated with 
hypoactivation of the dorsal striatum during a fMRI social rewards task in 
adolescents and young adults with ASD but not NCs 405,406.  
1.8.2 Altered Function and Functional Connectivity During Inhibition Tasks 
There has been evidence of altered function in the dACC during executive 
control inhibition tasks in individuals with ASD. The Cued Letter Go/No-Go 
Task is one example of an inhibition task. During this task, individuals are 
asked to press a button after each letter appears. During the inhibition 
condition, the participant is asked to inhibit a response to a particular letter. 
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During inhibition conditions relative to non-inhibition conditions, researchers 
have reported hypoactivation of the dACC in participants with ASD compared 
to NCs 407. Another group also reported hypoactivation in the dACC during a 
similar letter inhibition task in individuals with ASD relative to NCs 408. 
Although neither study reported performance differences during the inhibition 
task, the neuroimaging evidence suggests altered dACC function in 
individuals with ASD 407,408. 
Researchers also investigated an antisaccade inhibition task in individuals 
with ASD. During this inhibition task, the participant was asked to move their 
eyes away from a marker to the left or right of a screen (antisaccade 
condition) compared to moving their eyes toward the marker (baseline 
condition). Compared to NCs, adults with ASD had a reduced BOLD 
response in the dACC and frontal eye field during the antisaccade task 
compared to the baseline condition 409. Adults with ASD also made 
significantly more errors during the antisaccade task than NCs 30,409. 
Interestingly, increased antisaccade BOLD response in the dACC predicated 
improved performance and faster RTs during this inhibitory task in individuals 
with ASD only. Finally, researchers also reported reduced resting-state 
functional connectivity in individuals with ASD between both the right and left 
dACC and the left frontal eye fields 409. This evidence suggests that reduced 
BOLD activity in the dACC and further functional connectivity was associated 




1.8.3 Altered Function During the Flanker Conflict Task 
During the conflict effect task, researchers also reported hypoactivation of the 
dACC in individuals with ASD compared to NCs. Hypoactivation in the dACC 
during incongruent trials was positively correlated with ERs on the conflict 
effect task in adult participants with ASD 26. This evidence suggests that the 
altered dACC conflict effect task response was associated with higher ER in 
individuals with ASD compared to NCs (figure 1.6). 
 
Figure 1.6 Positive correlation between the conflict effect error rate and 
hypoactivation of the ACC in participants with autism spectrum disorder (Reproduced 
from Fan et al. (2012)) 
There was a significant correlation between conflict effect performance and BOLD response 
in the ACC in participants with ASD. In other words, participants had a reduced flanker 
conflict effect ER with greater BOLD response in the dACC during incongruent trials when 
compared to congruent trials. This relationship was not shown in NCs 
Another research group reported a similar result during a variation of the 
conflict effect task in which participants indicated the gaze direction of 
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people’s faces rather than arrow direction. Participants with ASD had 
reduced activation of the dACC during incongruent conditions compared to 
congruent gaze conditions. However, in contrast to the previous study, there 
were no group differences in performance 53. Both of these studies 
suggested altered function of the dACC in association with variations of the 
conflict effect task in individuals with ASD compared to NCs. 
We hypothesised that individuals with ASD would continue to have reduced 
conflict effect performance compared to NCs when completing the ANT 
outside of an MRI scanner. We were also interested in exploring if Glu and 
Glx concentrations in the dACC had any relationship to conflict effect 
performance in both NCs and individuals with ASD. 
1.9 GENERAL SUMMARY, HYPOTHESISE AND OVERVIEW 
To summarise, Glu is the most prominent excitatory neurotransmitter in the 
brain 133 and is a critical component of neural communication, plasticity and 
cortical maturity 225,410. Pathological alterations in Glu receptor signalling and 
cycling can be harmful to the brain, particularly during development 196–200. 
There has been evidence of altered Glu concentrations in both the brain 247 
and blood 211 of individuals with ASD. 
Researchers have applied 1H-MRS to report altered in vivo concentrations of 
both Glu and Glx in individuals with ASD, although the results of this 
research have been inconsistent 247. Variation in participant characteristics, 
1H-MRS methodology and region of interest (ROI) may partially contribute to 
conflicting results. There is also little understanding of how Glu or Glx 
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concentrations are associated with behaviour and brain function in individuals 
with ASD. 
In this thesis, we first applied a 1H-MRS sequence optimised to obtain in vivo 
Glu concentrations in the dACC to determine if high functioning adult 
participants with ASD have altered Glu concentrations compared to NCs. For 
comparisons both to Glu concentrations with this study and to other 1H-MRS 
investigations, we also assessed Glx concentrations in the dACC. Based on 
evidence of altered Glx 225,233,237 and Glu 217,230,231,237 concentrations in the 
ACC, we hypothesised that our sample of adult participants with ASD would 
also have altered (reduced or increased) Glu and Glx concentrations in the 
dACC. We also investigated the relationship between participant 
characteristics (age, IQ and Autistic Diagnostic Observation-Generic Module 
4 (ADOS) scores) and metabolite concentrations to determine if cohort 
characteristics might have contributed to the conflicting results in previous 
studies.   
Additionally, we investigated if metabolite concentrations might be associated 
with inhibition to distraction in ASD. Several neuroimaging studies have 
reported altered function of the dACC both at rest 398,399,411 and during a 
range of non-social cognitive tasks in individuals with ASD compared to NCs 
404, such as the conflict effect task 26. Hypoactivation of the dACC was also 
associated with reduced conflict effect performance in individuals with ASD 
26. Given that preliminary studies have reported an association between 
dACC Glu concentrations and inhibitory performance tasks in NCs 257,258, we 
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explored the relationship between Glu and Glx concentrations in the dACC 
and conflict effect performance in individuals with ASD compared to NCs. We 
hypothesised that altered Glu and Glx concentrations would be associated 
with reduced inhibitory performance on the conflict effect task in individuals 
with ASD.  
Finally, research has begun to demonstrate that Glu and Glx concentrations 
in the ACC are associated with functional connectivity to other brain regions 
in NCs 258,287. Abnormal excitatory processes in the dACC might impact the 
development, refinement and synchronization of the dACC with other brain 
regions. Therefore, we further investigated the relationship between Glu and 
Glx concentrations and dACC resting-state functional connectivity in 
participants with ASD compared to NCs. We hypothesised an altered 
relationship between metabolite concentrations and functional connectivity in 
individuals with ASD compared to NCs. In addition to highlighting an avenue 
for future research, the primary objectives of this study was to provide a more 
meaningful understanding of in-vivo Glu and Glx concentrations in 




















In both development and adulthood, maintenance of Glu in the brain is 
crucial for effective neuronal communication and cerebral health. As we 
discuss in chapter one, researchers applying 1H-MRS in individuals with ASD 
have reported altered Glu and Glx concentrations, but the results of these 
studies are contradictory 247. Therefore, further investigation of these 
metabolite concentrations is warranted. 
When reviewing 1H-MRS investigations of Glu or Glx concentrations in 
individuals with ASD, differences in scanning and post-processing 
methodology can influence the quality of metabolite concentrations 412,413.  
On the 1H-MRS spectrum, the Glu metabolic peak closely overlaps with Gln. 
Therefore, Glu is challenging to measure independently 230,243,414,415. Within 
this thesis, we were interested in investigating Glu concentrations in 
individuals with ASD. Therefore, we applied 1H-MRS parameters optimised to  
measure Glu concentration. An explanation of scanning parameters and 
post-processing methods is discussed in relation to this study goal (chapter 
2.4.3 and 2.4.4). 
Furthermore, to understand Glu concentrations in the brain in more detail, we 
investigated the relationship between participant demographics, core 
symptoms of the disorder, resistance to distraction inhibitory performance 
and functional connectivity in individuals with ASD compared to NCs. We 




To start, the ANT, which includes an inhibitory performance task, is 
presented (chapter 2.2). Next, a basic overview of MRI (chapter 2.3) and the 
various MRI sequences applied in this thesis are presented (chapter 2.4). 
Next, the metabolite concentrations measured and presented in this thesis 
are summarised (chapter 2.5). Then the specific methodology applied in this 
thesis is presented in full detail (chapter 2.6). The final section of this chapter 
includes demographic and clinical characteristics of participants within this 
investigation (chapter 2.7). The primary purpose of this chapter is to discuss 
and present the data collection methods applied in this thesis. 
2.2 ATTENTIONAL NETWORK TEST 
The ANT is a visuospatial behavioural assessment of attention. Throughout 
the ANT, the participant is asked to indicate the direction of a centre target 
arrow. There are three sub-tests to the ANT: the alerting, orienting and 
conflict effect. We previously presented the conflict effect (chapter 1.7.3), 
which is associated with decreased efficiency as measured by RT and ER in 
association with the addition of conflicting, incongruent flanker arrows 
361,365,416. In NCs, several investigations have reported both decreased RT and 
accuracy in association with incongruent flanker conditions compared to 
congruent flanker conditions 26,304,363,417. Successful completion of the 
incongruent trials of the conflict effect involves increased executive control to 
inhibit and resist non-target stimuli and motor priming 254,338,361,418,419. 
Although not a primary focus, the ANT also includes the alerting and 
orienting effect. Firstly, the alerting effect is the performance penalty 
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associated with a lack of a prior cue that a target is about to appear. It is 
thought to be a measure of internal vigilance to the task 26,363,417. Therefore, 
an altered alerting effect in ASD groups could indicate that participants were 
less vigilant during the task. The orienting effect is defined as the increased 
RT or error percentage associated with disengaging attention from a cue 
location and re-engaging attention to the target flanker location 26,363,417,420,421. 
The inclusion of these variables in the ANT permitted greater variation in 
stimuli types as would more typically happen in everyday life. The inclusion of 
other stimulus sub-conditions (alerting and orienting effect) and the random 
presentation limited obvious repetition between stimulus types during conflict 
effect trials.  
We included the conflict effect task as our primary behavioural measure 
mostly because of its functional association with the dACC. Again, several 
studies have reported an increased BOLD response in the dACC during 
incongruent flanker conditions compared to congruent conditions in NCs 
26,304. Researchers have also reported a decreased BOLD response in the 
dACC in adults with ASD. A decreased BOLD response in the dACC was 
also associated with reduced performance on the conflict effect task in 
individuals with ASD 26,304. Based on this research, we felt the task would be 






The primary advantage of this assessment was that we could administer the 
assessment by computer thus reducing social interactions in a clinical group 
with deficits in social behaviours and skills 422–424. Previous research has 
demonstrated that social interaction during various executive control tasks 
can impact the performance of individuals with ASD differently than NCs 
272,424,425. For example, one research group compared performance on a 
modified version of the conflict effect task under normal conditions compared 
to when participants were given the additional social motivation of being told 
they were competing against other children. Children with ASD had no 
improvement in performance between conditions while NCs had 
improvements with greater social motivation 272. Therefore, the ability to 
administer the ANT by computer limits social interaction and the potential 
variable impact of social motivation on performance in both groups. 
2.2.2 Disadvantages 
The primary disadvantage of the ANT is its monotony. Although it can be 
administered in less than twenty minutes, the assessment is repetitive and 
uninteresting. We stressed that each participant complete the test to the best 
of their abilities, but boredom may have impacted performance or compliance 
in some cases. In fact, 2 NCs and 2 participants with ASD were excluded 
because they did not complete incongruent flanker conditions at greater than 




2.3 MAGNETIC RESONANCE IMAGING 
2.3.1 Basic Principles  
Magnetic resonance imaging technology obtains information about tissue by 
exploiting its magnetic properties and is currently one of the most widely 
utilised tools to investigate the brain. Hydrogen protons inside water and fat 
are sensitive to magnetic fields and will align with a uniform superconducting 
magnet, initiating a net tissue magnet vector (B₀). When a radio frequency 
(RF) pulse at the resonance frequency of hydrogen nuclei is further applied, 
the net magnetic vector of hydrogen is redirected (B₁). When the RF pulse 
stops, hydrogen moves back into resting-state and emits a radio wave which 
is picked up by an RF receiver coil of the scanner 276,426. 
During an MRI scan, magnetic gradient coils also subject tissue to three 
orthogonal gradient magnetic fields, which slightly alter the resonance 
frequency of hydrogen at different locations. As hydrogen protons are only 
sensitive to an RF pulse at a specific resonance frequency, slightly altering 
the magnetic field by location allows MRI to localise signal and target 
particular sections of tissue during a scan 427,428. 
2.3.2 Advantages 
Most MRI sequences are non-invasive and in-vivo. Researchers can obtain 
an image of the brain without having to apply radioactive tracers, as is the 
case with PET 427,429,430. 
Magnetic resonance imaging can be utilised to investigate many parameters 
in the brain 427,429. The versatility of MRI technology was also an advantage 
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in this thesis. During a single scanning session, we were able to obtain an 
anatomic three-dimension magnetisation-prepared rapid gradient-echo (MP-
RAGE), resting-state echo planar image (EPI) and 1H-MRS sequence. Our 
multimodal imaging sequence permitted more detailed investigation of the 
relationships between measured parameters of the brain including structure, 
function and metabolite concentrations 431. 
2.3.3 Disadvantages 
Even with these advantages, MRI is not a perfect technology. Firstly, with 
current technological constraints, neuroscientists cannot investigate the brain 
at a microscopic or individual neuronal level. At 3 T, each voxel in an fMRI 
image is equivalent to about 10,000 neurones. Reduced precision limits the 
conclusions which can be made about the data 429. 
Furthermore, to obtain a quality MRI scan, a participant must lay inside a 
small cylinder without moving while the scanner makes a great deal of noise. 
The environment of an MRI scanner is far from natural and can elicit 
increased anxiety and claustrophobia in individuals, likely impacting brain 
function during an MRI scan 432,433. 
We tried to reduce participant stress associated with an MRI scan by 
explaining what to expect during the scan, listening to the sound of the 
machine, practising being in a mock scanner and discussing any of the 
participant's questions or concerns 434. These strategies did appear to 
improve the experience of participating in an MRI scan. Nevertheless, there 
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were some individuals who were unable to participate in this study due to 
claustrophobia (NC = 1, ASD =2). 
2.4 MAGNETIC RESONANCE IMAGING SEQUENCES 
We briefly introduce and highlight the various multimodal MRI techniques that 
were utilised. 
2.4.1 Structural Magnetic Resonance Imaging 
Magnetic resonance imaging technology is well suited to measure soft tissue 
and can differentiate between tissue types in the brain. It is used to generate 
pictures of brain anatomy. Various tissue types have different concentrations 
of water and fats and, therefore, different concentrations of hydrogen 
protons. For example, CSF, having greater proportions of water, has different 
intensities compared to grey matter (GM) and WM 427,429,430. 
2.4.2 Functional Magnetic Resonance Imaging 
The BOLD contrast neuroimaging method utilises MRI technology to 
measure variations in the magnetic qualities of blood oxygenation in the brain 
115,435,436. Blood with reduced concentrations of oxygen has increased 
magnetic qualities 437 leading to increased MRI signal distortion, faster signal 
decay and a slightly weaker signal. The percentage signal change is minimal 
(less than 2%) 429,435,438. Signal change is too small to be detected visually 
and requires statistical analysis software to reveal BOLD fluctuations 276,439. 
Functional MRI measures localised changes in magnetic properties which 
are considered an indirect measure of neuronal activity 440. 
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Fundamentally, fMRI is useful for investigating localised brain function, in 
which specific brain regions are associated with particular behaviours and 
cognitions 429. An fMRI scan measures the hemodynamic response (HR), 
which occurs in association with increased neuronal activity as evident 
through changes in the BOLD signal (figure 2.1). The HR is an 
overcompensation of CBF and oxygenated blood following both neuronal 
firing and oxygen consumption. The HR typically takes between six and nine 
seconds to reach a peak.  
 
Figure 2.1 The Hemodynamic Response (adapted from Astolfi et al. (2004)). 
Biological principles associated with the HR. When a neurone fires, it also consumes an 
increased amount of oxygen from local CBF (left). Increased energy consumption is 
following by a compensatory increase in CBF (right) and oxygen levels. The result is an 
increased proportion of oxygenated blood and a change in the BOLD signal. 
2.4.3 Proton Magnetic Resonance Spectroscopy 
Proton magnetic resonance spectroscopy harnesses MRI technology to non-
invasively quantify different molecular populations in a region of the brain 
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412,415,441,442 and is useful in providing in vivo biochemical information 412,415. 
In this thesis, we applied 1H-MRS as part of a multimodal imaging sequence 
to investigate Glu and Glx concentrations in the dACC. In the section, we 
present a brief technical background to 1H-MRS to lay the foundation for our 
1H-MRS protocol and analysis. 
To start, 1H-MRS indirectly quantifies and measures the concentrations of 
various molecules containing hydrogen 443. Electrons can slightly shift or alter 
the influence of an external magnetic field on hydrogen nuclei, which leads to 
a minor shift in its resonance frequency. Slight differences in resonance 
frequency due to the molecular environment of a molecule is known as the 
chemical shift or signature of a molecule 413. The various chemical signatures 
in a sampled brain region are classified and quantified within the 1H-MRS 
signal and have historically been expressed in parts per million (ppm) to the 
Larmor frequency of tetramethylsilane 413.  
In the brain, 1H-MRS is used to measure biochemical substances that are 
involved in metabolism and therefore, these substances are called 
metabolites. Given current technological constraints, 1H-MRS can only detect 
the chemical shift of metabolites in concentrations greater than .05 millimoles 
per litre of brain tissue (Mm) 413,444. At 3 T, 1H-MRS typically measures NAA 
and N-acetyl-aspartyl-glutamate (NAA+NAAG), creatine plus 
phosphocreatine (Cre), choline containing compounds (Cho; the combined 
signal of phosphorylcholine, glycerophosphorylcholine, acetylcholine and free 
choline), myo-inositol (mI) and Glx in the brain 412,414. Typically, the 1H-MRS 
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spectrum within the brain is between 0 and 4.2 ppm while water’s chemical 
signature appears at 4.7 ppm 412,414. 
2.4.4 Technical Considerations of Proton Magnetic Resonance 
Spectroscopy 
There is no standardised 1H-MRS scanning sequence or post-processing 
strategy because experimental criteria vary depending on technological 
limitations, the metabolite of interest and researcher expertise. 
Methodological variation needs to be considered when comparing studies 
and interpreting results 412,413.  
Structural or fMRI sequences measure water. In comparison, inhomogeneity 
in a 1H-MRS experiment is a greater constraint because the metabolites 
investigated exist in much lower concentrations and thus have a much 
weaker signal. Therefore, the signal to noise ratio (SNR) is much weaker 251 
and any increase in noise is a greater detriment.  
This disadvantage becomes even more problematic when measuring Glu 
concentrations 412,413, which closely overlap with metabolites such as Gln on 
the 1H-MRS spectrum. The goal of this section is to present data acquisition 
and post-scan processing methods which were applied in this study to 
facilitate the independent measurement of Glu concentrations within this 1H-





Software packages which process 1H-MRS data include the linear 
combination model (LCModel) 445 and the Magnetic Resonance User 
Interface (MRUI) 446. Both of the above spectral packages fit the raw spectra 
to a priori metabolite peak models which improve Glu and Gln isolation 
414,447
. 
In the analysis of Glu and Glx concentrations in individuals with ASD 
previous research has more often applied the LCModel to process raw 
spectroscopy data 225,226,228–232,236,237,240,241,243,246,443. Given the wide use of 
the LCModel and access to the software in our department, we also applied 
the LCModel to our 1H-MRS data to allow for improved isolation of Glu to 
Gln. 
2.4.4.2 Cramér-Rao low bounds 
Cramér-Rao lower bounds (CRLB) scores of variance are a commonly 
utilised metric of certainty in 1H-MRS experiments. A CRLB score quantifies 
how closely the measured metabolite fits with a priori metabolite peak models 
taking into account spectral resolution and noise. It is a useful metric to 
compare the validity of metabolite measurements compared to predicted 
models both between studies and groups444,445,448. 
The application of improved shimming methods during data collection is one 
method to improve CRLB scores. Shimming is defined as the addition of 
hardware or technical methods during scanning which improve homogeneity 
in the magnetic field. Shimming reduces noise and improves spectral 
resolution 449. It can be difficult to compare shimming methods between 
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studies as they are specific to the scanner model and often unreported. 
Nevertheless, CRLB scores are an indirect indicator of effective shimming 
techniques because shimming can greatly improve CRLB scores 450. 
A CRLB score below 20% has been suggested as a useful standard for 
metabolite inclusion 451. Although some single voxel spectroscopy studies did 
not report CRLB scores 217,238, most previously reported single voxel 
spectroscopy studies investigating Glu or Glx concentrations in individuals 
with ASD were all below or near the 20% CRLB cut-off 225,226,228–
231,237,240,241,243,245,246. Given this precedent, we also elected to include 
metabolite measurements with a CRLB below 20%.  
2.4.4.3 Increased Tesla Strength 
Another important moderator of Glu measurement with 1H-MRS is T strength. 
At 1.5 T, it is nearly impossible to differentiate the Glu chemical signal from 
Gln, Gamma-Aminobutyric acid (GABA) and glutathione because these 
metabolites have a similar chemical signature 232,251. In early 1H-MRS 
studies, which used 1.5 T scanners, research groups typically reported Glx 
225,232,233,235,236,238,242,244,245,452. Researchers considered Glx a good index of 
Glu concentrations 247,413,414 based on evidence that Glu accounts for 40-60% 
of the Glx metabolic peak 414,453. 
Of course, this interpretation of Glx has been problematic because it is 
unclear what proportions of the various metabolite concentrations contribute 
to the Glx peak. This becomes more problematic when comparing clinical 
groups to NCs. For example, one post-mortem study reported a reduced ratio 
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of Glu to Gln in individuals with ASD compared to NCs in the ACC 454 
suggesting that the relationship between these metabolites might be altered 
in this disorder. This highlights the importance of measuring Glu 
concentrations separately to Gln. 
Increasing the external magnetic field increases the magnitude of various 
chemical shifts leading to an increased chemical spread on a 1H-MRS 
spectrum and improvement in the SNR. Increasing the external magnetic 
field allows greater signal differentiation in closely coupled molecules like Glu 
and Gln 412,455–457. Tesla strength cannot be increased indefinitely, because 
increased magnetic strength also introduces greater field inhomogeneity 
450,458–460. Most 1H-MRS studies reporting Glu in individuals with ASD applied 
a magnetic strength of 3 T 226,237,243 or 4 T 230. In this experiment, we utilised 
a 3 T scanner to quantify Glu concentrations separate to Gln.  
2.4.4.4 Multi or Single Voxel Spectroscopy 
Spectroscopy studies also vary in the number of voxels investigated. Multi-
voxel spectroscopy further applies orthogonal magnetic gradients to obtain 
the chemical shift of several voxels (typically between 20 and 100) at various 
locations across the brain during the same scanning session 251,412. One 
advantage of multivoxel spectroscopy is a spatially diverse representation of 
metabolite concentrations. On the other hand, multivoxel spectroscopy 
increases magnetic inhomogeneity across the brain, resulting in reduced 
metabolite peak definition and variation in water suppression between voxels.  
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More practically, multivoxel spectroscopy greatly increases acquisition time 
413,427 leading to greater difficulties with head movement and participant 
compliance. For example, Doyle et al. (2014) reported that their multivoxel 
spectroscopy sequence was completed in 45 minutes. In comparison, our 
single voxel spectroscopy scanning sequence was completed in less than ten 
minutes. The researcher needs to consider participant compliance when 
selecting their 1H-MRS parameters 251. 
Single voxel spectroscopy applies 1H-MRS to a single voxel in the brain 412. 
Although limited spatially, single voxel spectroscopy is less constrained by 
magnetic field inhomogeneities and, therefore, typically obtains clearer 
metabolic peaks 413,427. Given the increased difficulty in obtaining Glu 
concentrations, it is little surprise that all other 1H-MS studies reporting Glu 
concentrations in individuals with ASD also applied single voxel spectroscopy 
217,226,230,237,243. To limit participant fatigue and also more accurately measure 
Glu concentrations, we applied single voxel spectroscopy within this study.  
2.4.4.5 Increased Voxel Size 
Increasing the voxel size investigated in a single voxel spectroscopy 
sequence can also improve the SNR 445,457,461 because the signal is 
proportional to the voxel size while noise remains constant 251. The voxel size 
in a 1H-MRS experiment is roughly a thousand times larger than a structural 
MRI voxel 412,462,463. On the other hand, the voxel size cannot be increased 
indefinitely because shimming techniques to improve SNR are less efficient 
over larger brain regions 251. 
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Most of the voxel sizes for single voxel spectroscopy Glu studies were 
between 6 and 9 cubic centimetres (cm3) 217,226,230,237,243. We elected to 
investigate a 30 x 20 x 15 mm (9 cm3) voxel, as this was in the range of most 
of the previous investigations. 
2.4.4.6 Pulse Sequence 
The type of pulse sequence also varied between previous 1H-MRS 
experiments. The two most common pulse sequences were point resolved 
spectroscopy (PRESS) 464 and stimulated echo acquisition mode (STEAM) 
465. In both sequences, there are three orthogonal slice selective pulses 
which intersect in three dimensions to select the VOI. The PRESS sequence 
applies one 90º and then two 180º pulses while steam has three 90º pulses. 
When comparing the two techniques, the PRESS sequence captures the full 
1H-MRS signal and therefore has an increased SNR relative to STEAM 
466,467. Nevertheless, STEAM permits shorter echo times (TE) than PRESS 
251. There has been evidence that the STEAM sequence can be used to 
obtain Glu concentrations 468. Nevertheless, as the PRESS sequence has 
been commonly utilised to measure Glu concentrations in individuals with 
ASD 217,226,228,230,231,237,241 and has been shown to capture more of the 1H-
MRS spectrum 466,467. Therefore, we elected to apply a PRESS sequence 
within our study. 
2.4.4.7 Relative or Absolute Metabolite Concentrations 
Many metabolite concentrations vary depending on GM, WM and CSF tissue 
type. Therefore, metabolite concentrations must be corrected for tissue 
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concentrations 412,469. Presenting metabolite concentrations as relative units 
is one method of correction. Relative concentrations are a quantified 
metabolite in proportion to another metabolite thought to be constant in but 
representative of tissue type. Typically investigators used Cre concentrations 
as a stable marker of tissue concentrations because previous research has 
reported that Cre is stable in adult NCs 247,251,413,470,471. 
From a practical perspective, relative ratios are a less technically complicated 
and labour intensive method of correcting for partial volume effects 472 and 
are therefore a much more common technique 413. Several single voxel 
spectroscopy investigations reported the relative ratio of Glx/Cre 238,245 and 
Glu/Cre 228,229 in the brains of individuals with ASD compared to NCs. 
On the other hand, relative ratios are less theoretically sound when 
comparing groups. Most published 1H-MRS investigations have not reported 
significant differences in Cre concentrations in individuals with ASD 
compared to NCs 247, including several 1H-MRS studies of the ACC/MFC 
225,233,237,473–475. Nevertheless, a handful of studies have reported altered Cre 
concentrations in adults with ASD compared to NCs in the hippocampal and 
amygdala complex 242,474,476,477 and ACC/MFC 477 suggesting some variations 
in Cre concentrations in association with the disorder 247. Therefore it is 
unclear if group differences in relative ratios were associated with the 
metabolite of interest or its proportion to the “stable” metabolite 413,478. 
In contrast, absolute quantification is a more theoretically sound method but 
requires increased scan acquisition time and more sophisticated post-
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processing techniques 413. One common strategy for absolute quantification 
is the acquisition of a 1H-MRS spectrum during data acquisition without water 
suppression which is applied during post-processing to correct for tissue 
concentration and possible variations in voxel size. In a single voxel 
spectroscopy experiment, the inclusion of a non-suppressed 1H-MRS voxel 
does not increase scanning time significantly 251,413,470. In our analysis, we 
acquired 16 averages of the water signal in less than one minute. Also, both 
a well-placed voxel 470,479 and directly correcting for CSF concentrations in 
the voxel will also correct for tissue variation between groups 480, and we 
included all of the above strategies in our analysis in reporting the absolute 
metabolite concentrations. 
2.4.4.8 Echo Time 
Furthermore, in the literature, reducing the time between a magnetic pulse 
and sampling in a 1H-MRS experiment, known as TE reduces T2-decay and 
therefore increases peak detail for metabolites with shorter relaxation times 
481 such as Glu 482–485. Therefore, the TE applied will vary with the metabolite 
of interest in a study. A longer TE (> 135 ms) produces a simpler 1H-MRS 
spectrum with a more defined baseline although it reduces metabolite 
information of less concentrated metabolites such as Glu 251,413. 
Previously reported studies investigating Glu at 3 T in individuals with ASD 
had a TE less than 35 milliseconds (ms) 217,226,228–231,237,241,243. Our 
investigation was the first to report Glu concentrations at a TE of 80 ms in 
individuals with ASD. Previous studies have suggested that shorter TEs have 
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been associated with an overestimation of Glu concentrations 482. 
Furthermore, previous research in a large number of participants has 
suggested that a TE of 80 ms was an optimal parameter to separate Glu from 
Gln in the ACC at 3 T in NCs 484. Other studies suggested a lower TE of 40 
ms was optimal 485,486. The optimal TE for determining Glu concentrations is 
still under investigation, but we elected to apply a slightly longer TE of 80 ms. 
2.4.4.9 Sedation 
Several studies sedated participants to increase compliance and reduce 
participant head movement 235,242,243. Moreover, two of these studies 
disproportionally applied sedation to participants with ASD compared to NCs 
235,242. Researchers investigating rodent brain slices demonstrated that 
sedatives such as propofol, thiopental and ketamine were associated with 
reduced Glu release 487. In humans, propofol administration was also 
associated with reductions in Glu concentrations as measured by 1H-MRS in 
the motor cortex, sensory cortex, hippocampus, thalamus and basal ganglia 
488. Given this evidence, 1H-MRS studies that investigated Glu/Glx 
concentrations in sedated participants are a useful first step in understanding 
Glu in ASD, but require replication in non-sedated participant populations. 
Beyond the obvious ethical considerations, this thesis chose not to 
administer sedatives because of the potential impact on Glu concentrations. 
We also tried to limit mild stimulants by instructing participants not to intake 




Variations in data collection, post-processing and interpretations greatly 
impact the value of a 1H-MRS study and must be taken into account in 
association with the Glu measurement 455. Magnetic resonance spectroscopy 
is still an immature MRI analysis method. One must also understanding the 
underlying principles of spectroscopy, various methods of analysis as well as 
the current limitations to fully appreciate an experiment 413. 
2.5 METABOLITES 
We briefly provide an overview of the metabolites investigated. 
2.5.1 Glutamate and Combined Glutamate and Glutamine  
We provided a detailed overview of Glu and Gln function previously (chapter 
1.3). Briefly, Glu is important for development, communication and neural 
plasticity. Regulation of extracellular Glu concentrations is critical for cerebral 
health. 
As we mentioned previously, the similar chemical structure between Glu and 
Gln result in a close overlap in  the respective signals from these metabolites 
on the 1H-MRS spectrum, 414. In NCs, Glu concentrations are quantified at 
2.34 ppm 414 and have concentrations between 6.0 and 12.5 Mm in the brain 
414. In contrast, Gln resonates at 2.45 ppm and exists in concentrations 
between 3 and 6 Mm in the brain 414,490. 
2.5.2 N-Acetyl-Aspartate 
N-acetyl-aspartate is synthesised in neurons and oligodendrocytes 470,491 and 
exists in large amounts in the brain 492,493. Following water and lipid 
suppression, NAA is the most dominant peak on the 1H-MRS brain spectrum 
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in healthy brain tissue. N-acetyl-aspartate has concentrations between 7.9 
and 16.6 Mm 414, resonates at 2.01 parts per million on the 1H-MRS spectrum 
413,441 and has similar concentrations in both GM and WM 248. Research 
suggests that NAA’s primary location in the mature brain is in the neuron 494–
497. Therefore, NAA is considered a marker of neuronal density and integrity 
247,251. 
2.5.3 N-acetyl-aspartyl-glutamate 
In contrast to NAA, NAAG is a neurotransmitter formed when NAA bonds 
with Glu 247,498. N-acetyl-aspartyl-glutamate might assist in communication 
between neurones and astrocytes 499. Although, research has also suggested 
that microglia can synthesise NAAG 500 suggesting some link outside of 
neurones and astrocytes. 
2.5.4 Quantifying N-Acetyl-Aspartate and N-Acetyl-Aspartyl-Glutamate 
Given a similar electron environment, NAA and NAAG are separated by .003 
ppm on the hydrogen chemical spectrum. It is virtually impossible to 
distinguish between these metabolites 441,501, although application of 
increased magnetic fields, faultless shimming or special editing techniques 
might allow differentiation 501,502. Given that we have not applied any of these 
strategies, we report both NAA and NAAG (NAA+NAAG) concentrations as 
recommended by the LCModel manual 451. In practice, NAAG only accounts 
for about 9% of NAA+NAAG concentrations in GM 501,502, although NAAG is 
more abundant in WM 248. Nevertheless, as we highlight previously, this limits 
the conclusions which we can make about our data. There has been 
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evidence of altered NAA concentrations in individuals with ASD compared to 
NCs, but this evidence has also been contradictory 247 
2.5.5 Creatine and Phosphocreatine 
As with NAA and NAAG, Cre signals overlap and are typically reported 
together 470. Cre is associated with additional energy reserves in the brain 
through adenosine triphosphate metabolism 247,248,470,491,503. Both neurones 
and glial cells contain Cre, but synthesis occurs outside of the brain 247,470. In 
1H-MRS, Cre resonates at both 3.03 and 3.93 ppm 247,470. Creatine and 
phosphocreatine have higher concentrations in GM than WM 248,442,491 and 
exist in concentrations around 5 to 10 Mm in the brain of NCs 414. 
Historically, Cre has been considered a constant metabolite in adulthood 
247,251,470. Nevertheless, there has been some evidence of altered Cre 
concentrations in children with ASD 235,242,474 and adult participants with ASD 
compared to NCs in various regions of the brain 226,232,236,477,504 including the 
ACC 505, suggesting that this metabolite may be impacted by disease 
processes of the disorder. 
2.5.6 Choline Containing Compounds 
Choline containing compounds (Cho) include phosphocholine and 
glycerophosphocholine. Cho concentrations are also associated with 
acetylcholine and free choline in the brain 247,470. Cho is associated with the 
creation and degradation of phospholipids, which are critical for cell 
membranes throughout the body 470,503,506. Changes in Cho concentrations 
have been interpreted as evidence of changes in phospholipids and 
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myelination 247,410,477,504,507,508. In adult participants, increased Cho 
concentrations have been associated with rapidly multiplying cancer cells in 
the brain in tumour patients 509,510. In an 1H-MRS experiment, Cho resonates 
at 3.2 ppm, and concentrations are typically between .9 and 2.5 Mm in the 
brain of NCs 247,414. Choline containing compounds have higher 
concentrations in WM because of Cho’s association with myelination 248,507. 
Children also have increased Cho concentrations as myelination within the 
brain is increased during development 511. 
Researchers have suggested that Cho concentrations might provide crucial 
biochemical information in association with tumour growth in the brain 509,510, 
but in adults with ASD, there has been little evidence of altered 
concentrations 247 in frontal 236, parietal 232,233,236,477 temporal 226,233 or the 
cerebellar lobe compared to NCs 237,504. Additionally, researchers reported no 
difference in Cho concentrations in the ACC 233,237,512. Nevertheless, there 
have been two adult studies reporting increased Cho concentrations in the 
hippocampus and amygdala complex 504 and the MPFC in individuals with 
ASD relative to NCs 477. 
2.5.7 Myo-inositol 
In the brain, mI is solely expressed in glial cells 503,513,513 and has been 
associated with water regulation 453,491,503,514. Some evidence suggests that 
mI might be associated with glial inflammation 503,515 and it is thought to be a 
marker of glial density and proliferation 248,470,470,503. The mI peak is located at 
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3.56 ppm 248,453,470 and concentrations are typically between 3 to 8 Mm in 
NCs 414. 
Most 1H-MRS studies also have reported no significant difference in mI 
concentrations in the brains of individuals with ASD 247 including those 
investigating the ACC/MFC 225,233,237. Nevertheless, one study in children with 
ASD reported increased mI concentrations in the ACC/MPFC compared to 
NCs 475. 
2.6 METHODS 
2.6.1 Study Population 
Participants with ASD were recruited both from psychiatrist referrals at the 
Royal Edinburgh Hospital and the “Number 6: One Stop Shop” for individuals 
with ASD, a regional ASD consultancy and psychiatric service in Edinburgh. 
Recruitment began in January 2013 and was completed in August 2014. 
Study exclusion criteria included being female, seizure in the previous 12 
months, a diagnosis of psychosis, schizophrenia, bipolar disorder or inability 
to safely participate in an MRI scan. In addition, we included only individuals 
with a total IQ above 80, because there has been evidence that reduced IQ 
in individuals with ASD compared to HC contributed to performance 
differences during inhibition tasks 358 (see chapter 1.7.3). Nevertheless, 
future studies would benefit from assessing individuals with lower IQ. 
Funding restricted our participant sample size and we, therefore, elected to 
investigate only adult participants. We investigated if metabolite 
concentrations and inhibitory performance differences occured in adult 
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participants with ASD compared to NCs. As we mentioned previously 
(chapter 1.4.2), most of the previous research in Glu and Glx metabolite 
concentrations in the ACC has focused on children and adolescents 247,358, 
and it is still unclear if metabolite abnormalities occur in adult participants 
with the disorder. Similarly, we investigated inhibitory resistance to distraction 
performance in adult participants with the disorder compared with NCs 
(chapter 1.7.3), which is also debated within the literature 27,358. We concede 
that it would have been beneficial to include children in this study to assess 
cross-sectional variation across the lifespan of the disorder and future studies 
with larger cohort sizes will hopefully investigate this further. 
During participant recruitment, we included a wide cross-section of age 
ranges to allow some analysis of how metabolite concentrations might vary 
from early to later adulthood in individuals with ASD compared to NCs. 
Nevertheless, the inclusion of such a large age range could also be 
considered a limitation of this study because it increased the variability in our 
participant sample. This limited the power of our analyses because we had to 
control for the impact of age in many group comparisons. 
Individuals with ASD were invited to participate if they had a clinical diagnosis 
of ASD from a multi-disciplinary assessment service for ASD in South East 
Scotland and were not known to have a learning disability. We recruited 25 
adult male participants between the ages of 23 and 53 with a diagnosis of 
high-functioning ASD. Before the final analysis, a further six participants with 
ASD were excluded because their total communication and social ADOS 
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(ADOS-G) scores were below seven, a criterion used to confirm a diagnosis 
of ASD. Following exclusion, we included a total of 19 participants with ASD 
in our statistical analysis. 
The NCs were contacts, associates and employees of the Psychiatry 
Department at the University of Edinburgh. In addition to previously outlined 
study exclusion criteria to those with ASD, NCs were als excluded if they had 
a personal history of ASD or a first-degree relative with a diagnosis of the 
disorder. We initially recruited 21 NCs between the ages of 24 and 58, but 
one NC withdrew consent from the study for personal reasons (NC = 20). 
The same participant population and recruitment procedure were used in all 
parts of this thesis, although some additional participants were excluded from 
analysis in subsequent chapters for various reasons (see chapter 3.2.1, 4.2.1 
and 5.2.1 for full details of participant exclusions for metabolite 
concentrations, ANT and resting-state functional connectivity analyses, 
respectively). For greater clarity and future reference, we present a chart 





Table 2.1 Exclusions and Final Participant Numbers For Each Thesis Chapter  
  Exclusion Reason Exclusion n Final n 
  ASD NC ASD NC Total 
Total Recruitment 
Numbers 
      25 21 46 
Chapter 2: Participants 
Included in Full Analysis 
 
ADOS-G < 7 6         
Withdrew Consent to 
Participant in Study 
  1 19 20 39 






  1       
Did not complete 1H-
MRS Scan 
  1       
Poor water 
suppression 
1   18 18 36 
Chapter 4: Attentional 
Network Test 
 
Do not complete 
Attentional Network 
Test 
  2       
Accuracy < 60 % 2 2 17 16 33 




Did not participate in 
resting-state MRI 
  2       
Scan lost   1       
Movement artefact > 
20% 
4   15 17 32 
The same recruitment procedure and participant sample were used throughout this thesis. In 
total, we obtained informed consent and collected data from 21 NCs and 25 individuals with 
ASD. At various parts of thesis analysis, participants were excluded for various reasons. We 
outline the reason for exclusion and final numbers for each analysis chapter within this 
thesis. For full detail of exclusions refer to chapter 2.6.1, 3.2.1, 4.2.1 and 5.2.1. 
ADOS-G, Combined social and communication score for the Autism Diagnostic Observation 
Schedule-Generic Module 4, ASD, autism spectrum disorder; IQ, intelligence quotient as 
measured by the Wechsler Abbreviated Scale of Intelligence; MRI, magnetic resonance 
imaging; NC, neurotypical controls 
 
2.6.2 Ethical Consent 
All participants in this study received written information regarding this study 
and gave written consent to participate. This study was approved by the 




2.6.3 Assessment Procedure 
Participants completed a battery of clinical and neuropsychological 
assessments including a background clinical and demographic assessment, 
the Wechsler Abbreviated Scale of Intelligence version III (WASI) and the 
ANT. A research health nurse or a doctoral student in the division of 
psychiatry administered psychometric assessments. A clinician or 
psychologist qualified in ADOS administration gave this assessment to all 
participants with ASD. Most of the participants completed all clinical and 
neuropsychological assessments on the same day. Assessment took 
between four and eight hours, depending on the speed with which the 
participant completed each assessment and took breaks. Participants were 
permitted to take as many breaks from the assessments as needed. Most 
participants completed a series of MRI imaging scans on a separate day to 
the psychometric assessments. Nevertheless, due to time constraints, one 
NC and one participant with ASD completed their psychometric assessments 
and MRI scan on the same day. All individuals with ASD were high-
functioning and able to attend the assessments independently without 
medical support or assistance from a guardian. 
2.6.4 Background Clinical and Demographic Information 
Each participant answered questions about their general demographic and 
clinical background. Background questions included employment, education, 




2.6.5 Clinical Assessment 
All individuals with ASD were given the Autistic Diagnostic Observation 
Schedule-Generic Module 4 (ADOS) to assess clinical symptoms of ASD as 
this module was designed for adults with this disorder. The ADOS is a semi-
structured assessment. The assessment measures observable symptoms of 
ASD made evident through conversation, practical tasks and questions by 
the interviewer 516,517. Following the assessment, the individual will receive 
two primary scores. Firstly, a communication score quantifies evidence of 
ASD related behaviours including language abnormalities or the use of 
gestures. Secondly, the social interaction score quantifies traits such as 
abnormal eye contact, facial expression, social reciprocity and empathy. The 
social and communication scores are added and known as the ADOS-G 
score. A score of seven or greater on the ADOS-G is the criterion for 
confirmation of ASD. Higher scores indicate more severe symptoms. The 
clinician will also give an imagination/creativity and stereotyped or repetitive 
behaviours scores when observed. The test takes around an hour to 
complete and allows direct observation of autistic behaviours in association 
with consistent semi-structured observation 517,518. 
The ADOS was designed to mirror a clinical diagnosis of ASD as defined by 
measures such as the DSM-IV 517, but the assessment is meant to be used in 
accordance with a clinical diagnosis. The ADOS diagnosis is solely based on 
observable behaviours at the time of assessment. Unlike the DSM-IV criteria, 
the ADOS does not consider developmental history. Therefore, the ADOS 
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must be supplemented with a clinical diagnosis of ASD taking into account 
information such as such as the age of onset 517,519. 
The combination of ADOS scores in supplement to a clinical diagnosis of 
ASD allows greater confidence that our participant group included individuals 
with ASD. The addition of the ADOS also permitted comparison to other 
previously published studies because the ADOS is a commonly presented 
metric in ASD cohorts. 
2.6.6 Neuropsychiatric Assessments 
The psychometric assessments applied were the WASI 520 (chapter 2.6.6.1) 
and ANT (chapter 2.6.6.2). 
2.6.6.1 Wechsler Abbreviated Scale of Intelligence 
The WASI is a standardised and quick measurement of IQ taking between 30 
and 90 minutes to compete. This assessment provides total, verbal and 
performance IQ scores which are modified based on the individual’s age 
521,522. The performance score is a nonverbal IQ measure 523. 
2.6.6.2 Attentional Network Test 
Apparatus 
The adult version of the ANT was downloaded from Jin Fan’s research 
webpage at www.sacklassays_and_tools/ant/jin.fan/erinstitute.org/cornell/ 
and saved to a Dell Inspiron laptop. The test was written in Java and run in a 
Windows environment. The ANT was completed on a laptop computer with a 
14-inch screen. The participant sat approximately 65 centimetres from the 




There were three main conditions of interest during the ANT: the alerting, 
orienting and conflict effect. The alerting effect quantified the performance 
deficit associated with a lack of external cue (no cue - double cue conditions). 
The orienting effect quantified the performance deficit associated with 
reorienting attention from non-target to target location (centre cue - spatial 
cue conditions). The conflict effect was a measure of the performance deficit 
associated with increased non-target conflict (incongruent flanker – 
congruent flanker conditions). Cue and flanker conditions are explained in 
detail in the next section. 
Stimuli 
Throughout the ANT, the goal was to indicate which direction the centre 
arrow was facing (left or right) by pressing the left or right arrow key. 
All stimuli were black and appeared against a grey background. The total 
time per trial was 4000 ms and included five consecutive events: central 
fixation cross, cue, short fixation period, target and post-target events (figure 
2.2). During the central fixation cross event, the fixation cross first appeared 
on a blank screen for between 400 and 1600 ms (labelled D1 in figure 2.2). 
The fixation continued to appear in the centre of the screen throughout the 
experiment, except for the centre cue condition in which the fixation cross 




Figure 2.2 Graphical Representation of Time Course of Attentional Network Test 
(adapted from Fan et al. (2002)). 
Visual time course of each trial in ANT. The visual time course moves left to right 
sequentially. D1 (first box on the left) is the central fixation cross condition which was 
followed by a cue, short fixation period, target and post-target events. The total time per trial 
was 4000 ms. 
Next, the cue event lasted 100 ms. During this event, one of the four cue 
conditions appeared: centre cue, no cue, double cue or spatial cue (figure 
2.3). The cue was always an asterisk. During the centre cue condition, an 
asterisk appeared over the fixation arrow. During the no cue condition, only 
the fixation cross remained on the screen. During the double cue condition, 
two arrows appeared above and below the fixation cross. During the spatial 
cue, an asterisk appeared above or below the fixation cross and always 
appeared in the same location as the upcoming target. Next, a short fixation 
event lasting 400 ms followed the cue event. This fixation period consisted of 




Figure 2.3 Graphical Representations of Cue Conditions for the Attentional Network 
Test (adapted from Fan et al. (2002)). 
Four equally presented cue conditions include (left to right) no cue, centre cue, double cue 
and spatial cue which were presented during the ANT. Spatial cues always appeared at the 
same location as the target arrow. 
During the target event, a series of arrows appeared on the screen. The 
target arrow could appear either above or below the fixation cross and was 
always the centre arrow. There were three flanker conditions: neutral, 
congruent and incongruent. During the neutral condition, a single arrow 
appeared without any flankers. During the congruent condition, two flankers 
appeared on either side of the target arrow and faced the same direction as 
the target arrow. During the incongruent condition, two incongruent flankers 
appeared on each side of the target arrow and pointed in the opposite 
direction of the target arrow (figure 2.4). Finally, there was a variable post-
target event which lasted 3500 ms minus the fixation and participant RT. 
Again, it consisted of a fixation cross on a blank screen. If the participant did 
not respond by the end of the trial, then the next trial would begin, and the 




Figure 2.4 Graphical Representations of Flanker Conditions for the Attentional 
Network Test (adapted from Fan et al. (2002)). 
Three equally presented flanker conditions which include (left to right) neutral flanker, 
congruent flanker and incongruent flanker. 
Test Instructions, Practice and Assessment Blocks 
At the start of the ANT, a participant was given an opportunity to read the 
written ANT instructions (figure 2.5). Each participant was instructed to 
indicate, with the left and the right arrow key, which direction the centre 
flanker was facing. Each participant received both verbal and written 





Figure 2.5 Test Instructions for the Attentional Network Test. 
The written instructions for the ANT appeared on the computer screen before the practice 
block. Comprehension of ANT written instructions required reading aptitude. Nevertheless, 
researchers confirmed that each participant understood the test requirements regardless of 
reading ability. Before the start of the practice test, ANT test administrators verbally 
reiterated the test instructions and answered any participant questions. Investigators also 
checked the accuracy of performance during the practice block. 
After reading the test instructions, a participant selected “Start practice” on 
the instruction screen with a laptop touchpad and then completed a block of 
24 practice trials. During the practice block, the experimenter supervised 
participant accuracy and assisted with any questions. Following each 
stimulus trial, either a black “NO RESPONSE”, black “CORRECT” or red 
“INCORRECT” appeared on screen, as applicable with each participant 
response. This provided feedback about the success of each trial. Except for 
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accuracy feedback for each response and a reduced trial number, the 
practice block was exactly the same as the test blocks. 
Following completion of the practice block, the participant started the 
assessment blocks by pushing the enter key on the keypad. At the start of 
the ANT test block, the experimenter moved away and did not disturb the 
participant unless the participant indicated that there was a problem. During 
the experiment, there were three experimental blocks which each consisted 
of 96 trials. During each experimental block, two trials of each cue condition, 
target location, target direction and flanker condition were presented in 
random order. Each block took approximately five minutes to complete. 
Participants were encouraged to rest between each practice and assessment 
block. 
Performance Calculations 
We calculated the M and SD for both RT and ERs for seven conditions of the 
ANT (four cue conditions plus three flanker conditions) for each individual. 
The RT calculation only included trials with correct responses because 
incorrect data points were likely associated with different cognitive 
processes. Any RTs greater than or equal to two standard deviations (SD) 
from the individual’s mean in each of the seven conditions were excluded 
from the condition means. This step was done to remove RTs that were not 
typical of the participant’s performance abilities. Including these trials might 
have skewed the results of the assessment. Error rates were the total 
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number of incorrect responses for each condition divided by the total number 
of trials for that condition multiplied by 100. 
We calculated the global RT by adding the RT for all seven conditions and 
dividing by seven. We calculated the global ER percentage by adding the 
total ER for each condition and dividing by 7. 
 Conditions were considered low cognitive demand because they had lower 
RT and ERs compared to the higher cognitive demand conditions in NCs 
26,304,363. We subtracted the RT mean and ER percentage of the low 
cognitively demanding conditions from the high cognitively demanding 
condition to obtain the alerting (no cue - double cue), orienting (centre cue - 
spatial cue) and conflict effect (incongruent flanker – congruent flanker) RT 
and ER. The conflict effect calculation did not include neutral target 
conditions. 
The formulas used to calculate ANT results in Fan et al. (2002) 363 varied 
slightly from those applied within this thesis . Firstly, Fan et al. (2002) did not 
report removing extreme scores from each of the seven. Secondly, they did 
not report global RTs or ERs. Finally, Fan and colleagues included a slightly 
altered neutral flanker condition in which the arrows lines appeared next to 
the centre arrow without an arrowhead 363. 
In this analysis, we also compare the results for individuals with ASD 
between the current study and Fan and colleagues (2012). Fan and 
colleagues (2012) did not include a centre cue condition but instead included 
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a valid and non-valid cue condition. During the valid condition, the cue 
appeared in the same place as the upcoming target. During the non-valid 
cue, the cue appears in the opposite position (either above or below the 
fixation) to the upcoming target. Differences in cue types slightly altered the 
calculation of the orienting effect. Nevertheless, the methodology for 
calculating the conflict effect has not changed between studies 26,363. 
2.6.7 Magnetic Resonance Imaging Acquisition 
Participants underwent all MRI scans at the Clinical Research Imaging 
Centre (CRIC) at the Queen’s Medical Research Institute (Edinburgh, 
Scotland, United Kingdom) on a Siemens 3 T whole-body MRI Verio scanner 
(Siemens Medical Systems, Erlangen, Germany) using the matrix head coil 
with 12 elements.  
Participants were not sedated or permitted to listen to music during the 
scanning sequence. Given the heightened anxiety often associated with 
being in a scanner, three participants with ASD underwent a practice MRI in 
a mock scanner before the actual MRI scan. As we previously mentioned, 
participants were asked to stop intake of nicotine, caffeine, alcohol or other 
non-legal drugs at least three hours before the MRI scan.  
During the entire scanning sequence, participants wore MR-compatible 
goggles. Participants wore headphones and earplugs to reduce scanner 
noise and minimise subject discomfort. During the anatomical MP-RAGE, 
resting-state EPI and 1H-MRS sequences participants looked at a blank 
screen. During all scans, participants were asked to attend to their breath or 
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the sound of the MRI scanner. During the resting-state fMRI scan, 
participants were instructed both before and immediately preceding the EPI 
acquisition to close their eyes. None of the participants included in the 
analysis had gross brain abnormalities. 
2.6.8 Magnetic Resonance Imaging Parameters 
2.6.8.1 Anatomical Three-Dimension Magnetization-Prepared Rapid 
Gradient-Echo (MP-RAGE) Sequence 
A localising scan identified the interhemispheric angle and the anterior 
commissure-posterior commissure (AC-PC) line. Next, a volumetric scan 
sequence applied a T1-weighted, MP-RAGE sequence to acquire 160 slices 
with a slice thickness of 1 mm (FOV = 256 x 256 mm², TR = 2300 ms, TE = 
2.98, T1 = 900 ms, flip angle = 9º). The full sequence took 5 min and 34 
seconds. 
2.6.8.2 Resting-State Echo Planar Sequence 
The resting-state fMRI data were obtained from a single-shot gradient EPI 
sequence (TR=1560 ms, TE=26 ms, TA=7.42 minutes, flip angle - 66 
degrees, 26 axial slices, voxel size = 3.4 x 3.4 x 4.0 mm, acquired with 
interleaved slice ordering, FoV = 220 X 220 mm) with 293 volumes acquired 
for each participant. The full scanning sequence took 7 minutes and 42 
seconds. 
2.6.8.3 Proton 1-Hydrogen Single Voxel Magnetic Resonance Spectroscopy 
Sequence 
Proton 1-Hydrogen Single Voxel Magnetic Resonance Spectra (PRESS – 
Point Resolved Spectroscopy; TR = 3000 ms, TE = 80 ms, 128 water un-
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suppressed averages, 16 water suppressed averages, 2048 data points, 
spectral width 2500 Hz., phase cycling set to Siemens 16 EXOR-cycle mode) 
were acquired in the dACC and were selected to optimise the measurement 
of Glu concentrations separate to Gln. The voxel was shimmed using 
Siemens advanced mode. These scanning parameters were optimal for the 
measurement of Glu concentrations 482–484. The dACC voxel measurements 
were 30 x 20 x 15 mm (9 cm³). The full sequence took 7 min and 36 seconds. 
Protocol for Selection of the Voxel of Interest 
The centre voxel was located at 3 (± 5), 18, 33 in MNI coordinates (figure 
2.6) and was equivalent to BA 32, although the voxel did have some overlap 
with BA 24 and 8. As part of a standard operating procedure, the coronal 
plane of the voxel was first set at 15 mm posterior to the genu of the corpus 
callosum. Next, the axial plane was assigned to the interhemispheric fissure. 
The sagittal slice was then defined as the anterior edge of the corpus 
callosum and centred on GM. Finally, the horizontal plane of the VOI was 
manually adjusted to follow the contour of the corpus callosum and based on 
individual differences so that the final voxel contained mostly GM and 





Figure 2.6 Centre Voxel Placement for Proton Magnetic Resonance Spectroscopy 
Sequence. 
The crosshairs represent the centre of our dACC voxel for the 
1
H-MRS sequence in the 
sagittal (left), axial (centre) and coronal plane (right), located at 3 (± 5), 18, 33 in MNI 
coordinates. The final voxel was manually positioned to following to contour of the corpus 
callosum in the transverse plane. The voxel size was 15 x 30 x 20 mm (9 cm³). 
2.7 DEMOGRAPHIC CHARECTORISTICS 
We present some the basic demographic details and compare individuals 
with ASD to NCs below on age (chapter 2.7.1), IQ (chapter 2.7.2), education 
(chapter 2.7.3) and employment status (chapter 2.7.4). We also present the 
ADOS diagnostic scores for participants with ASD (chapter 2.7.5). During 
age and IQ group comparisons, if the data complied with the assumptions of 
a parametric test, we applied an independent samples t-test to compare 
these demographic variables for each group. If the data violated the 
assumptions of normality and we were unable to transform the data, we then 
applied the appropriate non-parametric test to compare groups. The data for 
education and employment status were categorical, and we, therefore, 






We compared NCs (M = 37.85, SD = 11.14, range = 24-58) and individuals 
with ASD (M = 37.68, SD = 9.26, range = 23 - 53) to determine if there were 
differences in age between groups. The age data did not comply with the 
assumptions of an independent samples t-test as the standardised residuals 
for age in the NC group were positively skewed and were not normally 
distributed according to the Shapiro-Wilk’s test (p = .015). 
Transformation failed to correct for non-normality, and therefore, a non-
parametric Mann Whitney U test was used to determine if there were 
differences in ages between groups. The distributions of age appeared 
slightly dissimilar. Nevertheless, age for NCs (mean rank = 19.92) and 
individuals with ASD (Mean rank = 20.08) were not significantly different (U = 
188.50, z = -.04, p = .967) using an exact sampling distribution for U (table 
2.1). 
2.7.2 Intelligence 
All participants in this study had a total IQ above 80 (NC: M = 120.33, SD = 
12.00, range = 93 - 139; ASD: M = 115.95, SD = 12.90, range = 87 – 136). 
One participant did not complete the WASI IQ test and we substituted the 
mean IQ for all NCs for this individual. 
Performance (NC: M = 120.31, SD = 11.43, range = 97 - 134; ASD: M = 
115.21, SD = 16.04, range = 76 - 138) and verbal IQ (NC: M = 115.95, SD = 
12.14, range = 86 - 135; ASD: M = 113.21, SD = 10.20, range = 89 - 129) 
were also compared separately between groups. There were no significant 
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differences between groups for total IQ (t(37) = 1.10, p = .279) and verbal IQ 
(t(37) = .76, p = .451) (table 2.1). 
For performance IQ, standardised residuals for the full model (p = .018) and 
the NC group (p = .030) were not normally distributed according to Shapiro-
Wilk's test. Therefore, we performed a reflect and square root transformation 
to correct for moderate negative skewing in performance scores which has 
the effect of reversing the scores and reducing their distribution. There were 
no significant differences between groups on the transformed performance 
IQ scores (t(37) = -.89, p = .378) (table 2.1). 
2.7.3 Education 
Participants were divided into tertiary, which was defined as those that had 
any attendance at university (NC = 17, ASD = 12) and high school, which 
was defined as those that attended high school only (NC = 3, ASD = 7). Cells 
sizes for NCs only attending high school were less than five. Therefore, we 
were unable to run a chi-square test. Instead, a Fisher’s exact test compared 
education level between groups. There was no statistically significant 
association between groups and education (p = .155) (table 2.1). 
2.7.4 Employment Status 
A chi-square test assessed group differences in employment rates 
(percentage of sample employed: NC = 90.00%; ASD = 42.11%). A chi-
square test for association was conducted between group and employment 
status. All cell frequencies were greater than five. NCs were significantly 
more likely to be associated with employment than participants with ASD 
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(χ2(1) = 7.64, p = .006) (table 2.2). Other studies support reduced 
employment and education rates in participants with ASD 4,524. Reduced 
participation may be related to symptoms of the disorder. For example, 
participants with ASD were less likely to be hired for a job due to 
communication problems made evident during the interview 525,526. Our 
sample size was not large enough to explore these relationships further. 
Table 2.2 Demographic Group Comparisons Between Neurotypical Controls and 
Individuals with Autism Spectrum Disorder 
 
NC Mean (SD) ASD Mean (SD) statistic p 
 
n =20 n =19 
  
Mean Age in Years 37.85 (11.14) 37.68 (9.26) U = 188.50, z = -.04 .967 
Percentage Attended 
Tertiary Education 1 
85.00 %  63.16 %  NA .155 
Percentage Employed 
2 
90.00 % 42.11% χ
2
 (1)= 7.64 .006 
Total IQ 120.33 (12.00) 115.95 (12.90) t(37)= 1.10 0.279 
Performance IQ 120.31 (11.43) 115.21 (16.04) t(37) = -.89 378 
Verbal IQ 115.95 (12.14) 113.21 (10.20) t(37) = .76 .451 
Participant numbers (n), mean and standard deviation (SD) and group comparisons of 
demographic information for NCs and individuals with ASD. Unless otherwise noted there 
were 20 NCs and 19 individuals with ASD included in the group comparisons. There was no 
significant difference between groups for age or IQ. Furthermore, there was no significant 
difference in the number of participants that had attended tertiary education between 
groups. Compared to individuals with ASD, NCs were more likely to be employed as 
compared to being a student or unemployed. Significant results are bolded. Significance 
reported at p < .05 level.  
1 Group comparisons included NC = 17, ASD = 12 
2 Group comparisons included NC = 18, ASD = 8 
ASD, autism spectrum disorder; IQ, intelligence quotient as measured by the Wechsler 
Abbreviated Scale of Intelligence; NA, not applicable; NC, neurotypical controls. 
 
2.7.5 Autism Diagnostic Observation Schedule 
All individuals with ASD including in this analysis had an ADOS-G score 
greater than or equal to seven (ADOS-G: M = 9.58, SD = 3.2, range = 7 – 18; 
communication: M = 3.32, SD = 1.22, range = 2 – 16; social: M = 6.16, SD = 
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2.41, range = 3 – 12). Individuals with ASD in this study scored low on 
imagination (M = .84, SD = .77, range = 0 – 2) and stereotyped behaviours 
(M = .84, SD = .96, range = 0 – 3) (table 2.3). 
Table 2.3 Autism Diagnostic Observation Schedule 
Scores for Individuals with Autism Spectrum Disorder 
(n=19) 
 Mean (SD) Range 
ADOS-G 9.58 (3.2) 7 - 18 
Communication 3.32 (1.22) 2 - 6 
Social 6.16 (2.41) 3 -12 
Imagination .84 (.77) 0 -2 
Stereotyped Behaviours .84 (.96) 0 -3 
Mean, standard deviation (SD) and range of scores for ADOS 
scores for participants with ASD. 
ADOS, Autism Diagnostic Observation Schedule; ADOS-G, 
combined social and communication scores for ADOS; ASD; 
autism spectrum disorder 
 
2.8  CONCLUSION 
In this chapter, we reviewed the various demographic, clinical, psychometric 
and neuroimaging measures which were investigated in association with Glu 
or Glx concentrations. The objective of this chapter was to highlight technical 
and theoretical considerations of the applied methodology as well as clearly 
detail study methodology in relation to participant recruitment and data 
collection. In the next chapter, we will present our measurement of Glu and 













The ACC has been one of the most investigated brain regions for Glu or Glx 
concentrations in individuals with ASD. Nevertheless, this research has been 
contradictory (chapter 1.4.2). We utilised 1H-MRS applied at a single voxel in 
the dACC to quantify both Glu and Glx concentrations to compare metabolite 
concentrations in a group of high functioning adults with ASD to NCs. We 
hypothesised that we would report altered (increased or decreased) Glu 
concentrations in individuals with ASD based on previous evidence of altered 
ACC Glu and Glx concentrations in adults with ASD 
237
. We also explored the 
relationships between demographics and core symptoms of the disorder to 
add further context to previously contradictory Glu and Glx studies in 
individuals with ASD compared to NCs. 
We also report NAA + NAAG, Cre, Cho and mI concentrations, which were 
secondary to our focus. Briefly, research suggests that NAA concentrations 
are associated with neural integrity and vitality 527–532. We reported NAA + 
NAAG because these metabolites have closely overlapping signal peaks 
441,501. Previous research regarding NAA has also been contradictory with 
several studies reporting reduced 237,533 or increased 225,512 or no difference 
233,242,474,475 in the ACC of adult participants with ASD compared to NCs.  
There has been less evidence of group differences in Cre, Cho and mI 
concentrations in the ACC of individuals with ASD (chapter 2.5). Therefore, 
we did not expect to find group differences in these metabolite concentrations 
but reported them to provide further reference and comparison to other 
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studies. Briefly, Cre is considered a stable marker of energy metabolism 247 
and Cho is thought to quantify membrane density and function of all cells in 
the brain 470. Finally, mI is thought to be a marker of glial density 503. 
Within this chapter we also included post-hoc investigations which assessed 
group differences in metabolite concentrations when excluding individuals 
taking psychotropic medications. We excluded these participants because 
there has been evidence that psychotropic medication moderated Glu and 
Glx concentrations in the human and rodent brains 534–542. For example, one 
research group reported that the administration of Fluvoxamine, a serotonin 
reuptake inhibitor, increased Glu release in depressed mice 543. The 
administration of psychotropic medications might lessen clear group 
differences in Glu or Glx concentrations. Ideally, it might have been beneficial 
to fully exclude participants taking psychotropic medications. Nevertheless, 
prior to participant recruitment, we felt it would be too difficult to exclude 
participants because of the wide use of these psychotropic medications in 
individuals with ASD. 
The dACC is integral to many cognitive processes 303, has a high density of 
glutamatergic receptors 544–546 and has altered function in participants with 
ASD compared to NCs 26,30,400,408,547–551. To our knowledge, this is the first 
study to investigate Glu concentrations specifically in the dACC for adult 
participants with ASD. This chapter will lay the foundations for further 
investigation into the relationship between Glu and Glx concentrations and 





The recruitment procedure was previously reported in chapter 2.6.1 and 
2.6.2. There were 20 NCs and 19 individuals with ASD included in the 
statistical analysis for this thesis. For the 1H-MRS analysis, a further three 
participants were excluded. The wrong single voxel spectroscopy sequence 
was applied to one NC during their scanning session, while another NC did 
not participate in an MRI scan. Furthermore, investigators excluded one 
individual with ASD due to evidence of poor water suppression which called 
into question the validity of this individual’s results. Following these 
exclusions, there were 36 total participants included in single voxel 
spectroscopy analysis (NC = 18, ASD = 18) for all NAA, Cre and Cho 
metabolite concentrations. 
From individuals with ASD, five participants were taking psychotropic 
medications, three were taking antidepressants only, and one was taking 
anticonvulsants only and one taking antidepressants and anticonvulsants. 
None of the participants had a reported history of seizure in the previous 12 
months. No NCs reported taking psychotropic medications. Therefore, there 
were 31 participants not taking psychotropic medication at the time of 
scanning (18 = NC, ASD = 13). Some participants also reported taking other 
medications including statins (NC = 1, ASD = 1), antibiotics (ASD = 1), 




Additionally, metabolite concentrations were excluded from this analysis if 
they had a CRLB value greater than or equal to 20%, which was a reliability 
guideline suggested for LCModel output 445,451. Therefore, investigators 
excluded participants from Glu (ASD = 2), Glx (ASD = 3) and mI (ASD = 1) 
concentrations analysis. Additionally, one NC was excluded from both Glu 
and Glx analysis because these metabolite concentrations were greater than 
three SDs from the mean. Following these exclusions, there was 33 
participants included in the Glu (17 = NC, 16 = ASD), 32 in the Glx analysis 
(17 = NC, 15 = ASD) and 35 in the mI analyses (18 = NC, 17 = ASD). 
3.2.2 Demographic, Clinical and Psychometric Data Collection 
The assessment procedure for background, demographic, clinical and 
neuropsychiatric assessment procedure were presented in chapter 2.6.3. 
Briefly, investigators collected age and current medications from all 
participants in this study. All participants completed the WASI from which full-
scale IQ was obtained  and presented in chapter 2.6.6.1. The background, 
clinical and demographic information were outlined in chapter 2.6.4. Finally, 
all participants with ASD completed the ADOS and scores were obtained as 
presented in chapter 2.6.5. 
3.2.3 Magnetic Resonance Imaging Data Collection 
The protocol for data acquisition of the anatomic MP-RAGE and single voxel 
1H-MRS sequences were reported in chapter 2.6.7. Acquisition parameters 
for the MP-RAGE and 1H-MRS were previously reported in chapter 2.6.8.1 
and 2.6.8.3, respectively. 
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3.2.4  Neuroimaging Data Processing 
3.2.4.1 Voxel Based Morphometry 
We segmented whole brain T1-weighted volumetric images into GM, WM 
and CSF maps in SPM8 (Statistical Parametric Mapping: The Wellcome 
Department of Cognitive Neurology, Institute of Neurology, London, UK, 
http://www.filion.ucl.ac.uk/spm/software/spm8) for the matrix laboratory 
(MATLAB version 2015b, the Mathworks Inc., Natick, MA, 2015). 
The processing steps for MP-RAGE images included: (1) inspection of 
scanner artefacts and gross anatomical abnormalities in volumetric scans (2) 
resetting the image origin to the anterior commissure (3) segmenting rigid 
body aligned GM, WM and CSF for each subject using the “New Segment” 
procedure in SPM8. 
3.2.4.2 Metabolite Quantification 
We fed raw proton spectra into the LCModel graphical user interface which 
automatically analyses proton spectra based on a standard basis set of 1H-
MRS metabolite peaks. The hydrogen proton spectra were also processed 
using both eddy current correction and internal water scaling. Water scaling 
contrasts the unsuppressed water signal intensity in the basis set and the 
sample with assumed tissue water concentrations 451. The LCModel analysis 
output metabolite concentrations and CRLB scores for NAA+ NAAG, Cho, 
Cre, Glu, Glx and mI. An example of the spectra output from this experiment 
is shown in figure 3.1 
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3.2.4.3 Calculation of Grey Matter, White Matter and Cerebral Spinal Fluid 
Concentrations in Reconstructed Single Voxel Spectroscopy Voxel 
We firstly reconstructed the single voxel spectroscopy voxel. The location of 
the original voxel acquired during the hydrogen proton single voxel 
spectroscopy sequence was reported in chapter 2.6.8.3. The centre of the 
single voxel spectroscopy voxel was identified through visual comparison of 
the three tag 1H-MRS files, which indicated the centre of the voxel, and the 
previously bias corrected, aligned T1 image. We drew a rectangular VOI 
around the centre voxel in the MarsBar toolbox 552. Each side of the VOI was 
dilated slightly by 1 mm to account for selection error (3.2 x 2.2 x 1.7 cm or 
11.96 cm³). The reconstructed voxel was then tilted in sagittal view in ImageJ 
version 1.48 553 to follow the contour of the corpus callosum as was done 
with the original voxel. The newly tilted voxel was then imported back into 
Marsbar and visually checked to confirm the correct location of the voxel with 
no overlap with the corpus callosum. Finally, GM, WM and CSF maps 
obtained during the “New Segment” procedure in SPM8 were applied to the 
reconstructed voxel to calculate the percentage GM, WM and CSF volume. 
3.2.4.4 Partial Volume Correction 
All metabolite values were further corrected for CSF content using the 
following formula: 
C = C0 * (1 / 1 - FCSF)  
C = Partial volume correction 
C0 = uncorrected metabolite concentration 
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F = fractional content of CSF in the ROI 
3.2.5 Statistical Analysis 
Investigators conducted all statistical analyses on SPSS 22.0 (SPSS, 
Chicago, Il, U.S.A.). During correlational analysis, we applied a Pearson’s 
correlation when the data complied with the assumptions of this parametric 
test. In all other cases, we applied a non-parametric Spearman’s rank-order 
correlation. During group comparisons, if the data complied with the 
assumptions of a parametric test, we applied the appropriate parametric test. 
If the data violated these assumptions, we attempted appropriate 
transformations so that the data complied with the assumptions of a 
statistical test and then re-ran the parametric test on the transformed data. 
When a transformation failed to correct for violations of the assumptions of a 
parametric test, we substituted the group comparison with the appropriate 
non-parametric test. Unless otherwise noted, significance was reported at 
uncorrected p < .05. 
3.2.5.1 Basic Demographic Group Comparisons 
Firstly, investigators compared participant groups on age and total IQ with 
independent samples t-tests. A more detailed explanation of participant 
demographics for all participants and clinical analysis for individuals with 
ASD compared to NCs is available in chapter 2.7. 
3.2.5.2 Correlations between Metabolite Concentrations and Autism 
Diagnostic Observation Schedule Scores 
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To investigate the relationship between metabolite concentrations and 
symptoms of the disorder, we also reported the correlation between Glu, Glx 
and NAA + NAAG concentrations and ADOS social and communication 
scores. We did not examine the relationship between imagination and 
stereotyped behaviour ADOS scores because most participants in our 
sample scored 0 on these sub-sections (chapter 2.7.5). Also, only individuals 
with ASD completed the ADOS and therefore, correlations between 
metabolites and ADOS scores were only possible for individuals with ASD. 
3.2.5.3 Cramér-Rao Lower Bounds Standard Deviation Scores Group 
Comparisons 
Next, we compared the CRLB SD scores for each metabolite between 
groups using the appropriate independent samples t-test or a non-parametric 
Mann Whitney U test. 
3.2.5.4 Group Comparisons in Grey Matter, White Matter, Cerebral Spinal 
Fluid Percentages and Metabolite Concentrations 
As a first step, investigators assessed if age or IQ correlated with tissue 
volume (GM, WM or CSF percentage) or metabolite concentrations (Glu, Glx, 
NAA + NAAG, Cho, mI and Cre). The purpose of this analysis was to identify 
potential confounding variables which also influenced metabolite 
concentrations. We wished to include these covariates even if it was weakly 
associated with metabolite concentration. Therefore, we did not correct for 
multiple comparisons and set the significance level at uncorrected p < .05. If 
there was a significant or trend correlation, age or IQ were included as 
covariates in group tissue volume or metabolite concentration comparisons 
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between groups through an analysis of covariance (ANCOVA) or non-
parametric Quade’s rank analysis of Covariance. 
When inclusion of a covariate was justified, we firstly checked for an 
interaction between covariate and group. If the interaction was not significant, 
the interaction was not included as a predictor in group comparisons. When a 
covariate was not justified, we compared tissue and metabolite 
concentrations between groups with independent samples t-tests. 
3.2.5.5 Post-Hoc Correlations between Metabolite Concentrations by Group 
The data for Glu, Glx and NAA + NAAG concentrations appeared to be 
moving in similar directions with age. Therefore, we also investigated the 
correlations between the primary metabolites of interest, NAA + NAAG and 
both Glu and Glx concentrations in each group. 
3.2.5.6 Post-Hoc Group Comparisons in Metabolite Group Comparisons 
Excluding Participants Taking Psychotropic Medications 
To check that group differences were not confounded by psychotropic 
medication, we compared Glu, Glx and NAA + NAAG, concentrations 
between groups excluding participants taking antidepressant and 
anticonvulsant medication. These individuals were referred to as 
“psychotropic medication free” or PMF. 
3.2.5.7 Corrections for multiple comparisons 
For group metabolite concentrations comparisons and further post-hoc 
analysis, we also considered if results remained significant when correcting 
for multiple comparisons with Bonferroni correction. In total, there were 16 
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group comparisons which should meet a corrected p-value < .003 to remain 
significant when correcting for multiple comparisons. 
3.3 RESULTS 
3.3.1 Example of Spectra Output  
We present LCModel spectra from two participants in this study in figure 3.1. 





Figure 3.1 Proton Magnetic Resonance Spectra Output from the LCModel for 
Anonymous Neurotypical Control and Individual with Autism Spectrum Disorder 
Proton magnetic resonance spectroscopy at 3 T as fit by the LCModel 
445,451
 from 
anonymous NC (top) and individual with ASD in this study (bottom). The three major peak 
metabolite landmarks are located at 3.22 for Cho, 3.03 for Cre and 2.0 for NAA. Glu is 
located at 2.3 ppm. 
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3.3.2 Basic Demographic Group Comparisons 
The age range for individuals included in the metabolite concentrations 
analysis were similar (NC: M = 37.67, SD = 11.08, range in years = 24 – 58; 
ASD: M = 37.28, SD = 9.35, range = 23 - 53). The standardised residuals for 
age in NCs were non-normally distributed and positively skewed (Shapiro-
Wilk’s test, p = .023), and we applied a logarithmic transformation to allow 
the data to comply with the assumptions of normality. Following 
transformation, there were no significant differences between groups in age (t 
(34) = .05, p = .962). 
We compared groups on total IQ with independent samples t-test (NC: M = 
121.58, SD = 11.98, range= 93-139; ASD M = 115.78, SD = 13.26, range = 
87 – 136). There were no significant difference between groups on total IQ 
scores (t (34) = 1.38, p = .177). 
3.3.3 Correlation Between Metabolite Concentrations and Autism Diagnostic 
Observation Schedule 
We did not report any significant association between Glu concentrations and 
total (rp(16) = .24, p = .381), social (rp(16) = .33, p = .211) or communication 
(rp(16) = -.03, p = .906) ADOS scores. We did not report any significant 
association between Glx concentrations and total (rp(15) = .21, p = .443), 
social (rp (15) = .30, p = .274) or communication (rp(15) = -.04, p = .886) 
ADOS scores. NAA + NAAG concentrations were non-normally distributed 
for individuals with ASD (Shapiro-Wilk p = .028) and, therefore, we applied a 
Spearman’s rank order correlation for all ADOS correlations with this 
metabolite. There were no significant correlations between NAA + NAAG and 
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total (rs(18) = .37, p = .135), social (rs(18) = .20, p = .417) or communication 
(rs(15) = .26, p = .297) ADOS scores. 
3.3.4 Group Comparisons of Cramér-Rao Lower Bounds Standard 
Deviation Values 
When comparing CRLB values for Glu concentrations and Glx concentrations 
between groups, the standardized residuals for the full participants group for 
Glu (Sharpo-Wilk = .045) and Glx (Sharpo-Wilk = .027) were non-normally 
distributed. A logarithmic transformation was applied to correct for positive 
skewing of Glu CRLB scores. Following transformation, there were no 
significant differences between groups for Glu CRLB scores (NC: M = 9.23, 
SD = 2.51, range= 6 - 15; ASD M = 10.25, SD = 3.04, range = 6 – 18; t(31)= -
1.06, p = .299). Researchers applied a square root transformation to correct 
for moderate positive skewing in the Glx CRLB values and following 
transformation there were no significant differences between groups (NC: M 
= 9.94, SD = 2.80, range= 6 - 15; ASD M = 10.93, SD = 3.17, range = 6 – 17; 
t(30)= -.94, p = .355). 
When comparing CRLB values by group, we were unable to correct non-
normality of standardized residuals by transforming the data for the full 
sample for NAA+NAAG (Sharpo-Wilk = .000), Cho (Sharpo-Wilk = .000) and 
Cre concentrations (Sharpo-Wilk = .000). Therefore we applied a Mann-
Whitney U non-parametric test to determine if there were differences in 
median CRLB scores between individuals with ASD and NCs. The CRLB 
percentage distributions for NAA+NAAG concentrations were similar and the 
median engagement scores were not significantly different between groups 
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(NC: M = 2.16, SD = .38, range=2 -3, Median = 2.0; ASD M = 2.44, SD = 
1.25, range = 2 – 7, Median = 2.0; U = 165, z = .146, p = .938). The 
distributions of CRLB scores for Cho concentrations were similar and the 
median scores were not significantly different between groups (NC: M = 3.61, 
SD = .61, range= 3 – 5, Median = 4.0; ASD M = 3.94, SD = 1.86, range = 3 – 
11, Median = 3.5; U = 159, z = -.106, p = .938). The distributions of Cre 
concentrations CRLB scores were similar and the median scores were not 
significantly different between groups (NC: M = 2.83, SD = .51, range= 2 - 4, 
Median = 3.0; ASD M = 3.39, SD = 1.33, range = 6 -19, Median = 3.0; U = 
131.50, z = .128, p = .901). 
Finally, there were no significant differences between groups for CRLB 
values between groups for mI (NC: M = 8.27, SD = 1.53, range= 6 - 11; ASD 
M = 8.76; SD = 1.63, range = 5 - 11; t(31)= -1.13, p = .269). The CRLB 
mean, SD, range and group comparisons for each metabolite are also 




Table 3.1 Cramér-Rao Lower Bounds Standard Deviation Percentages for Neurotypical 
Controls and Individuals with Autism Spectrum Disorder 
 NC ASD   
Metabolite n Mean % (SD) 
Range 
% 
n Mean % (SD) Range statistic p 
Glu 
2
















18 2.16 (.38) 2 -3 18 2.44 (1.25) 2 -7 
U = 165, 




 18 3.61 (.61) 3 - 5 18 3.94 (1.86) 3 -11 
U = 159, 




 18 2.83 (.51) 2 - 4 18 3.39 (1.33) 6 -19 
U = 
131.50, 
z = .128  
.901 




Participant numbers, mean, standard deviation (SD) and range CRLB percentages for non-
transformed metabolite concentrations for NCs and participants with ASD. All CRLB values 
greater than or equal to 20 were excluded from this analysis. Significance reported at 
uncorrected p < .05 level. 
1
 Non-parametric Mann-Whitney U non-parametric test applied as data did not comply with 
assumptions of a parametric test. 
2
 Data transformation applied to comply with assumptions of independent samples t-test. 
ASD, autism spectrum disorder; Cho, choline containing compounds; Cre, creatine plus 
phosphocreatine; Glu, glutamate; Glx, glutamate and glutamine; mI, myo-inositol; NAA + 
NAAG, N-acetyl-aspartate and N-acetyl-aspartyl-glutamate; NC, neurotypical controls. 
 
3.3.5 Group Comparisons In Grey Matter, White Matter and Cerebral Spinal 
Fluid Percentages in Reconstructed Voxel 
There was a significant correlation between age and GM (rp(36) = -.39, p = 
.019) and CSF (rp(36) = .52, p = .001) percentages in reconstructed dACC 
voxel. As age increased, GM decreased and CSF increased. There were no 
other significant associations between age or IQ and tissue percentages. 
Therefore, when comparing groups for tissue volume percentages, we 
included age as a covariate for GM and CSF percentages. 
Next, we compared tissue volume percentages in the reconstructed dACC 
voxel between groups. After adjustment for age, there were no significant 
differences between groups for GM tissue percentage (NC: M = 61.75%, SD 
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= 4.79%, range= 52.36 – 68.52%; ASD M = 62.26%, SD = 3.94%, range = 
55.57 – 68.10 %; F(1,33) = .10, p = .750). Age was a significant predictor of 
GM tissue percentage (F(1,33) = 5.90, p = .021). There were no significant 
differences in WM (NC: M = 21.87%, SD = 4.05%, range= 14.17 – 29.40%; 
ASD M = 22.21%, SD = 4.74%, range = 15.60 – 30.57 %; t (34) = .23, p = 
.817) between groups. 
Finally, when controlling for age, the standardized residuals for CSF 
percentages for the full group (Shapiro-Wilk p = .021) and NCs (Shapiro-Wilk 
p = .008) were positively skewed and non-normally distributed. We applied a 
logarithmic transformation to CSF percentages to correct for non-normality. 
Following transformation of CSF percentages, there were no significant 
differences between groups for CSF percentages (NC: M = 16.38%, SD = 
4.26%, range= 10.03 – 23.66%; ASD M = 15.53%, SD = 3.74%, range = 9.36 
– 30.57 %; F(1,33) = .35, p = .561). Age was a significant predictor of CSF 
concentrations (F(1,33) = .11.77, p = .002). The mean, SD, range and group 




Table 3.2 Grey Matter, White Matter and Cerebral Spinal Fluid Percentages in 
Reconstructed Dorsal Anterior Cingulate Voxel for Neurotypical Controls (n = 18) and 





NC Range % 
ASD Mean % 
(SD) 













14.17 – 29.40 22.21 (4.74) 15.60 – 30.57 
t(34) = 
















The GM, WM and CSF non-transformed tissue percentages, SD and range for NCs and 
individuals with ASD. There were no significant differences in tissue concentrations in the 
reconstructed voxel in the dACC . Significance was reported at p < .05 level. Group 
comparisons for GM and CSF were corrected for age.  
1
A logarithmic transformation was applied to CSF percentage in single voxel spectroscopy 
voxel to correct for non-normality in data for group comparisons. 
ASD, autism spectrum disorder; NC, neurotypical controls.
 
 
3.3.6 Correlation Between Metabolite Concentrations and Age and 
Intelligence 
Next, we applied the Pearson’s product-moment correlation to investigate if 
age and IQ correlated with metabolite concentrations across all participants 
when the data were normally distributed. For the full sample, the data for 
NAA+NAAG (Sharpo-Wilk p < .001) and IQ (Sharpo-Wilk p = .029) were non-
normally distributed, and a non-parametric Spearman's rank order correlation 
was used in substitute of the Pearson’s product-moment correlation for 
comparisons involving these variables. 
There was no significant correlation between IQ and any metabolite 
concentration (p > .05). Across all participants, age was negatively correlated 
with several metabolite concentrations including NAA + NAAG (rs = -.46, p = 
.005) and Glu (rp= -.40, p = .022). There were also weak trend correlations 
between age and Glx (rp = -.30, p = .098) and Cho (rp= -29, p = .092). The 
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correlations between age, IQ and metabolite concentrations are also 
presented in table 3.3. 
Table 3.3 Correlation between Metabolite Concentrations and Both Age and 
Intelligence Quotient for All Participants 
 
 Age IQ 
 
n r p = r p = 




 .17 .357 




 .27 .139 
NAA + NAAG 36 -.46 .005 .04 .830 




 .07 .705 




 .02 .919 
mI 35 .14 .421 
1
 -.01 .974 
Correlation between age, IQ and metabolite concentrations. Investigators applied the 
Spearman’s rank-order correlation unless otherwise noted. The IQ score was obtained from 
the Wechsler Abbreviated Scale of Intelligence. Significance reported at uncorrected p < .05 
level.  
1
 Pearson’s correlation applied 
Cho, choline containing compounds; Cre, creatine plus phosphocreatine; Glu, glutamate; 




Age was included as a covariate in group comparisons for Glu, Glx, NAA + 
NAAG and Cho concentrations given a significant or trend correlation.  
3.3.7 Group Comparisons in Metabolite Concentrations 
When comparing Glu concentrations between groups (table 3.4), the 
assumption of homogeneity of variances was violated, as assessed by 
Levene’s test for equality of variance (p = .033). We were unable to transform 
the data in a way that corrected for this heterogeneity. Therefore, we applied 
a non-parametric Quade’s rank analysis of covariance 554 to investigate if the 
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distribution of rank for Glu concentrations differed between groups when 
accounting for age. We found no significant group differences (NC: M = 8.87, 
SD = .81, range= 7.49 -10.37; ASD M = 8.31, SD = 1.58, range = 5.61 – 
10.84; F(1,31) = . 90, p = .349). A scatterplot of the relationship between Glu 
concentrations and age by is presented in figure 3.2. 
 
Figure 3.2 Glutamate Concentrations by Age for Neurotypical Controls (n = 17) and 
Participants with ASD (n = 16) 
Scatterplot of the relationship between age and Glu concentrations for NCs and individuals 
with ASD. 
Individuals with ASD had a trend reductions in Glx concentrations (NC: M = 
10.42, SD = .79, range= 9.20 – 11.80; ASD M = 9.55, SD = 1.79, range = 
5.83 – 12.50; F(1,29)=4.06, p=.053) compared to NCs. Age also was a trend 
predictor of Glx concentrations (F(1,29)=3.71, p=.064). There was no 


















scatterplot of the relationship between Glx concentrations and age by group 
is presented in figure 3.3. 
 
Figure 3.3 Glutamate and Glutamine Concentrations by Age for Neurotypical Controls 
(n = 17) and Participants with ASD (n = 15) 
The association between age and Glx concentrations in both individuals with ASD and NCs 
is presented in the above scatterplot. Age was only a trend predictor of Glx concentrations. 
Next, a reflect and square root transformation was applied to NAA + NAAG 
concentrations to correct for moderate negative skewing and non-normally 
distributed residuals for participants with ASD (Sharpo Wilk p =.005). For 
NAA + NAAG, age was a significant predictor (F(1,33) = 10.33, p =.003) 
while there was a trend difference between groups (NC: M = 11.95, SD = 
1.04, range= 9.91 -13.89; ASD M = 11.07, SD = 1.89, range = 6.24 -12.80; 
F(1,33) = 4.08, p =.052). We present a scatterplot of the relationship between 




















Figure 3.4 N-Acetyl-Aspartate and N-Acetyl-Aspartyl-Glutamate Concentrations by 
Age for Neurotypical Controls (n = 18) and Participants with ASD (n = 18) 
The relationship between age and NAA + NAAG is presented in the scatterplot for NCs and 
individuals with ASD. Age was significantly associated with reduced NAA + NAAG 
concentrations in both individuals with ASD and NCs. 
There were no significant differences in Cho concentrations between groups 
(NC: M = 1.89, SD = .25, range= 1.43 – 2.34; ASD M = 2.00, SD = .34, range 
= 1.49 – 2.53; F(1,33)=1.17, p=.286). Age was also not a significant predictor 
of Cho concentrations (F(1,33)=2.95, p=.095). There were no significant 
differences in Cre between groups (NC: M = 7.54, SD = .56, range= 6.74 – 
8.35; ASD M = 7.47, SD = .91, range = 5.29 – 8.87; t (34) = .09, p=.770). 
 For mI concentrations, a reflect and square root transformation was applied 
to correct for moderate negative skewing and non-normally distributed 
residuals for the entire group (Sharpiro-Wilk p =.034) and individuals with 
ASD (Sharpiro-Wilk p =.034). For the transformed mI concentrations, there 



























1.12, range= 4.21 – 8.62; ASD M = 6.63, SD = 1.52, range = 3.83 – 8.28; 
t(1,33) = .11, p=.743). 
In conclusion, there were no significant differences between groups at 
uncorrected (p < .05) for metabolite concentrations or the more conservative 
Bonferroni-corrections for multiple comparisons (p < .003). 
Table 3.4 Mean Metabolite Concentrations for Neurotypical Controls and Participants 
with Autism Spectrum Disorder 
 NC ASD  
Metabolite n Mean (SD) Range n Mean (SD) Range statistic p 
Glu 
1
 17 8.87 (.81) 
7.49 – 
10.37 
16 8.31 (1.58) 
5.61 – 
10.84 
F(1,31) = .90 .349 
Glx 17 10.42 (.79) 
9.20 – 
11.80 





















Cho 18 1.89 (.25) 
1.43 – 
2.34 




Cr 18 7.54 (.56) 
6.74 – 
8.35 
18 7.47 (.91) 
5.29 – 
8.87 
t(34) = .09 .770 
mI 
2
 18 6.84 (1.12) 
4.21 – 
8.62 
17 6.63 (1.52) 
3.83 – 
8.28 
t(33) = .11 .743 
Non-transformed means and standard deviations for metabolite concentrations in NCs and 
individuals with ASD. We report all metabolite values less than 20 CRLB. Significance 
reported at uncorrected p < .05 level.  
1
 Non-parametric Quade’s rank analysis of Covariance applied as data did not comply with 
assumptions of a parametric test. 
2
 Data transformed to comply with assumptions of a parametric test. 
ASD, autism spectrum disorder; Cho, choline containing compounds; Cre, creatine plus 
phosphocreatine; Glu, glutamate; Glx, glutamate and glutamine; mI, myo-inositol; NAA + 
NAAG, N-acetyl-aspartate and N-acetyl-aspartyl-glutamate; NC, neurotypical controls. 
 
3.3.8 Post-Hoc Correlations Between Metabolite Concentrations by Group 
We also investigated the relationship correlation between NAA + NAAG 
concentrations and both Glu and Glx in each group (table 3.5). The data for 
NAA + NAAG concentrations was non-normal. Therefore, non-parametric 
Spearman’s rank correlations were used. For NCs, there was a positive 
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significant relationship between NAA + NAAG and Glu concentrations (rs(17) 
= .58,p= .014). There was no significant relationship between NAA + NAAG 
and Glx concentrations (rs(17) = .12,p= .639). 
For individuals with ASD, there was also a significant positive relationship 
between NAA + NAAG concentrations and Glu concentrations (rs(16) = 
.70, p = .002) and also Glx (rs(15) = .55,p= .032). 
Bonferroni adjusted alpha levels of p < .003 were also considered. Following 
this adjustment, only the correlation between NAA + NAAG and Glu 
concentrations in individuals with ASD survived this correction for multiple 
comparisons. 
Table 3.5 Correlation Between Metabolites for Neurotypical Controls and Participants 
with Autism Spectrum Disorder 
Metabolite x Metabolite NC ASD 
NAA + NAAG x Glu rs(17) = .58, p = .014 rs(16) = .70, p = .002  
NAA + NAAG x Glx rs(17) = .12, p = .639 rs(15) = .55, p = .032  
Spearman correlations between Glu, Glx and NAA + NAAG concentrations by group 
Individuals with ASD had a significant correlation between NAA + NAAG concentrations and 
both Glu and Glx. In contrast, NCs only had a significant relationship between NAA + NAAG 
and Glut. Unadjusted significance values are reported at p < .05. Bonferroni adjusted p-
values are significant at p < .003.  
ASD, autism spectrum disorder; Glu, Glutamate; Glx, glutamate and glutamine; NAA + 
NAAG, N-acetyl-aspartate and N-acetyl-aspartyl-glutamate; NC, neurotypical controls. 
 
3.3.9 Post-Hoc Group Comparisons in Metabolite Concentrations In 
Psychotropic Medication Free Participants Only 
For PMF participants, age was a significant predictor of Glu concentrations, 
(F(1,26) = 7.99, p =.009) while group was not (NC: M = 8.87, SD = .81, 
range= 7.49 – 10.37; ASD M = 8.41, SD = 1.53, range = 5.62 10.84; F(1,26) 
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= 2.48, p = .127). For Glx concentrations, there was a significant interaction 
between age and group (NC: M = 10.42, SD = .80, range= 9.20 – 11.80; ASD 
M = 9.58, SD = 1.54, range = 7.08 – 12.50; F(1,24) = 4.58, p = .043). 
For NAA + NAAG concentrations, a reflected and square root transformation 
was applied to correct for heterogeneity of variance (Levene’s test p = .045). 
Following transformation, both group (NC: M = 11.95, SD = 1.04, range= 
9.91 – 13.89; ASD M = 10.90, SD = 2.14, range = 6.24 – 12.80; F(1,28) = 
5.19, p = .031,) and age (F(1,28) = 10.20, p = .003) were significant 
predictors of NAA+NAAG concentrations. None of the group comparisons 
survived Bonferroni correction for multiple comparisons (p < .003). The 
mean, SD and range of these metabolite concentrations for PMF participants 
are presented in table 3.6. 
Table 3.6 Metabolite Concentrations for Neurotypical Controls and Individuals with 




NC Mean (SD) Range 
ASD 
n 
ASD Mean (SD) Range 
Glu 17 8.87 (.81) 
7.49 – 
10.37 
12 8.41 (1.53) 
5.62 – 
10.84 
Glx 17 10.42 (.80) 
9.20 – 
11.80 





18 11.95 (1.04) 
9.91 – 
13.89 
13 10.90 (2.14) 
6.24 – 
12.80 
Metabolite concentrations for non-transformed means, standard deviations (SD) and range 
for NCs and participants with ASD not currently taking psychotropic medications. We report 
all metabolite values with a CRLB less than 20%. Significance reported at uncorrected p < 
.05 level. 
ASD, autism spectrum disorder; Glu, glutamate, Glx, glutamate and glutamine; NAA + 






Our primary goal in this chapter was to investigate group differences in Glu 
and Glx concentrations in the dACC between groups. We also investigated 
the relationship between metabolite concentrations and the core symptoms 
of ASD. We review the results for Glu (chapter 3.4.1), Glx (3.4.2) and NAA + 
NAAG concentrations (3.4.3). 
We discuss results which did not survive correction for multiple comparisons 
and it is important not to overemphasize these findings. We made many 
group comparisons in a small cohort of inividuals. We cannot rule out the the 
possiblity that uncorrected significant group differences were false positive 
findings (type I error) and due to chance. Therefore, these results are a good 
starting point but our findings require further replication in a larger cohort of 
individuals with ASD.  
3.4.1 Glutamate 
Increased or decreased Glu concentrations did not differentiate individuals 
with high functioning ASD from NCs in both the full group and reduced PMF 
group. Moreover, ADOS scores did not have a significant correlation with 
metabolite concentrations (Glu, Glx or NAA + NAAG) in individuals with ASD, 
suggesting that metabolite concentrations were not altered in association 
with the disorder. 
In contrast to these results, Tebartz van Elst and colleagues reported 
reduced Glu concentrations in the pACC in adults with ASD compared to 
NCs 237. The scan acquisition, methodology and participant characteristics 
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were similar between the Tebartz van Elst study and this investigation. For 
example, both studies used a 3 T MRI scanner to investigate Glu 
concentrations. They also investigated a group of high functioning individuals 
with ASD with an average age around 35 (Tebartz Van Elst Mean age: NC: 
M = 35.79, SD = 8.5; ASD:  M = 35.31, SD =  9.1). Given the similarities 
between studies, one possible explanation for contradictory results was that 
Glu concentrations were altered in the pACC but not the dACC in individuals 
with ASD. 
Nevertheless, we did report that age significantly correlated with Glu 
concentrations in both groups. As a participant aged, there was a reduction in 
Glu concentration in the dACC. In agreement, other studies have reported 
reductions with age in Glu concentrations in other brain regions, such as the 
motor cortex in NC participants 555. 
Tebartz van Elst and colleagues matched groups on age, but they did not 
control for age during group comparisons. Investigators also had slightly 
increased statistical power with an increased sample size (Tebartz Van Elst 
Group size: NC = 29, ASD = 29). In our study, a scatterplot of the relationship 
between age and Glu concentrations suggested a sharper reduction with age 
in individuals with ASD compared to NCs (figure 3.2), but the statistical 
analysis did not support such a conclusion. Nevertheless, given contradictory 
results between studies, further investigation of how age is associated with 




3.4.2 Glutamate and Glutamine Concentrations 
In the full participant group, we reported no significant difference in Glx 
concentrations between groups. Nevertheless, in the PMF participants, 
researchers reported an interaction between age and group for Glx 
concentrations. Again, this result did not survive correction for multiple 
comparisons but weakly suggests that individuals with ASD and PMF have 
greater reductions in Glx concentrations with age.   
It may be that Gln concentrations are atypical rather than Glu concentrations 
in individuals with ASD. Cochran and colleagues reported significantly 
increased Gln concentrations but not Glu concentrations in the pACC of 
adolescents with ASD compared to NCS 241.In ACC post-mortem tissue, 
investigators reported a reduction in kidney-type glutaminase, which has 
been associated with converting Glu to Gln 454. Given this evidence, it may 
be useful to investigate Gln in more detail. 
Interestingly, we also reported an uncorrected correlation between NAA + 
NAAG and Glx concentrations only in individuals with ASD. Our analysis 
cannot determine if one of these metabolites might be driving the other. 
Reductions in neural integrity or density, as measured by NAA + NAAG, were 
associated with reduced quantities of neurones which lead to reductions in 
Glx concentrations. Of course, cross sectional differences in metabolite 
concentrations with age could also be associated with differences in 
therapeutic interventions between generations rather than loss of neural 
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function over time. Replication of this result is required both in a larger cohort 
but also in a longitudinal study. 
Two previous studies have reported no differences in Glx concentrations in 
both the dACC 556 and pACC 239. Libero et al. (2015) (age NC: M = 24.9, SD 
= 1.13; ASD: M  = 26.8, SD = 1.35) and Aoki et al. (2012) (age NC: M = 29.5, 
SD = 6.2; ASD M = 29.5, SD =6.9) included younger participants than those 
in this investigation. In comparison, Tebartz van Elst et al. (2014) reported 
reductions in Glx concentrations in older participants 237. Given that we report 
an interaction between Glx concentrations and age in PMF participants, this 
may partially explain the differences between these studies. 
It is unclear why we did not find an interaction between age and group for Glx 
concentrations in the full sample of participants. One possibility was that 
psychotropic medications might have moderated Glu or Glx concentrations in 
the brain, as some studies have suggested 534–536,557. Therefore, psychotropic 
medications resulted in a less clear relationship between age and group. As 
we mentioned earlier in this discussion, we had a small sample size, and 
these associations would be more clearly investigated with a larger sample of 
participants.  
3.4.3 N-Acetyl-Aspartate and N-Acetyl-Aspartyl-Glutamate 
The results for NAA + NAAG were not our primary focus, but we discuss 
these results here briefly. In both the full group and PMF group, age was a 
significant predictor of NAA+NAAG concentrations. One cross-sectional 
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study reported NAA age-related reductions of around 12% in the medial 
frontal lobe between 20 to 70 years of age in NCs 558. Therefore, age-related 
reductions in NAA concentrations might be evident in broad age ranges of 
NCs and individuals with ASD. 
Tebartz and colleagues reported a reduction in NAA concentrations in a 
group of participants in an older age range in the pACC 237. We reported no 
significant group differences in the full sample, but a significant reduction in 
PMF individuals with ASD for NAA + NAAG concentrations compared to NCs 
when controlling for the impact of age. 
Unlike Glx, our investigation did not report a significant interaction between 
age and NAA + NAAG concentrations between groups. Nevertheless, these 
relationships require more investigation. Cross-sectional studies have also 
suggested some variation in the trajectory of NAA concentrations in the 
amygdala-hippocampal region 559 and in the pACC 252 with age in individuals 
with ASD compared to NCs. 
3.5  CONCLUSION 
Contrary to our original hypothesis, our data did not support altered Glu 
concentrations in individuals with ASD. Instead, in PMF participants, there 
was weak evidence of greater reductions in Glx concentrations in adult 
participants with age compared to NCs. The data weakly suggest disease-
specific variation in Glx metabolites with age and a more detailed 
understanding of these relationships will be useful in designing treatment 
interventions throughout the lifespan of individuals with this disorder. 
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 Unfortunately, the strength of our conclusions were limited by a small 
sample size and these associations must be replicated in a larger study. 
None of our group metabolite comparisons survived correction for multiple 
comparisons. 
Nevertheless, age-related reductions in metabolite concentrations in this 
study stress the importance of investigating older participants with ASD. To 
date, ASD studies have mostly focused on early development and prevention 
in children and adolescents with this disorder 560. Older participants have 
differing and potentially more significant needs than younger participants with 
ASD 560,561. Furthermore, longitudinal research in older participants might 












In this chapter, we focus on the conflict effect task, which is thought to 
measure the speed and accuracy of inhibiting interference from distracting 
stimuli not relevant to a task goal 26,338,361,363. Our primary motivation for 
using the conflict effect task was the close functional association to the 
dACC, a focus of this thesis. Greater incongruency and visual dominance of 
incongruent flanker arrows surrounding a target arrow have been associated 
with an increased BOLD response in the dACC in NCs 26,304,328. 
Although the conflict effect has also been associated with other brain regions 
such as the supplementary motor area, DLPFC and VLPFC in NCs 26,304, 
researchers have specifically reported hypoactivation of the dACC in 
association with the conflict effect task in individuals with ASD. This evidence 
suggests that the conflict effect task might be a simple behavioural measure 
of altered function in the dACC in individuals with ASD compared to NCs. 
Researchers also reported that conflict effect accuracy was associated with 
impairments in language and communication scores 26 as defined by the 
Autism Diagnostic Interview-Revised 218. This association suggested that 
performance on this task might be associated with core behaviours of the 
disorder. 
Although there has been considerable evidence of altered Glu and Glx 
concentrations in the dACC 237,247. There has been little understanding of 
how altered metabolite concentrations might be associated with behaviour. 
Investigators have reported that Glu concentrations in the dACC have a 
133 
 
direct correlation to behavioural measures of impulsivity in NCs 257,258. In this 
analysis, we explore if Glu and Glx metabolite concentrations in the dACC 
might be associated with inhibition to distraction as quantified by the conflict 
effect. 
The conflict effect is part of the ANT (chapter 2.2), an assessment of various 
forms of attentional processes. Although not a primary focus, the ANT also 
measures the alerting and orienting effect. The alerting effect is thought to 
measure internal vigilance 26,363,417,420,421. The orienting effect quantifies an 
individual’s ability to disengage attention from a cue location and reengaging 
attention at the target arrow location 26,363,417,420,421. As a first step, we 
expected to replicate evidence of the alerting, orienting and conflict effect 
performance deficit across participants in this study. In contrast to Fan and 
colleagues 26, this experiment was completed outside of an MRI scanner to 
determine if participants with ASD continued to exhibit consistent conflict 
effect performance deficit when in a quiet laboratory environment. 
Researchers have also reported a relationship between age and 
performance on the conflict effect task 562,563 and have suggested that older 
individuals were more susceptible to interference from non-target flankers 
562,564. In contrast, although other executive control tasks, such as working 
memory tasks have been associated with IQ, there is less evidence that 
inhibition tasks are related to IQ in NCs 565. Nevertheless, lower IQ in 
individuals with ASD compared to NCs might contribute to executive control 
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differences between these groups 566,567. Therefore, this investigation 
assessed the relationship between ANT performance and both age and IQ. 
In conclusion, the primary objective was to investigate group performance 
differences on the conflict effect task and the relationship to metabolite 
concentrations. We hypothesised that conflict effect performance might index 
altered dACC brain function in individuals with ASD. 
4.2  METHODS 
4.2.1 Study Populations 
The recruitment procedure (chapter 2.6.1) and ethical consent (chapter 2.6.2) 
have previously been reported in chapter 2. We report the additional 
participant exclusions all ANT (4.2.1.1) and metabolite concentrations 
(4.2.1.2) analyses within this research chapter. 
4.2.1.1 Attentional Network Test 
There were some additional exclusions for the ANT assessment. Two NCs 
did not complete the ANT when we administered the other neurocognitive 
assessments. We were unable to obtain these assessments at a later date. 
We also excluded four participants from the ANT analysis because of an 
accuracy rate below 60% for incongruent flanker stimuli conditions (NC = 2, 
ASD = 2). In this case, participant exclusion was done to confirm that 
included participant had understood and actively participated in the ANT. In 
the end, there were 33 participants (NC = 16, ASD = 17) included in the final 
analysis. In the final participant group, one participant had a block of five or 
more consecutive errors which were related to technical issues during the 
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assessment. Therefore, we removed seven trials from the start of this 
participants test data set. 
4.2.1.2 Metabolite Concentrations 
For the correlations between the ANT and metabolite concentrations, we 
excluded further participants. One NC did not complete a 1H-MRS scan. 
Also, we excluded one individual with ASD from metabolite analysis due to 
evidence of poor water suppression.  
We also excluded metabolite concentrations from the analysis if they had a 
CRLB value greater than or equal to 20. Therefore, we excluded further 
participants from Glu (ASD = 2) and Glx (ASD = 3) analyses. One further NC 
was excluded from both Glu and Glx analyses because metabolite 
concentrations were greater than three SDs from the mean. Following these 
exclusions, there were a total of 28 participants included in the Glu (14 = NC, 
14 = ASD) and 27 in the Glx analyses (14 = NC, 13 = ASD). 
4.2.2 Demographic, Clinical and Psychometric Data Collection 
Participants in this study provided background clinical and demographic 
information (chapter 2.6.4) and also completed the WASI, ADOS and ANT as 
previously summarised in clinical (2.6.5) and psychometric data (chapter 
2.6.6) collection procedures. 
4.2.3 Attentional Network Test 
The ANT apparatus, testing stimuli, assessment protocol and method for 
calculating the results were reported in chapter 2.6.6.2. Briefly, the goal on all 
sub-sections of the ANT was to indicate the direction that the target arrow 
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was pointing. Manipulation of pre-target cues and non-target flanker arrow 
directions test three separate sub-conditions which include the alerting, 
orienting and flanker conflict effect. Researchers measure performance by 
increases in RT and ERs 363. 
4.2.4 Magnetic Resonance Imaging Acquisition 
The protocol for data collection of the anatomic MP-RAGE and 1H-MRS 
sequence was reported in chapter 2.6.7. Sequence parameters for the MP-
RAGE and 1H-MRS were reported in chapter 2.6.8.1 and 2.6.8.3, 
respectively. 
4.2.5 Neuroimaging Data Processing 
The methodology for metabolite quantification, calculation of CSF in the voxel 
and partial volume correction were reported in chapter 3.2.4. 
4.2.6 Statistical Analysis 
Investigators conducted all statistical analyses on SPSS 22.0 (SPSS, 
Chicago, Il, U.S.A.). During correlational analysis, researchers applied a 
Pearson’s correlation when the data complied with the assumption of this 
parametric test. In all other cases, investigators applied a non-parametric 
Spearman’s rank-order correlation. During group comparisons, if the data 
complied with the assumptions of a parametric test, we applied the 
appropriate parametric test. If the data violated these assumptions, we 
attempted appropriate transformations and then re-ran the parametric test on 
the transformed data. Unless noted, when a transformation failed to correct 
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for violations of the assumptions of a parametric test, we substituted the 
appropriate non-parametric test. All RT values are presented in ms. 
4.2.6.1 Basic Demographic Group Comparisons 
Firstly, we compared age and total IQ between groups. A more detailed 
analysis of participant demographics for all participants and clinical analysis 
for individuals with ASD are available in chapter 2.7. 
4.2.6.2 Attentional Network Analysis Full Participant Group 
We present the full details for how we calculate the ANT in the chapter 
2.6.6.2. Briefly, we compared the RT and ER for the easier (low cognitive 
demand) and more difficult (high cognitive demand) condition for the alerting, 
orienting and conflict RT in all participants with paired samples signed tests 
with continuity correction because the data did not comply with the 
assumptions of a parametric test. We did not investigate RTs or ERs for the 
neutral flanker condition because this condition was not used to calculate 
alerting, orienting or conflict effect results. 
Next, we determined if there was a correlation between age or IQ and ANT 
measures (alerting, orienting, conflict effect and global RT and ERs) 
measures for the entire group. The purpose of this analysis was to identify 
variables which might also contribute to and confound group comparisons of 
ANT performance. As it was reasonable that age or IQ might influence ANT 
performance, we wished to include a covariate even if it was only weakly 
associated. Therefore, we did not correct for multiple comparisons and set 
the significance level at uncorrected p < .05. If there was a significant 
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association, age or IQ was used as a covariate in future group comparisons 
for the appropriate ANT performance measure. 
4.2.6.3 Attention Network Test Group Comparisons 
We compared alerting, orienting, conflict and global RT and ER between 
groups. As mentioned above, when age or IQ correlated with an ANT 
performance measure (RT or ER), it was included as a covariate in an 
ANCOVA between groups. When a covariate was not justified, researchers 
compared group performance (RT or ER) with independent samples t-tests. 
When the data and the transformed data did not comply with the 
assumptions of a parametric test, we instead applied the appropriate non-
parametric test. The significance level was set at uncorrected p < .05. When 
there was evidence of group differences at an uncorrected alpha level, we 
further considered if results remained significant when correcting for multiple 
comparisons with Bonferroni correction. In total, there were 6 group 
comparisons which would result in a corrected p-value < .008. 
4.2.6.4 Attention Network Test and Correlation with Autism Diagnostic 
Observation Schedule for Participants with ASD 
We investigated if there were any significant correlations between the ADOS 
and ANT measures (RT and ER) in individuals with ASD only. This 
correlational analysis could not be made across the full group because NCs 




4.2.6.5 Attention Network Test and Correlation with Metabolite 
Concentrations 
We investigated if there was a correlation between metabolite concentrations 
(Glu, Glx and NAA + NAAG) and RT on the ANT (global, alerting, orienting or 
conflict) in all participants, NCs and individuals with ASD. We did not 
investigate the relationship between metabolite concentrations and ANT 
accuracy because participants were highly accurate. When there was 
evidence of a significant correlation between ANT performance and either 
ADOS scores (chapter 4.2.6.4) or metabolite concentrations at an 
uncorrected p < .05, we further considered if results remained significant 
when correcting for multiple comparisons with Bonferroni correction. In total, 
there were 48 correlational analyses which would result in a corrected p-
value < .001. 
4.2.6.6 Compare Participant Characteristics and Attentional Network Test 
Results of Current Study to Fan et al. (2012) 
We also present basic participant characteristics (age, IQ, ADOS-G Scores) 
and ANT performance outcomes (Alerting, Orienting, Conflict and Global 
RT/accuracy) between the current study and Fan et al. (2012) for comparison 
purposes within the discussion. 
4.3 RESULTS 
4.3.1 Basic Demographic Group Comparisons 
We compared NCs (M = 36.88, SD = 11.00, range = 24 – 58) and 
participants with ASD (M = 38.12, SD = 8.91, range = 23 - 53) on age. The 
standardised residuals for age in NCs were non-normally distributed and 
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moderately positively skewed (Shapiro-Wilk’s test, p = .040), and therefore 
we applied a logarithmic transformation to allow the data to comply with the 
assumptions of normality. Following transformation, there were no significant 
differences between groups in age (t (31) = -.47, p = .644). 
Independent samples t-tests were used to compare groups for total IQ (NC: 
M = 122.25, SD = 12.19, range=93-139; ASD M = 117.35, SD = 11.95, range 
= 87 – 136). The data standardized residuals for the full sample (Shapiro-
Wilk = .015) were non-normally distributed. A reflect and square root 
transformation corrected for minor negative skewing in the full sample. 
Following transformation, there were no significant differences between 
groups for the transformed total IQ (t(31) = -1.35, p = .187). 
4.3.2 Attentional Network Test 
4.3.2.1 Main Effects for Response Times and Error Rates 
Standardized residuals were non-normal for all sub-conditions (no cue, 
centre cue, double cue and spatial cue, congruent flanker, incongruent 
flanker) of RT and ER effects across the entire group (Shapiro-Wilk p < .05). 
Data transformation failed to correct for non-normal distributions and 
therefore non-parametric paired samples signed tests with continuity 
correction were used to investigate group differences in the median 
difference between median high cognitively demand and median low 
cognitive demand trials. As part of this parametric test, when the overall 
differences between the low and high cognitive demand condition were equal 
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to zero that individual’s data set was considered a tie and excluded for the 
non-parametric analysis. Therefore, we report the number of participant ties. 
For the full participant group (16 NC: 17 ASD), there was a significant 
difference in RTs between the high and low cognitive demand condition for 
alerting (M = 25.76, SD = 20.37, range = -15.61 – 78.33), orienting (M = 
37.04, SD = 23.65, range = -15.16 – 89.63) and conflict effect (M = 127.53, 
SD = 45.18, range = 55.05 – 276.92). All participants had a positive conflict 
effect RT. Four participants had a negative alerting effect and two had a 
negative orienting effect. No participants were considered ties and excluded 
from RT comparisons (table 4.1) 
Table 4.1 Non-Parametric Paired Signed Test with Continuity Correction Comparing 
Median Response Time Between Low and High Cognitive Demand Condition for Full 
Participant Sample (n = 33) 
Median Low CD  Median High CD  Median Effect z p  
Double Cue No Cue Alerting      
594.88 613.05 25.93 4.18 < .001 
Spatial Cue Centre Cue Orienting      
553.54 594.88 36.06 4.87 < .001 
Congruent Incongruent Conflict      
502.57 681.89 110.70 5.57 < .001 
Median RTs for high CD, low CD and overall effect (alerting, orienting and conflict). Total is 
the overall mean for all conditions. Significance reported at p < .05 level. There were no 
ties.  
CD, cognitive demand. 
 
Participants were highly accurate on the ANT (overall global accuracy rate: M 
= 99.23%, SD = 1.05%, range = 95.00% - 100.00%). Exact sign tests found 
no significant difference in ER between high and low cognitively demanding 
conditions of the alerting (M = -.29%, SD = 1.25%, range = -4.17 – 1.57%) 
and orienting (M = -.32%, SD = 1.42%, range = -4.17 – 4.48%) conditions. 
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Incongruent target conditions elicited a significantly greater ER across 
participants compared to congruent conditions in the conflict effect ER (M = 
1.55%, SD = 2.12%, range = -1.04 – 7.50%). However, this result should be 
taken with caution as 13 participants had difference scores of 0 and were 
excluded from the exact sign test (table 4.2). 
Table 4.2 Non-Parametric Paired Signed Test with Continuity Correction Comparing 
Median Error Rates Between Low and High Cognitive Demand Condition for Full 
Participant Sample (n = 33) 
Median Low CD Median High CD Median Effect 
p  Tie 
Double Cue No Cue Alerting      
0.00% 0.00% 0.00% 0.45 17 
Spatial Cue Centre Cue Orienting      
0.00% 0.00% 0.00% 0.15 21 
Congruent Incongruent Conflict      
0.00% 0.00% 1.04% < 0.001 13 
Median ERs for low CD, high CD and overall effect (alerting, orienting and conflict). Initially, 
there were 33 participants included in this statistical analysis. Tie is the number of 
participants with a 0 difference effect. We excluded these participants from the analysis. 
Significance reported at p < .05 level.  
CD, cognitive demand, ER, error rates 
 
4.3.2.2 Correlation between Age and Full Wechsler Abbreviated Scale of 
Intelligence Score with Attentional Network Test Performance 
We applied the Pearson’s product-moment correlation to investigate if age 
and IQ correlated with performance on the ANT across all participants (table 
4.3). The full data for the conflict effect RT (Shapiro-Wilk = .005), global RT 
(Shapiro-Wilk = .001), alerting error (Shapiro-Wilk < .001), orienting error 
(Shapiro-Wilk < .001), conflict error (Shapiro-Wilk < .001) and total accuracy 
(Shapiro-Wilk < .001) were non-normal, and therefore, Spearman rank order 
correlations were run for these analyses. 
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The Spearman’s rank order correlation revealed a significant association 
between conflict effect RT and age (n = 33, rs = .35, p = .043) (figure 4.1). 
There was also a significant correlation between age and total RT (n = 33, rs 
= .61, p < .001). There were no other significant correlations (table 4.3). 
Table 4.3 Correlation for Age and Full Wechsler Abbreviated Scale of Intelligence Score 




r p r p 
Mean RT 
Alerting -.16 = .369 .15 = .395 
Orienting .12 = .518 .03 = .854 
Conflict
 1
 .35 = .043 -.22 = .224 
Global 
1





 .34 = .054 -.08 = .677 
Orienting 
1
 -.15 = .416 .04 = .819 
Conflict 
1
 -.04 = .840 .09 = .605 
Global 
1
 .06 = .724 -.17 = .344 
Incorrectly answered RTs were excluded from mean RTs. There was a significant correlation 
between conflict and global RT with age. Pearson Correlation was run for each correlation 
unless noted otherwise. Significant correlations are reported at uncorrected p < .05 level. 
Global is defined as the overall mean for all conditions.  
1






Figure 4.1 Relationship between Conflict Effect and Age (NC = 17, ASD = 16) 
There was a significant correlation between age and flanker conflict effect RT for all 
participants (r =.35, p = .043). As age increased, there was also an increase in the conflict 
effect RT. The direction and slope of the association appear similar between groups. Conflict 
effect RT presented in ms. 
4.3.2.3 Group Response Time Comparisons 
We then investigated group differences in ANT performance (table 4.4). The 
mean global RT for correctly answered trials for NCs was 627.94 ms (SD = 
112.80, range = 477.82 – 897.79 ms) and 654.51 ms (SD =153.16, range = 
498.32 – 1073.69 ms) for participants with ASD. As mentioned above, age 
was correlated with global RT and was included as covariates in an analysis 
of covariance (ANCOVA) comparing overall RT to correctly answered trials 
between NC and participants with ASD. Data for global RT was non-normally 
distributed (Shapiro-Wilk’s test, p = .027) and this was largely driven by four 
participants with large RT concentrations over 800 ms. Transformation of 




























considered outliers as no cases had standardised residuals greater than ± 3 
SDs. Nevertheless, when these values were removed from the data set, the 
data complied with the assumptions of normality. As an ANCOVA is fairly 
robust to deviations from normality, we elected to run an ANCOVA with (NC 
= 16, ASD = 17) and without these participants (NC =15, ASD=14) and then 
compared results. There were no significant differences between groups in 
RT for the full (F(1,30) = .19, p =.668) or reduced sample (F(1,26) = 1.19, p = 
.285). Age for full sample (F(1,30) = 12.28, p =.001) and reduced sample 
(F(1,26) = 16.13, p =.000) significantly predicted RT during correctly 
answered trials. 
Alerting (NC: M = 26.34 , SD = 18.85, range = -15.61 – 62.69 ms; ASD: M = 
25.22 , SD = 22.27, range = -11.14 – 78.33 ms) and orienting RT (NC: M = 
37.44, SD = 24.25, range = -11.68 – 89.63 ms; ASD: M = 36.66, SD = 23.81, 
range = -15.16 – 87.85 msec) were compared between groups. There was 
no significant difference between groups for alerting effect (t(31) = .16, p = 
.877) and orienting effect (t(31) = .09, p = .926) 
Next we compared conflict effect RT by group (NC: M = 134.47, SD = 50.75, 
range = 85.82 – 276.92 msec; ASD: M = 120.99, SD = 39.68, range = 55.05 
– 214.83 ms). Age was included as a covariate in this group comparison. 
There was no significant difference for conflict effect RT between groups 
(F(1,30)=1.39, p=.285), but age was a significant predictor of conflict effect 
RT (F(1,30) = 10.57, p=.003). None of the data was significant at uncorrected 
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p < .05 and therefore would also have not survived the more stringent 
corrected p < .008 level (table 4.4). 
Table 4.4 Group Comparisons for Alerting, Orienting, Conflict and Global Response 
Times 
Effect NC Mean (SD) ASD Mean (SD) statistic p  
Alerting 26.34 (18.85) 25.22 (22.27) t(31) = .16 0.877 





 134.47 (50.75) 120.99 (39.68) F(1,30)=1.39 0.246 
Global 
1
 627.94 (112.80) 654.51 (153.16) F(1,26) = 1.19 .285 
There were no significant differences in RT between groups. The alerting effect = mean no 
cue RT - mean double cue RT. The orienting effect = mean spatial cue RT - mean centre 
cue RT. The conflict effect = mean incongruent flanker RT - mean congruent flanker RT. 
Significance reported at uncorrected p < .05 level.  
1 
Age included as a covariate in group comparison. 
2 
Results reported for a reduced sample.  
ASD, autism spectrum disorder; NC, neurotypical controls; SD, standard deviation 
 
4.3.2.4 Group Error Rate Comparisons 
Error rates for alerting (NC: M = .01%, SD = 1.53%, range = -1.43 – 1.43%; 
ASD M = -.48%, SD = 1.48%, range = - 4.17 – 1.57%) and orienting effect 
(NC: M = -.52%, SD = 1.23%, range = - 4.17 – 1.39%; ASD M = -.15%, SD = 
1.60%, range = -2.78 – 4.48% ) percentage error were low for both NC and 
participants with ASD. There were no in group differences in accuracy for 
alerting (t(31) = .90, p = .926) and orienting ERs (t(31) = -.75, p = .457). 
We also investigated group differences in conflict ER (NC: M = 1.37%, 
Median =1.04% SD = 1.85%, range = -1.04 – 5.21%; ASD M = 1.73%, 
Median = 1.72%, SD = 2.39%, range = 0 – 7.5%). Standardized residuals 
were non-normally distributed for conflict ER as assessed by the Shapiro-
Wilk’s test for the full model (p = .000), NCs (p = .007) and individuals with 
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ASD (p = .000). Data transformation did not correct for non-normality and 
therefore, a non-parametric Kruskal-Wallis test was run. Distributions of 
scores for both groups were similar as assessed by inspection of a boxplot 
for each group. Median scores for conflict ER were not statistically different 
between groups (X2(1) = .09, p = .765). 
Finally, we compared groups on global ER between groups (NC: M = .67 
Median = .52 %, SD = .74 %, range = 0 - 2 %; ASD M = .87 %, Median = .69 
%, SD = 1.28 %, range = 0 – 5%). Data were non-normally distributed for 
global ER as assessed by the Shapiro-Wilk’s test for the full model (p = 
.000), NCs (p = .007) and individuals with ASD (p = .000). Data 
transformation did correct for non-normality and therefore, a non-parametric 
Kruskal-Wallis test was run. Distributions of scores for both groups were 
similar as assessed by inspection of a boxplot for each group. Median scores 
for global ER were not statistically different between groups (X2(1) = .02, p = 
.896). None of the data was significant at uncorrected p < .05 and therefore 
would also have not survived the more stringent corrected p < .008 level. 





Table 4.5 Group Percentages for Alerting, Orienting and Conflict and Global Error 
Rates 
Effect NC Mean% (SD ) ASD Mean% (SD ) statistic p  
Alerting .01 (1.53) -.48 (1.48) t(31) = .90,  .926 
Orienting -.52 (1.23) -.15 (1.60) t(31) = -.75 .457 
Conflict 
1
  1.37 (1.85) 1.73 (2.39) X
2
(1) = .09 .765 
Global 
1
 .67 (.74) .87 (1.28) X
2
(1) = .02 .896 
There were no significant differences in ER between groups. The alerting effect = 
percentage no cue ER - percentage double cue ER. The orienting effect = percentage 
spatial cue ER - percentage centre cue ER. The conflict effect = percentage incongruent 
flanker ER - percentage congruent flanker ER. Global ER was the total number wrong minus 
the total number of trials multiplied by 100. Significance reported at uncorrected p < .05 
level. Unless otherwise noted, groups were compared with independent samples t-tests.  
1 
Non-parametric Kruskal-Wallis test run as data were non-normally distributed 
ASD, autism spectrum disorder; NC, neurotypical controls; SD, standard deviation 
 
4.3.2.5 The Relationship between ANT Effect Scores and Autism Diagnostic 
Observation Schedule for Participants with ASD 
ADOS scores were non-normally distributed, and therefore, a Spearman rank 
order correlation was run to compare ADOS and ANT sub-scores. For 
participants with ASD, conflict RT had a strong negative correlation with 
ADOS communication scores (rs = -.73, p = .001) and overall ADOS total 
score (rs = -.58, p = .015). Increased communication symptoms were 
associated with a reduced conflict effect in participants with ASD (figure 4.2). 
Nevertheless, neither of these relationships survived correction for multiple 
comparisons (p < .001). There were no other significant relationships 




Figure 4.2 Relationship Between Conflict Effect Response Time and Autism 
Diagnostic Observations Schedule (ADOS) Communication Score for Participants 
with Autism Spectrum Disorder (n = 17). 
For participants with ASD, increased communication scores, as measured by the ADOS, 
were associated with reduced conflict effect RT. Conflict RT is presented in ms. 
4.3.2.6 The Relationship between Attentional Network Test Scores and 
Metabolite Concentrations 
The data for global RT (Shapiro-Wilk = .001) and conflict RT (Shapiro-Wilk = 
.005) were non-normally distributed for the full sample. For consistency, we 
ran non-parametric Spearman’s rank order correlation for these correlations 
for the full, NC and ASD analyses. The Pearson’s correlation was used for all 
other correlations. 
There were no significant correlations between the alerting, orienting, conflict 
and global RT and metabolite concentrations (Glu, Glx and NAA + NAAG) for 
the full participant sample (table 4.6), NCs (table 4.7) or individuals with ASD 






















ADOS Communication Score 
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for multiple comparisons as there were no significant correlations at 
uncorrected p < .05. 
Table 4.6 Correlation Between Metabolite Concentrations and Mean Response Times, 
for All Study Participants 
  
Glu (n = 28) Glx (n = 27) 
NAA + NAAG (n = 
31) 
  
r p r p 
r p 
Mean RT 
Alerting  .05 .809 .11 .594 
-.09 .651 








 -.22 .265 .29 .143 
-.15 .431 
There were no significant correlations between Glu, Glx or NAA + NAAG and ANT RT. 
Pearson correlations were run unless noted otherwise. Significant correlations are reported 
at uncorrected p < .05 level. Global is defined as the overall mean for all conditions.  
1




Table 4.7 Correlation Between Metabolite Concentrations and Mean Response Times 
for NCs 
  
Glu (n = 1) Glx (n = 13) 
NAA + NAAG (n = 
15) 
  
r p r p 
r p 
Mean RT 
Alerting  .15 .601 -.07 .823 
.01 .967 








 -.39 .164 -.37 .197 
-.16 .567 
There were no significant correlations between Glu, Glx or NAA + NAAG and ANT RT. 
Pearson correlations were run unless noted otherwise. Significant correlations are reported 
at uncorrected p < .05 level. Global was defined as the overall mean for all conditions.  
1







Table 4.8 Correlation Between Metabolite Concentrations and Mean Response Times, 
for Individuals with ASD 
  
Glu (n = 14) Glx (n = 13) 
NAA + NAAG (n = 
16) 
  
r p r p 
r p 
Mean RT 
Alerting  -.03 .932 .14 .660 
-.14 .594 








 -.18 .533 -.43 .138 
-.21 .431 
There were no significant correlations between Glu, Glx or NAA + NAAG and ANT. Pearson 
correlations were run unless noted otherwise. Significant correlations are reported at 
uncorrected p < .05 level. Global was defined as the overall mean for all conditions.  
1




4.3.2.7 Study Comparisons of Attentional Network Test Data for Participants 
with Autism Spectrum Disorder 
We present a comparison table of the participant numbers, mean age, IQ and 
ANT scores for participants with ASD compared to Fan and colleagues 
201226. In the current study, individuals with ASD were slightly older but had 
similar IQ scores compared to Fan et al. (2012). Comparing studies, our 
investigation had slightly reduced global RT, conflict EP and increased 




Table 4.9 Participant Characteristics and Results from Fan et al. (2012) Compared to 
Current Trial for Individuals with Autism Spectrum Disorder 
 
Fan et al. (2012) 
(n = 12) 
Current Study 
(n = 17) 
 Mean (SD) Mean (SD) 
Age 30 (6) 38 (9) 
IQ 115 (14) 117 (12) 
ADOS-G 12.2 (4.1) 9.65 (3.3) 
Alerting RT NR 25 (22) 
Orienting RT NR 37 (24) 
Conflict RT 151 (72) 121 (40) 
Global RT 878 (164) 654 (153) 
Alerting EP NR 0 (1)% 
Orienting EP NR 0 (2)% 
Conflict EP 18 (15)% 2 (2) % 
Global Accuracy Rate 79 (12)% 99 (1)% 
Demographic, ADOS-G and ANT performance results for Fan et al. (2012) and the current 
study. Participants in Fan et al. (2012) completed the ANT inside an MRI scanner 
ADOS-G, total communication and social ADOS scores, ASD, Participants with autism 
spectrum disorder; EP, error percentage; IQ, intelligence; NR, not reported; SD, standard 
deviation; RT, response time. 
 
4.4 DISCUSSION 
We investigated conflict effect performance in association with individuals 
with ASD relative to NCs and in association with core symptoms of the 
disorder. We also explored the relationship between conflict effect 
performance and metabolite concentrations. 
We will firstly discuss our replication of the main effects of the ANT in all 
participants (chapter 4.4.1) and the ANT’s relationship with age but not IQ 
(chapter 4.4.2). We then discuss the lack of significant performance 
differences between groups and suggest some possible reasons why our 
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study did not replicate the previous investigation of the ANT in adults with 
ASD 26 (chapter 4.4.2). Finally, we did not find any relationship between 
metabolites and ANT performance (chapter 4.4.5). In individuals with ASD, 
we did report a relationship between conflict effect performance and 
communication deficit (chapter 4.4.4), but this correlation did not survive 
correction for multiple comparisons.  
4.4.1 Main Effects Attentional Network Test 
Across participants, RTs were higher during the more cognitively demanding 
conditions for the alerting, orienting and CEs , as has been shown previously 
26,304,363,417,568. In contrast, participants were highly accurate, and there was 
no support for an alerting or orienting error effect across participants. There 
was some support for greater error during the high conflict incongruent 
flanker conditions compared to congruent flanker conditions across 
participants. Nevertheless, almost 40% of participants were excluded from 
the conflict error analysis because they had equal accuracy rates for 
incongruent and congruent flanker conditions, and therefore, this final 
statistical conclusion requires caution. Taken as a whole, RT was a better 
measure of variation in performance between groups than error. 
In our ANT analysis, we did not investigate evidence of fatigue (see chapter 
2.2.2) because we had few observable errors. Our inability to measure the 
impact of fatigue because of ER ceiling effects is a limitation of this study and 
hopefully future studies will assess the impact of fatigue on performance with 
a more difficult inhibition to distraction task.   
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4.4.2 Basic Demographic Characteristics and the Attentional Network Test 
On the ANT, there was a positive correlation between age and both global 
accuracy and conflict RTs (figure 4.5). These associations have been 
supported by other studies 562–564,569, suggesting that, as both NCs and 
individuals with ASD age, their performance on the ANT declines. We did not 
report a relationship between IQ and ANT performance, which has also been 
previously shown 565. Nevertheless, these results require further replication 
as our sample only included a small cross-sectional analysis of men with 
average to above average intelligence. Further studies would benefit from 
investigating a larger, more diverse longitudinal sample of participants. 
4.4.3  Group Differences on the Attentional Network Test 
There were no significant performance differences between groups on global, 
alerting, orienting or conflict effects (table 4.4 and 4.5). In comparison to our 
investigation, Fan et al. (2012) reported group differences in conflict effect 
performance for individuals with ASD compared to NCs 26 in participants with 
similar characteristics to our study. For example, both studies investigated 
similar participant sizes of high functioning adults with ASD (table 4.9). 
Nevertheless, there was some variation in participant characteristics between 
studies, which might contribute to contradictory results and, therefore, 
deserve mention. Firstly, participants in this study were slightly older than 
those in Fan et al. (2012) (table 4.9). Nevertheless, both our own and 
previous analysis suggests that increased age was associated with increased 
conflict effect RT  562,563. Instead, compared to Fan and colleagues, our 
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investigation reported lower mean conflict effect RT and ER with an older 
mean participant age. 
Individuals in the previous study also reported higher mean ADOS scores 
than the participants in this study, which may have contributed to greater 
performance differences in individuals with ASD in Fan et al. (2012) (table 
4.9). Fan and colleagues also included five female participants (NC = 2, ASD 
= 3), which may have contributed both to increased ADOS scores or varied 
the characteristics of the ASD group. One study investigated symptoms of 
ASD in over two thousand individuals with ASD between females and males. 
Investigators reported more severe symptoms in females with the disorder 
including greater communication, cognitive and adaptive deficits 570. 
Furthermore, in contrast to our study, participants in Fan et al. (2012) 
completed the assessment inside an MRI scanner. We hypothesise that this 
difference might have increased the stress and complexity of the ANT. This 
hypothesis is supported by increased mean global and conflict effect RT 
performance for individuals with ASD when inside a scanner 26 which 
suggests increased cognitive effort (table 4.9). Researchers have reported 
that executive control tasks elicit a widening gap in performance differences 
between NCs and individuals with ASD when the cognitive complexity 
increased 571–576. For example, one research group reported significant 
performance differences in mean RT and ER only when presentation speed 
increased during a response inhibition task in individuals with ASD compared 
to NCs 574. 
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Therefore, we suggest that performance deficit previously reported by Fan 
and colleagues 26 might have been more evident due to the increased 
complexity of completing the task inside an MRI scanner 571. Altered function 
of the dACC in individuals with ASD compared to NCs does not always 
translate into inhibitory performance differences 53,408. With age, adult 
participants with ASD may learn adaptive strategies to mask altered 
behaviours and brain function 109, which may only become apparent during 
more complex, real-world, multidimensional cognitively demanding situations. 
Relatedly, conducting the ANT in a laboratory might have preferentially 
benefited individuals with ASD. The goal of conducting the ANT in a 
laboratory was to reduce external social and other stressful confounds. 
Nevertheless, this task was not an ecological valid representation of an 
inhibitory behaviour. Participants with ASD benefit from laboratory 
environments 425,577 and perform well under highly structured conditions with 
defined behavioural requirements and little irregularity 578,579. Unfortunately, 
these situations are not typical of the real world and might explain the 
reported disconnect between carer rated and laboratory assessments of 
executive control in participants with ASD 580,581. 
Alternatively, hypoactivation of the dACC as previously reported during the 
ANT assessment 26 might have been associated with reduced motivation or 
compliance. As we mentioned previously, researchers have linked the dACC 
with task motivation. For example, individuals with epilepsy have reported 
feelings of increased task preservation with electrical stimulation of the dACC 
157 
 
360. Therefore, reduced activation of the dACC during previous studies might 
suggest reduced motivation in the task leading to performance deficits in 
individuals with ASD 26. 
In conclusion, our data suggest that when in a laboratory environment, 
individuals with ASD did not exhibit any conflict effect performance 
differences compared to NCs. We suggest that differences in autistic 
severity, task complexity or motivation might lead to differences between this 
study and Fan and colleagues, 2012 26. 
4.4.4 Correlation between Conflict Effect and Communication Score in 
Participants with Autism Spectrum Disorder 
We report that higher ADOS communication scores were associated with 
reduced conflict effect scores. In other words, increased communication 
deficits were associated with reduced RT differences between incongruent 
flankers compared to congruent flankers in participants with ASD (figure 4.2). 
This result was unexpected especially as the previous study reported that 
greater communication deficit was also associated with increased conflict 
effect ER in individuals with ASD 
26
. It may be that more severe 
communication deficit in individuals with ASD were associated with a similar 
cognitive response for both congruent and incongruent stimuli associated 
with decreased conflict effect RTs in our study but increased ER when task 
difficulty increased when completing the ANT within an MRI scanner 26. 
Nevertheless, the relationship between ADOS communication scores and 
conflict effect RTs did not survive correction for multiple comparisons, and we 
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cannot rule out the possibility of a type I error within our study. Therefore, 
these relationships warrant further investigation and replication. 
4.4.5 Correlation between Conflict Effect and Metabolite Concentrations 
We were also interested in the relationship between metabolites and the CE, 
but did not report any significant relationship. In future experiments, a more 
difficult and regionally specific task might allow greater inference into the 
relationship between Glu or Glx concentrations and behaviour. 
4.5  CONCLUSION 
There was no evidence of reduced performance on the conflict effect task in 
individuals with ASD compared to NCs. Furthermore, there was no evidence 
of an association between performance on an inhibition to distraction task 
and dACC metabolite concentrations. Our data suggest that individuals with 
ASD with more severe communication deficits performed better on the 
conflict effect task, although this association did not survive correction for 
multiple comparisons. Future research must investigate the association 
between ASD severity and performance on the conflict effect task as well as 
assess the impact that environment has on inhibitory task performance in 












We previously presented the salience network (chapter 1.7.5.1), with the 
dACC and anterior insular cortex as core salience network brain regions 
302,306. One study reported that increased resting-state functional connectivity 
between these core salience network regions (the anterior insula and dACC) 
was associated with an increase in self-reported prescan anxiety in NCs 302. 
This suggests that functional connectivity between salience network regions 
were associated with a conscious response to one’s environment. 
Other fMRI studies have reported that the dACC is functionally associated 
with various tasks requiring increased executive control 26,254,334,334,394–
397,582,583 including inhibition to distraction tasks, such as the ANT 26,304 . 
Additionally, one group reported that when NCs completed the ANT in an 
MRI scanner, left dACC to DLPFC functional connectivity was associated 
with conflict effect performance 387. Further resting-state functional 
connectivity analysis suggests that the dACC is temporally correlated with 
cognitive brain regions such so the DLPFC even in the absence of a 
cognitive task 302,306,381. Researchers have hypothesized that the dACC might 
moderate both incoming sensory information from paralimbic and subcortical 
brain regions and, in turn, influence the outgoing behavioural and cognitive 
response to that sensory information 302. 
Throughout this research chapter, we implemented a seed-to-voxel functional 
connectivity analysis of the dACC because we were interested in mapping 
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the functional connectivity of only this region in relation to the rest of the 
brain.  
As a first step in our functional connectivity analysis, we investigated dACC 
functional connectivity within each group. Based on previous studies 
302,306,381, we hypothesized that the dACC would be functionally connected 
with cognitive brain regions such as the DLPFC and other salience network 
regions, such as the insular cortex. We investigated if there were group 
differences in dACC functional connectivity and if there was a relationship 
between dACC seed-based functional connectivity and autistic severity as 
quantified by the ADOS in individuals with ASD. 
We wished to investigate brain function without having to interpret the varied 
group response to a defined experimental paradigm, such as the ANT 584. 
Therefore, we also investigated how dACC resting-state functional 
connectivity was associated with conflict effect performance in both NCs and 
individuals with ASD. Additionally, we investigated if there were any group 
differences in these associations. 
Finally, there has been evidence that Glu concentrations have a relationship 
to functional connectivity (chapter 1.6). For example, researchers have 
reported that dACC Glu concentrations were associated with inhibitory 
behaviours by moderating the functional connectivity between the dACC and 
other midbrain regions 258. Therefore, our primary objective in this chapter 
was to explore the relationships between Glu and Glx concentrations and 
dACC seed-to-voxel functional connectivity in individuals with ASD compared 
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to NCs. To our knowledge, we are the first group to investigate such a 
relationship in individuals with ASD, and this analysis was mostly exploratory. 
Given evidence of an imbalance in Glu signalling and concentrations in 
individuals with ASD compared to NCs 194,207,247, we hypothesised that there 
might be an altered relationship between dACC Glu or Glx and seed-to-voxel 
resting-state functional connectivity for individuals with ASD compared to 
NCs. 
5.2 METHODS 
5.2.1 Study Populations 
The full study population, ethical consent and assessment procedure 
resulting in a final 20 NCs and 19 individuals with ASD were reported in 
chapter 2.6.1, 2.6.2 and 2.6.3 respectively. 
5.2.1.1 Resting- State Functional Connectivity  
For our seed-to-voxel analysis, we further excluded two NCs because they 
did not complete a resting-state EPI sequence. One additional NC resting-
state EPI scan was lost due to technological issues. Four participants with 
ASD were also excluded because they had greater than 20% of their fMRI 
scans labelled for movement artefact during the preprocessing steps. Our 
final functional connectivity analysis included 17 NCs and 15 adults with high 
functioning ASD. 
5.2.1.2 Resting-State Functional Connectivity Association to Attentional 
Network  
Two participants did not complete the ANT (NC = 1, ASD = 1) resulting in a 
total of 16 NCs and 14 individuals with ASD included in the final ANT 
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participant numbers. There were an additional four participants (NC =2, ASD 
=2) with low accuracy rates for the incongruent conditions of the conflict 
effect task (below 60%). Therefore, these participants were excluded from 
the conflict effect performance with a final 14 NCs and 12 individuals with 
ASD included in the analysis. 
5.2.1.3 Resting-State Functional Connectivity Association to Metabolite 
Concentrations Study Population 
From the total participant numbers for the functional connectivity analysis 
(20=NC, 19=ASD), one further NC was excluded from all metabolite analyses 
because the incorrect scanning sequence was applied and the 1H-MRS 
sequence was not usable. 
Metabolite concentrations were only included in the analysis if the CRLB 
percentage score was less than 20% 445. We excluded a further three 
participants from the Glu (NC = 1; ASD = 2) and four participants from the 
Glx analysis (NC = 1; ASD =3) because CRLB scores were greater than 
20%, There were 15 NCs and 13 individuals with ASD included in the Glu 
analysis and 15 NCs and 12 individuals with ASD for the Glx analysis. 
5.2.2 Demographic, Clinical and Psychometric Data Acquisition 
We included age, IQ, ADOS and conflict effect RT scores in this analysis. 
The assessment procedure for the obtaining this data was reported in 
chapter 2.6.3. Briefly, all of these assessments were completed in a quiet 




5.2.3 Demographic, Clinical and Psychometric Data 
All participants provided basic demographic information, which included age 
as specified in chapter 2.6.4. Participants also completed the WASI which is 
fully detailed in chapter 2.6.6.1. All participants with ASD completed the 
ADOS to confirm ASD diagnosis as explained in chapter 2.6.5. The conflict 
effect RT was defined as the increase in RT associated with the addition of 
incongruent non-target stimuli when compared to conditions only including 
congruent non-target stimuli. The ANT assessment was reported in chapter 
2.6.6.2. 
5.2.4 Magnetic Resonance Imaging Acquisition 
The acquisition procedure for the anatomical MP-RAGE, 1H-MRS and 
resting-state EPI sequences were reported in chapter 2.6.7. Briefly, 
participants were asked to close their eyes and attend to their breathing or 
the external scanner noise when participating in the resting-state EPI scan. 
The EPI scan lasted 7 minutes and 42 seconds.  During all of the other 
scans, participants were asked to relax and try to stay as still as possible.  
5.2.5 Magnetic Resonance Imaging Parameters 
The scanning parameters for the anatomical MP-RAGE, resting-state EPI 
and 1H-MRS sequences were reported in chapter 2.6.8.1, 2.6.8.2 and 
2.6.8.3, respectively. 
5.2.6 Imaging Preprocessing 
All functional connectivity preprocessing, first and second level analyses 
were performed in CONN-fMRI functional connectivity toolbox v16.b 585 
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(http://www.nitrc.org/projects/conn) an SPM12 (Statistical Parametric 
Mapping: The Wellcome Department of Cognitive Neurology, Institute of 
Neurology, London, UK, http://www.filion.ucl.ac.uk/spm/software/spm12) 
toolbox for the matrix laboratory (MATLAB version 2015b, the Mathworks 
Inc., Natick, MA, 2015). This software program was selected because it is 
well validated, powerful and simple use in seed-to-voxel analysis. 
The anatomical MP-RAGE and EPI image origins were first manually re-
centred to the anterior commissure. Anatomical images were then skull-
stripped, normalised to MNI space and segmented into GM, WM and CSF 
brain masks. Structural WM and CSF masks were later utilised to extract 
principal components (5 each) from WM and CSF functional time series and 
then added as confounds during the first level analysis to correct for the non-
neural artefact as part of the Component Based Noise Correction method 
(aCompCor) method 586.  
Global signal regression has been a common preprocessing step to remove 
non-neural artefact in resting-state fMRI. It takes the average signal over all 
the voxels of the brain at each time point and regresses out this average from 
the data. The technique assumes that global signal changes are non-neural 
artefact and of no interest to the analysis 587. Research has shown that global 
signal regression removes motion confounds 277 and even improves tissue 
specificity 588. Nevertheless, global signal regression also overvalues 
connectivity outcomes, alters the sight of significant associations and creates 
spurious negative correlations 589–591. 
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One alternative to GSR is the aCompCor method 586. Unlike global signal 
regression, aCompCor allows for variation in nuisance signals across the 
brain, as is typical of non-neural artefact. Furthermore, aCompCor makes no 
predictions about the relationship between noise and signal change further 
allowing nonlinear correction. Studies have compared these two methods 
and support aCompCor as an improved strategy for removing noise 592. 
Given evidence that the aCompCor is a better method, we applied it within 
this study. 
Before preprocessing of the functional EPI images, we removed the four 
images to reduce magnetisation equilibrium effects. During the preprocessing 
steps, functional images were unwrapped and realigned to the first volume 
using a six-parameter rigid body transformation. The six parameters of rigid 
body head motion were later applied as regressors during the first level 
analysis. Next, images were normalised to MNI template brain using non-
linear registration. 
We further applied signal and motion correction through the Artefact 
Detection Toolbox (ART) 593,594. We applied motion artefact scrubbing 
parameters to reduced motion artefact (global z-value threshold > 3, subject 
motion threshold of .5 mm in translational or rotational directions). All time 
points marked above this threshold were later included as covariates in the 
first-level analysis and regressed out of the analysis. All functional images 
were smoothed with an 8 mm³ isotropic Gaussian kernel. 
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Lastly, linear detrending was applied to reduce scanner drift and low band-
pass filtering. It reduced the frequency range of interest to 0.008 – 0.9 Hz a 
range typically representative of resting-state neuronal variance investigating 
low-frequency oscillations 595–597. 
5.2.7 Modified Whole Brain Mask 
The field of view for our EPI functional images was not optimised to include 
the cerebellum, and therefore, we removed the cerebellum from the default 
CONN brain volume mask (mask.volume.brainmask.nii). This brain mask 
sets the voxels which are correlated with the seed region in a seed-based 
functional connectivity analysis. 
The CONN analysis toolbox included a default GM atlas which was defined 
by a combination of cortical and subcortical regions from the FSL Harvard-
Oxford maximum likelihood cortical atlas and the cerebellar regions from the 
Automated Anatomical Labelling Atlas 598. We subtracted the cerebellar GM 
defined region in the default GM atlas from the default CONN brain volume 
mask. This step provided a clear outline of the cerebellum. Next, the new 
mask image was manually altered in Brain Suite (Version 16a1; 
http://brainsuite.org/) to remove any remaining mask regions posterior and 
ventral to the cerebellum. Also, WM in the cerebellum was removed manually 
from the new mask because the default GM atlas did not remove WM from 
the original mask. This updated mask was then imported into CONN and 
utilised as our analysis mask. Only voxels in this mask were correlated with 
the seed region. 
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5.2.8 Seed Regions 
We conducted a seed-to-voxel analysis using two 5 mm diameter sphere 
region of interest corresponding with our initial centre voxel for the dACC 
spectroscopy analysis (3 (±5), 18, 33 MNI). We shifted the centre voxel of our 
single voxel spectroscopy laterally to create separate non-overlapping right 
and left ROIs. Our final seed ROIs were 5 mm sphere seeds located on the 
right (5, 18, 33 MNI) and left (-5, 18, 33 MNI) dACC. Seed regions were 
created in the MarsBar (version 44) 552 toolbox for SPM12 and imported into 
the CONN for the seed-to-voxel functional connectivity analysis. 
5.2.9 Statistical Analysis 
5.2.9.1 Demographic, Neuropsychological and Artefacts Group Comparisons 
Age, IQ and total number of identified movement outlier scans group 
comparisons were assessed in SPSS (SPSS Inc., Released 2013. IBM 
SPSS Statistics for Windows, Version 22, Armonk, NY: IBM Corp). We 
compared age, total IQ and total number of flagged outlier scans between 
groups with independent samples t-tests. Again, outlier scans were flagged 
during the motion artefact scrubbing preprocessing step. When the data did 
not comply with the assumptions of the appropriate parametric test, we 
applied the appropriate transformation and then reapplied a parametric test. 
A more detailed demographic analysis was presented for the full participant 
sample in chapter 2.7. We also previously reported conflict effect RT within 




5.2.9.2 First Level Seed-to-Voxel Functional Connectivity Analysis 
For each individual participant functional connectivity map, we calculated the 
Pearson correlation coefficients between the average BOLD time series of all 
voxels in each seed region and the time series of each voxel lying in GM in 
our adapted study mask. Correlation coefficients indexed the strength of the 
linear relationship between the seed region and each voxel. Correlation 
coefficients from subject-specific maps were then converted to normally 
distributed scores through the application of Fisher’s r to z transformation for 
the second-level general linear model analysis. 
5.2.9.3 Second-Level Analysis of Seed-to-Voxel Functional Connectivity 
Throughout the second level analysis, we only reported clusters with a voxel-
wise height threshold of p < 0.001, greater than 50 voxels and with a false 
discovery rate (FDR) correction for multiple comparisons at the cluster-level p 
< .05. 
Using the Conn toolbox, one sample t-tests were applied to seed-based 
functional connectivity z-maps to investigate within-group (NC and ASD 
separately) average functional connectivity in association with both the left 
and right dACC seed regions. We compared group (NC vs ASD) seed-to-
voxel connectivity maps with independent samples t-tests. 
Within each group, bivariate linear regression analyses were utilised to 
evaluate the association between dACC seed-based functional connectivity 
and the metabolite concentrations (Glu and Glx). Another bivariate linear 
regression analysis was utilised to evaluate the association between seed-
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based functional connectivity and the conflict RT within each group. For 
individuals with ASD, we applied bivariate linear regression models to 
investigate the association between seed-based functional connectivity and 
autistic severity (as quantified by ADOS scores). We only investigated the 
relationship to ADOS social and communication scores because most 
individuals with ASD scored zero on imagination and stereotyped behaviours 
(see chapter 2.7.5). Finally, multiple linear regression analysis was used to 
investigate between group differences in the relationship between functional 
connectivity and both metabolite concentrations (Glu and Glx) and conflict 
effect RT. 
All significant cortical and subcortical voxels reported were labelled according 
to the Harvard-Oxford Cortical and Subcortical Atlas 599–602 
(http://www.cma.mgh.harvard.edu/fsl_atlas.html). For greater clarity, we also 
reported the closest GM regions within 5 mm of the peak voxel coordinate 
according to the Tailarach Daemon atlas in WFU-pickatlas software 603,604. 
Most GM regions were defined by BA 378 unless they were sub-cortical 
structures without a BA label. 
5.3 RESULTS 
The results of the resting-state seed-to-voxel analysis are presented below. 
To start, basic demographic information demonstrated that individuals with 
ASD were well matched to NCs on age and IQ (chapter 5.3.1). There were 
no significant differences between the numbers of identified outlier scans by 
group (chapter 5.3.2). Next, the seed-to-voxel analysis group maps for the 
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left and right dACC seed regions within (chapter 5.3.3) and between groups 
(chapter 5.3.4) are presented. Then we present the results of the association 
between dACC functional connectivity and symptoms of the disorder (chapter 
5.3.5.1), executive control RT performance (chapter 5.3.5.2), Glu (chapter 
5.3.5.3) and Glx (chapter 5.3.5.4). 
5.3.1 Age and Intelligence 
We firstly compared NCs (n = 17, M = 39.42, SD = 11.37, range = 24 - 58) 
and individuals with ASD (n = 15, M = 35.93, SD = 9.70, range = 23 - 53) on 
age. The overall standardized residuals for the full model were positively 
skewed (Sharpo-Wilk = .041). Following transformation to correct for non-
normality in the data, there were no significant differences between groups 
on the square root transformation of age (t(30) = .90, p = .376). 
We then compared the total IQ (NC: n = 17, M = 120.09, SD = 12.64, range= 
93 - 139; ASD: n = 15, M = 116.40, SD = 11.16, range = 90 – 129) between 
groups. The standardized residuals for individuals with ASD were moderately 
negatively skewed (Sharpo-Wilk = .038) and we therefore applied a reflect 
and square root transformation to total IQ. Following transformation, there 
were no significant differences between groups on the transformed total IQ 
(t(30) = -1.13, p = .268). 
5.3.2 Group Comparison Movement Outlier Scans 
The number of movement outlier scans were compared between groups (NC: 
n = 17, M = 15.29, SD = 0, range 0 – 40; ASD: n = 15, M = 16.71, SD =, 
range 0 - 54). In each group standardized residuals were both positively 
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skewed and non-normally distributed (NC: Sharpo-Wilk = .028; ASD: Sharpo-
Wilk = .020). Following transformation, there were no significant difference in 
the number of transformed outlier scans between groups (t(30) = .73, p = 
.472). 
5.3.3 Functional Connectivity Within Groups 
For NCs, there were four clusters significantly correlated with the right dACC 
seed region (t(1,16)≥ 3.69, k ≥ 537). The first cluster overlapped with the 
bilateral insular cortex, opercular cortex, frontal orbital cortex, pre and 
postcentral gyrus, inferior frontal gyrus (pars triangularis and pars 
opercularis), supramarginal gyrus, temporal pole, superior temporal gyrus 
(including the planum polare, planum temporale and Heschl’s gyrus), 
putamen, pallidum, thalamus, brain-stem (cluster t-score = 12.39; p-cluster 
FDR < .001; MNI peak coordinates (36, 14, -04); cluster voxel size = 16,398; 
nearest (±5) GM peak voxel = BA 13). The second cluster overlapped with 
the cingulate cortex (anterior and posterior), bilateral paracingulate, frontal 
medial cortex, juxtapositional lobule cortex (also known as the supplementary 
motor cortex), pre-central gyrus, post-central gyrus, superior parietal lobule 
(including the precuneus), and right superior and middle frontal gyrus (cluster 
t-score = 16.47; p-cluster FDR < .001; MNI peak coordinates (06, 16, 34); 
cluster voxel size = 9,573; nearest (±5) GM peak voxel = BA 32). The third 
cluster overlapped with the right frontal pole and middle frontal gyrus (cluster 
t-score = 7.43; p-cluster FDR < .001; MNI peak coordinates (28, 40, 24); 
cluster voxel size = 603; nearest (±5) GM peak voxel = BA 10). The final 
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cluster overlapped with the left frontal pole and middle frontal gyrus (cluster t-
score = 6.48; p-cluster FDR < .001; MNI peak coordinates (-34, 36, 30); 
cluster voxel size = 537; nearest (±5) GM peak voxel = BA 9). 
In NCs, there were five clusters associated with the left dACC seed (t(1,16)≥ 
3.69, k ≥ 86). The first cluster overlapped with bilateral cingulate gyrus 
(anterior and posterior division), paracingulate gyrus, medial, superior and 
middle frontal cortex, precuneous cortex, juxtapositional lobule cortex (also 
known as the supplementary motor cortex), pre-central gyrus and right frontal 
pole (cluster t-score = 15.73; p-cluster FDR < .001; MNI peak coordinates (-
06, 18, 34); cluster voxel size = 10,387; nearest (±5) GM peak voxel = BA 
32). The second cluster overlapped with right insular cortex, opercular cortex, 
frontal orbital cortex, frontal pole, inferior frontal gyrus (pars opercularis and 
triangularis), pre and postcentral gyrus, supramarginal gyrus, (anterior and 
posterior division), temporal pole, superior temporal gyrus (including the 
planum polare, planum temporale and Heschl’s gyrus), middle temporal 
gyrus, pallidum, putamen, thalamus, accumbens (cluster t-score = 11.44; p-
cluster FDR < .001; MNI peak coordinates (38, 16, -02); cluster voxel size = 
8,037; nearest (±5) GM peak voxel = BA 13). The third cluster overlapped 
with the left insular cortex, opercular cortex, frontal orbital cortex, inferior 
frontal gyrus (including pars opercularis and triangularis), pre and postcentral 
gyrus, supramarginal gyrus, temporal pole, superior temporal gyrus 
(including the planum polare, planum temporale and Heschl’s gyrus), 
putamen, amygdala, accumbens, caudate, pallidum (cluster t-score = 13.43; 
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cluster FDR < .001; MNI peak coordinates (-42, 14, 00); cluster voxel size = 
6,933; nearest (±5) GM peak voxel = BA 13). The forth cluster overlapped 
with the left frontal pole and middle frontal gyrus (cluster t-score = 9.95; p-
cluster FDR < .001; MNI peak coordinates (-32, 46, 30); cluster voxel size = 
1,230; nearest (±5) GM peak voxel = BA 10). The final cluster overlapped 
with the right precentral gyrus (cluster T-score = 6.29; p-cluster FDR = .047; 
MNI peak coordinates (60, 08, 34); cluster voxel size = 86; nearest (±5) GM 




Table 5.1 Seed-to-Voxel Analysis for Neurotypical Controls (n = 17)  
Brain Region Hemisphere 
MNI 
coordinates 
GM kE T-score p-value 
  x y z     
RDACC Seed         
Insula B 36 14 -04 
BA 
13 
16,398 12.39 < .001 
Anterior 
Cingulate 
B 06 16 34 
BA 
32 
9,573 16.47 < .001 
Frontal Pole R 28 40 24 
BA 
10 
603 7.43 < .001 
Frontal Pole L -34 36 30 BA 9 537 6.48 < .001 
Left DACC 
Seed 
        
Anterior 
Cingulate 
B -06 18 34 
BA 
32 
10,387 15.73 < .001 
Insula R 38 16 -02 
BA 
13 
8,037 11.44 < .001 
Insula L -42 14 00 
BA 
13 
6,933 13.43 < .001 
Frontal Pole L -32 46 30 
BA 
10 
1,230 9.95 < .001 
Precentral 
gyrus 
R 60 08 34 BA 9 86 6.29 = .047 
Clusters positively correlated with the right and left dACC in NCs (voxel-wise uncorrected p < 
0.001 and FDR cluster corrected p < .05). Brain region and hemisphere represent brain 
region overlapping with the largest number of voxels in the cluster. MNI coordinates 
represent peak effect in a cluster. GM represent closest GM defined area (within 5 mm) to 
peak voxel coordinate according to the Talairach Daemon atlas in WFU-pickatlas software 
603,604
. Cluster size, kE, represents the spatial extent or the number of voxels in a cluster. T-
score and p-value are at the cluster level. 
Amg, amygdala; bilateral; dACC, dorsal anterior cingulate cortex, BA; Brodmann area; FDR, 
false discovery rate; Hemi, hemisphere; Hip, Hippocampus; L, left; MNI, Montreal 
Neurological Institute; R, right 
 
For individuals with ASD, there were nine clusters positively correlated 
between the right dACC seed (t(1,14) ≥ 3.79, k ≥ 151). The first and largest 
cluster overlapped with the bilateral cingulate gyrus (anterior and posterior), 
paracingulate gyrus, juxtapositional lobule cortex (also known as the 
supplementary motor cortex), pre-central gyrus, post-central gyrus, superior 
frontal gyrus and superior parietal lobule. The cluster also including the right 
insula cortex, operculum cortex, frontal orbital cortex, frontal pole, middle 
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frontal gyrus, inferior frontal gyrus (including pars opercularis and pars 
triangularis), precuneous, supramarginal gyrus, superior temporal gyrus 
(including the planum polare, planum temporale and Heschl’s gyrus), 
putamen, pallidum and thalamus (cluster t-score = 12.06; p-cluster FDR < 
.001; MNI peak coordinates (06, 18, 32); cluster voxel size = 19,624; nearest 
(±5) GM peak voxel = BA 32). The second cluster overlapped with the left 
insular cortex, operculum cortex, frontal orbital cortex, inferior frontal gyrus 
(including pars opercularis), supramarginal gyrus (anterior division), pre and 
postcentral gyrus, superior temporal gyrus (including the planum polare, 
planum temporale, Heschl’s gyrus and temporal pole), putamen, (cluster t-
score = 9.04; p-cluster FDR < .001; MNI peak coordinates (-50, 06, 04); 
cluster voxel size = 6945; nearest (±5) GM peak voxel = BA 22). The third 
cluster overlapped with the right frontal pole and middle frontal gyrus (cluster 
t-score = 7.14; p-cluster FDR < .001; MNI peak coordinates (28, 42, 30); 
cluster voxel size = 605; nearest (±5) GM peak voxel = BA 10). The forth 
cluster overlapped with the left lateral occipital cortex and middle temporal 
gyrus (cluster t-score = 7.68; p-cluster FDR < .001; MNI peak coordinates (-
42, -72, -06); cluster voxel size = 511; nearest (±5) GM peak voxel = BA 19). 
The fifth cluster overlapped with the left temporal/ occipital fusiform cortex, 
inferior temporal gyrus and lingual gyrus (cluster t-score = 6.23; p-cluster 
FDR < .001; MNI peak coordinates (-30, -58, -20); cluster voxel size = 416; 
nearest (±5) GM peak voxel = BA 19). The sixth cluster included the left 
frontal pole and middle frontal gyrus (cluster t-score = 6.17; p-cluster FDR < 
.001; MNI peak coordinates (-30, 36, 26); cluster voxel size = 404; nearest 
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(±5) GM peak voxel = BA 10). The seventh cluster included the right lateral 
occipital cortex, middle temporal gyrus and temporal/ occipital fusiform cortex 
(p-cluster FDR < .001; MNI peak coordinates (cluster t-score = 7.28; 48, -64, 
0; cluster voxel size = 290; nearest (±5) GM peak voxel = BA 9). The eighth 
cluster overlapped with the right precuneus (cluster t-score = 5.38; p-cluster 
FDR = .003; MNI peak coordinates (16, -60, 42); cluster voxel size = 177; 
nearest (±5) GM peak voxel = BA 7). The final cluster overlapped with the left 
precuneus and lateral occipital cortex (cluster t-score = 5.79; p-cluster FDR = 
.006; MNI peak coordinates (-14, -74, 36); cluster voxel size = 151; nearest 
(±5) GM peak voxel = BA 7). 
For individuals with ASD, the left dACC seed region overlapped with seven 
clusters. The first cluster included the bilateral cingulate gyrus, paracingulate 
gyrus, superior frontal gyrus, juxtapositional lobule cortex (also known as the 
supplementary motor cortex), pre-central gyrus, post-central gyrus, 
precuneus, superior parietal lobule (cluster t-score = 14.62; p-cluster FDR < 
.001; MNI peak coordinates (-08, 16, 34); cluster voxel size = 10,029; nearest 
(±5) GM peak voxel = BA 32). The second cluster included the right insular 
cortex, opercular cortex (frontal, central and parietal), frontal orbital cortex, 
frontal pole, inferior frontal gyrus (including pars triangularis and opercularis), 
supramarginal gyrus, pre and post-central gyrus, superior temporal gyrus 
(including the planum polare, planum temporale and Heschl’s gyrus), middle 
temporal gyrus (posterior division), temporal pole, putamen, pallidum, 
thalamus (cluster t-score = 8.71; p-cluster FDR < .001; MNI peak coordinates 
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(46, 12, 00); cluster voxel size = 8,444; nearest (±5) GM peak voxel = BA 
13). The third cluster overlapped with the left insular cortex, opercular cortex, 
frontal orbital cortex, inferior frontal gyrus (including pars triangularis and 
opercularis), supramarginal gyrus, pre and post-central gyrus, superior 
temporal gyrus (including the planum polare, planum temporale, Heschl’s 
gyrus and temporal pole), putamen, pallidum, thalamus, accumbens and 
amygdala (cluster t-score = 8.94; p-cluster FDR < .001; MNI peak 
coordinates (-42, 08, 04); cluster voxel size = 7,259; nearest (±5) GM peak 
voxel = BA 13). The forth cluster encompassed the left frontal pole and 
middle frontal gyrus (cluster t-score = 9.63; p-cluster FDR < .001; MNI peak 
coordinates (-32, 44, 26); cluster voxel size = 917; nearest (±5) GM peak 
voxel = BA 10). The firth cluster overlapped with the right frontal pole and 
middle frontal gyrus (cluster t-score = 6.66; p-cluster FDR < .001; MNI peak 
coordinates (28, 44, 30); cluster voxel size = 524; nearest (±5) GM peak 
voxel = BA 10). The sixth cluster comprised of the left lateral occipital cortex 
and occipital fusiform gyrus (cluster t-score = 7.31; p-cluster FDR < .001; 
MNI peak coordinates (-46, -76, -08); cluster voxel size = 471; nearest (±5) 
GM peak voxel = BA 19). The seventh cluster overlapped with the brainstem 
and hippocampus (cluster t-score = 6.20; p-cluster FDR = .015; MNI peak 
coordinates (-10, -16, -14); cluster voxel size = 139; nearest (±5) GM peak 




Table 5.2 Seed-to-Voxel Analysis For Individuals with Autism Spectrum Disorder (n = 
15) 








  x y z     
RDACC Seed         
Anterior Cingulate B 06 18 32 
BA 
32 
19,624 12.06 < .001 
Insula L -50 06 04 
BA 
22 
6,945 9.04 < .001 
Frontal Pole R 28 42 30 
BA 
10 
605 7.14 < .001 
Lateral Occipital 
Cortex 
L -42 -72 -06 
BA 
19 
511 7.68 < .001 
Temporal Occipital 
Fusiform Cortex 
L -30 -58 -20 
BA 
19 
416 6.23 < .001 
Frontal Pole L -30 36 26 
BA 
10 
404 6.17 < .001 
Lateral Occipital 
Cortex 
R 48 -64 00 BA 9 290 7.28 < .001 
Precuneous L 16 -60 42 BA 7 177 5.38 = .003 
Precuneus R -14 -74 36 BA 7 151 5.79 =.006 
Left DACC Seed         
Anterior Cingulate B -08 16 34 
BA 
32 
10,029 14.62 < .001 
Insula R 46 12 00 
BA 
13 
8,444 8.71 < .001 
Insula  L -42 08 04 
BA 
13 
7,259 8.94 < .001 
Frontal Pole L -32 44 26 
BA 
10 
917 9.63 < .001 
Frontal Pole R 28 44 30 
BA 
10 
524 6.66 < .001 
Lateral Occipital 
Cortex 
L -46 -76 -08 
BA 
19 
471 7.31 < .001 
Brain Stem/ 
Hippocampus 
L -10 -16 -14 
Sub 
N 
139 6.20 .015 
Clusters significantly associated with the right and left dACC in individuals with ASD (voxel-
wise uncorrected p < 0.001 and FDR cluster corrected p < .05). Brain region and 
Hemisphere represent brain region overlapping with the largest number of voxels in the 
cluster. MNI coordinates represent peak effect in a cluster. GM represent closest GM defined 
area (within 5 mm) to peak voxel coordinate according to the Talairach Daemon atlas in 
WFU-pickatlas software 
603,604
. Cluster size, KE, represents the spatial extent or the number 
of voxels in a cluster. T-score and p-value are at the cluster level. 
B, bilateral; dACC, dorsal anterior cingulate cortex, BA; Brodmann area; FDR, false 
discovery rate; Hemi, hemisphere; L, left; MNI, Montreal Neurological Institute; R, right; Sub 




Figure 5.1 Right Dorsal Anterior Cingulate Resting-State Functional Connectivity 
Maps for Each Group 
 
Regions of the brain which were functionally correlated with the right dACC for individuals 
with ASD in red (t(1,14) ≥ 3.79, k ≥ 151) and NCs in blue (t(1,16) ≥ 3.69, k ≥ 537). Results 




Figure 5.2 Left Dorsal Anterior Cingulate Resting-State Functional Connectivity Maps 
for Each Group 
Regions of the brain which were functionally correlated with the left dACC for individuals with 
ASD (n =15) in red (t(1,14) ≥ 3.79, k ≥ 139) and NCs (n= 17) in blue (t(1,16) ≥ 3.69, k ≥ 86). 
Results were voxel-wise uncorrected p < .001 and FDR cluster corrected p < .05. 
5.3.4 Functional Connectivity Between Groups 
There were no significant differences between groups in dACC functional 
connectivity for either seed region at voxel-wise uncorrected p < 0.001 and 




5.3.5 Functional Connectivity and Associations 
5.3.5.1 Autism Diagnostic Observation Scores 
For individuals with ASD, there were no significant associations between 
dACC functional connectivity and ADOS scores (total, communication or 
social) at voxel-wise uncorrected p < 0.001 and FDR cluster corrected p < 
.05. 
5.3.5.2 Conflict Effect Response Time 
For individuals with ASD, the connectivity between the left dACC to right 
superior lateral occipital cortex (LOC) was significantly and negatively 
associated with conflict RT (cluster t-score = -6.15,  p-cluster FDR = .028; 
MNI peak coordinates (30, -60, 56); cluster voxel size = 133; nearest (±5) 
GM peak voxel = BA 7). In other words, RTs for incongruent flanker 
conditions were closer to congruent flanker RTs (considered improved 
conflict effect performance) when there was closer coupling between the left 
dACC and the LOC in individuals with ASD. There were no other significant 
relationships or group interactions between functional connectivity for the 





Figure 5.3 Left Dorsal Anterior Cingulate Seed-to-voxel Cluster Correlated with 
Conflict Response Time in Individuals with Autism Spectrum Disorder (n = 12) 
 
Individuals with ASD had improved performance during tasks requiring increased cognitive 
control in association with increased functional connectivity between the left dACC and the 
right occipital cortex cluster (cluster t-score = -6.15,.p-cluster FDR = .028; MNI peak 
coordinates (30, -60, 56); cluster voxel size = 133; nearest (±5) GM peak voxel = BA 7). The 
cluster is shown in blue. 
 
For further clarification of this association in NCs and individuals with ASD, 
we ran a ROI-to-ROI analysis of functional connectivity between the left 
dACC and previously identified right superior LOC cluster for all participants. 
184 
 
Then we visually investigated the association between connectivity and 
conflict RT via a scatterplot. Individuals with ASD have a clear relationship 
between the left dACC and right LOC functional connectivity. This 
relationship was less evident in NCs (figure 5.4). 
 
Figure 5.4 Conflict Response Time and Left Dorsal Anterior Cingulate Functional 
Connectivity to the Right Lateral Occipital Cortex 
In individuals with ASD (n = 12), conflict RT scores were negatively associated with 
functional connectivity between the left dACC and the Right LOC. This relationship was not 
shown in NCs (n = 14). 
5.3.5.3 Glutamate 
In NCs, there was no significant relationship between resting-state functional 
connectivity and Glu concentrations for the left or right dACC seed region. 
For individuals with ASD, connectivity between the right dACC and a cluster 
overlapping with the left anterior temporal fusiform cortex, temporal pole, 
frontal orbital cortex and parahippocampal gyrus were significantly and 
negatively associated with dACC Glu concentrations (cluster t-score = -8.49; 
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p-cluster FDR < .001; MNI peak coordinates (-34, 02, -26); cluster voxel size 
= 326; nearest (±5) GM peak voxel = BA = 28) (figure 5.5). 
Furthermore, in individuals with ASD, connectivity between the left dACC and 
the left anterior temporal fusiform cortex, parahippocampal gyrus and 
temporal pole was significantly and negatively associated with dACC Glu 
concentrations (figure 5.6) (cluster t-score = -7.19, p-cluster FDR = .015; MNI 
peak coordinates (-32, -02, -36); cluster voxel size = 158; nearest (±5) GM 





Figure 5.5 Glutamate Concentrations Associated with Right Cingulate to Left Medial 
Temporal Lobe Functional Connectivity in Individuals with Autism Spectrum Disorder 
(n = 13) 
Glu concentrations in individuals with ASD were positively associated with right dACC 
connectivity and a cluster primarily located in the left medial temporal lobe (cluster t-score = -
8.49; p-cluster FDR < .001; MNI peak coordinates (-34, 02, -26); cluster voxel size = 326; 






Figure 5.6 Glutamate Concentrations Associated with Left Cingulate to Left Medial 
Temporal Lobe Cluster Functionally Connectivity in Individuals with Autism Spectrum 
Disorder (n = 13) 
Glutamate concentrations in individuals with ASD were positively associated with left dACC 
connectivity and a cluster in the left temporal lobe (cluster t-score = -7.19; p-cluster FDR = 
.015; MNI peak coordinates (-32, -02, -36); cluster voxel size = 158; nearest (±5) GM peak 
voxel = BA 28). The significant cluster is displayed in blue. 
 
5.3.5.4 Glutamate and Glutamine Concentrations 
For NCs, connectivity between the left dACC functional connectivity in a 
cluster overlapping with the right insular and central opercular cortex was 
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significantly and positively associated with dACC Glx concentrations and 
(cluster t-score = 7.21; p-cluster FDR < .001; MNI peak coordinates (36, -10, 
20); cluster voxel size = 162; nearest (±5) GM peak voxel = BA 13). 
Additionally for NCs, the connectivity pattern between the left dACC in a 
cluster overlapping with the right supramarginal gyrus was significantly and 
negatively associated with dACC Glx concentrations (cluster t-score = -7.41, 
p-cluster FDR = .004; MNI peak coordinates (56, -36, 52); cluster voxel size 
= 197; nearest (±5) GM peak voxel = BA 40). There were no further 






Figure 5.7 Left Dorsal Anterior Cingulate Cortex Functional Connectivity in Two 
Clusters Associated with Glutamate and Glutamine Concentrations in Neurotypical 
Controls (n = 15) 
The associations between left dACC Glx concentrations and functional connectivity in NCs.  
(Left) Glx concentrations in NCs were positively associated with resting-state functional 
connectivity between the left dACC and a cluster including the insular cortex and central 
operculum cortex (cluster t-score = 7.21; p-cluster FDR < .001; MNI peak coordinates (36, -
10, 20); cluster voxel size = 162; nearest (±5) GM peak voxel = BA 13). (Right) Glx 
concentrations were also negatively associated with functional connectivity between the left 
dACC and the right supramarginal gyrus (cluster t-score = -7.41; p-cluster FDR = .004; MNI 
peak coordinates (56, -36, 52); cluster voxel size = 197; nearest (±5) GM peak voxel = 40).  
For individuals with ASD, Glx concentrations for the dACC were significantly 
and negatively associated with right dACC functional connectivity between 
five clusters. The first cluster overlapped with the left temporal pole, temporal 
fusiform cortex, amygdala, hippocampus, frontal orbital cortex and 
parahippocampal gyrus (cluster t-score =-11.43; p-cluster FDR < .001; MNI 
peak coordinates (-32, 02, -26); cluster voxel size = 429; nearest (±5) GM 
peak voxel = BA 28). The second cluster overlapped with the right superior 
temporal gyrus (including the planum polare, planum temporale and Heschl’s 
gyrus), insular cortex, central and parietal operculum cortex (cluster t-score = 
190 
 
-9.40; p-cluster FDR < .001; MNI peak coordinates (42, -16, -06); cluster 
voxel size = 349; nearest (±5) GM peak voxel =BA 13). The third cluster 
overlapped with the right temporal pole, anterior parahippocampal gyrus, 
hippocampus, amygdala and temporal fusiform cortex (cluster t-score = -
8.86; p-cluster FDR < .001; MNI peak coordinates (28, -06, -30); cluster voxel 
size = 319; nearest (±5) GM peak voxel =BA 28). The fourth cluster 
overlapped with the left superior temporal gyrus (including the planum polare, 
planum temporale and Heschl’s gyrus) (cluster t-score = -10.24; p-cluster 
FDR = .027; MNI peak coordinates (-38, -28, 02); cluster voxel size = 105; 
nearest (±5) GM peak voxel = BA 13). The final cluster overlapped with the 
brain stem (cluster t-score = -8.39; p-cluster FDR = .046; MNI peak 
coordinates (-04, -20, -26); cluster voxel size = 86; nearest (±5) GM peak 
voxel = Pons) (table 5.3). 
For individuals with ASD, increased Glx concentrations for the dACC were 
associated with decreased left dACC functional connectivity between two 
clusters. The first cluster overlapped with the right superior temporal gyrus 
(including the planum temporale and Heschl’s gyrus) and central and parietal 
operculum (cluster t-score = -8.90; p-cluster FDR = .001; MNI peak 
coordinates (54 -24 10); cluster voxel size = 244; nearest (±5) GM peak voxel 
= BA 41). The second cluster overlapped with the left temporal fusiform 
cortex, anterior parahippocampal gyrus and inferior temporal (cluster t-score 
= -9.23; p-cluster FDR = .001; MNI peak coordinates (-36 -08 -32); cluster 
voxel size = 255; nearest (±5) GM peak voxel = BA 20) (table 5.3). For 
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individuals with ASD, there were no clusters with a positive association with 
Glx and functional connectivity for the left or right dACC. 
Table 5.3 Glutamate and Glutamine Concentrations Association with Seed-to-Voxel 
Resting-State Functional Connectivity in Individuals with Autism Spectrum Disorder 
(n=12) 
Brain Region Hemi 
MNI 
coordinates 
GM kE t-score p-value 
  x y z     
RDACC Seed         
Superior Temporal 
Gyrus (Temporal Pole) 
L -32 02 -26 BA 28 429 -11.43 <.001 
Superior Temporal 
Gyrus/ Insula 
R 42 -16 -06 BA 13 349 -9.40 <.001 
Temporal Pole R 28 -06 -30 BA 28 319 -8.86 <.001 
Superior Temporal 
Gyrus 
L -38 -28 02 BA 13 105 -10.24 = .027 
Brain Stem B -04 -20 -26 Pons 140 -8.39 = .006 
Left DACC Seed         
Superior Temporal 
Gyrus 
R 54 -24 10 BA 41 244 -8.90 = .001 
Temporal Fusiform 
Cortex 
L -36 -08 -32 BA 20 225 -9.23 = .001 
Association between Glx concentrations and seed-to-voxel resting-state functional 
connectivity (right and left dACC) in individuals with ASD (voxel-wise uncorrected p < 0.001 
and FDR cluster corrected p < .05). Increased Glx concentrations were associated with 
decreased functional connectivity in the above clusters. There were no significant positive 
associations between Glx and resting-state seed-to-voxel functional connectivity for 
individuals with ASD. 
Brain region and Hemi represent brain region overlapping with the largest number of voxels 
in the cluster. MNI coordinates represent peak effect in a cluster. GM represent closest GM 
defined area (within 5 mm) to peak voxel coordinate according to the Talairach Daemon 
atlas in WFU-pickatlas software 
603,604
. Cluster size, kE, represents the spatial extent or the 
number of voxels in a cluster. p-value is reported at the cluster level. 
Amg, amygdala; bilateral; dACC, dorsal anterior cingulate cortex, BA; Brodmann area; FDR, 
false discovery rate; Hemi, hemisphere; Hip, Hippocampus; L, left; MNI, Montreal 
Neurological Institute; NA, Not applicable; R, right; 
 
For the right dACC, there was a significant interaction between group and 
Glx concentration in two clusters. The first cluster overlapped with the right 
insular cortex, superior temporal cortex (Heschl’s gyrus) and central and 
parietal operculum (cluster t-score = 5.49; p-cluster FDR = .003; MNI peak 
coordinates (38, -14, 18); cluster voxel size = 271; nearest (±5) GM peak 
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voxel = BA 13). The second cluster overlapped with the left thalamus, 
hippocampus, parahippocampal gyus, precuneous, posterior cingulate cortex 
and lingual gyrus (cluster t-score = 6.78; p-cluster FDR = .003; MNI peak 
coordinates (-14, -36, 04); cluster voxel size = 251; nearest (±5) GM peak 





Figure 5.8 Cluster 1: Brain Region with Group Interaction in Association Between 
Right Dorsal Anterior Cingulate Seed Functional Connectivity and Glutamate and 
Glutamine Concentrations 
There was a significant interaction between groups in the relationship between Glx 
concentrations and functional connectivity between the right dACC and cluster overlapping 
with the right insular cortex, operculum and superior temporal cortex (cluster t-score = 5.49; 
p-cluster FDR = .003; MNI peak coordinates (38 -14 18); cluster voxel size = 271; nearest 





Figure 5.9 Cluster 2: Brain Region with Group Interaction in Association Between 
Right Dorsal Anterior Cingulate Seed Functional Connectivity and Glutamate and 
Glutamine Concentrations 
There was a significant interaction between groups in the relationship between Glx 
concentrations and functional connectivity between the right dACC and cluster overlapping 
with the subcortical structures such as the left thalamus, hippocampus and parahippocampal 
gyrus (cluster t-score = 6.78; p-cluster FDR = .003; MNI peak coordinates (-14, -36, 04); 
cluster voxel size = 251; nearest (±5) GM peak voxel = thalamus). The cluster is highlighted 












Figure 5.10 Contrasting Group Relationships between Glutamate and Glutamine 
Concentrations and Right Dorsal Anterior Cingulate Functional Connectivity 
(Top) The relationship between Glx concentrations and right dACC functional connectivity 
with a cluster overlapping with the right insular cortex, superior temporal cortex and 
opercular cortex by group. (Bottom) The relationship between Glx concentrations and right 
dACC functional connectivity with a cluster overlapping with the left thalamus, hippocampus, 
parahippocampal gyrus, precuneus, posterior cingulate cortex and lingual gyrus by group. In 
NCs, as Glx concentrations increased there was a definite increase in FC. In contrast, for 





For the left dACC, there was a significant interaction between group and Glx 
concentrations in a cluster overlapping with the right insular cortex, superior 
temporal cortex (Heschl’s gyrus) and central and parietal operculum (cluster 
t-score = 6.33; p-cluster FDR < .001; MNI peak coordinates (32, -04, 18); 
cluster voxel size = 420; nearest (±5) GM peak voxel = BA 13) (figures 5.8, 







Figure 5.11 Brain Regions with Group Interaction in Association between Left Dorsal 
Anterior Cingulate Seed Functional Connectivity and Glutamate and Glutamine 
Concentrations 
There was a significant interaction between groups in the relationship between Glx 
concentrations and functional connectivity between the right dACC and cluster overlapping 
with the right insular cortex, operculum and superior temporal cortex (cluster t-score = 6.33; 
p-cluster FDR < .001; MNI peak coordinates (; 32, -04, 18); cluster voxel size = 420; nearest 





Figure 5.12 Contrasting Group Relationships between Glutamate and Glutamine 
Concentrations and Left Dorsal Anterior Cingulate Functional Connectivity 
The relationship between Glx concentrations and right dACC functional connectivity with a 
cluster overlapping with the insular cortex, superior temporal cortex (Heschl’s gyrus) and 
opercular cortex. In NCs, as Glx concentrations increased there was a definite increase in 
functional connectivity. In contrast, for individuals with ASD, the relationship between Glx 
and functional connectivity is less defined but appears to show a negative relationship. 
5.4 DISCUSSION 
We investigated the relationship between Glu and Glx concentrations and 
functional connectivity to add further context into how altered metabolite 
concentrations might contribute to ASD pathology. Our analysis suggests 
that Glx concentrations have an altered relationship to dACC seed-to-voxel 
resting-state functional connectivity within salience network brain regions in 
individuals with ASD compared to NCs (chapter 5.3.5.3). To our knowledge, 
we are the first group to report this relationship, and therefore, more research 
is required. Nevertheless, our analysis suggests an incongruence between 
local metabolites and long-distance function in individuals with ASD. 
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Although not our primary focus, we also reported that increased dACC 
resting-state functional connectivity to the occipital lobe correlated with 
improved conflict effect RT only in participants with ASD (chapter 5.3.5.2). 
We did not report any group difference in functional connectivity (chapter 
5.3.4) nor did we report any association between dACC functional 
connectivity and core ASD symptoms (as measured by the ADOS) in 
individuals with ASD (chapter 5.3.5.1). We discuss these results in more 
detail below. 
5.4.1 Functional Connectivity Within and Between Groups 
Overall, the data further support evidence that the dACC is functionally 
connected to neocortical, motor, paralimbic and subcortical brain regions in 
both NCs and individuals with ASD. Resting-state functional connectivity 
analyses have linked the dACC with frontal cognitive brains regions such as 
the DLPFC and VLPFC 380,381. In agreement with these studies, our dACC 
seed regions were positively correlated with seed regions in the superior, 
middle and inferior frontal gyrus in NCs. In agreement with Cao and 
colleagues 381, we also reported that the dACC was positively correlated with 
other parietal regions such as the precuneus and the supramarginal gyrus 
302. Again, like previous analyses 302,380,381, we also reported that the dACC 
was positively correlated with the motor areas including the pre, post-central 
gyrus and supplementary motor cortex. Our results also replicate previous 
functional connectivity studies reporting an association between the dACC 
and paralimbic, limbic and subcortical regions 302,380,381. The dACC was 
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functionally connected with the insular cortex, operculum, frontal orbital 
cortex and temporal pole. We also reported that the dACC was correlated 
with the thalamus, striatum, pallidum and nucleus accumbens. 
In agreement with Zhou et al. (2016), we did not report group differences in 
dACC seed-to-voxel functional connectivity in individuals with ASD compared 
to NCs. Furthermore, there were no significant associations between dACC 
functional connectivity and ADOS scores in participants with ASD, 
suggesting that the functional connectivity between the dACC and the brain 
had little relationship to a diagnosis of ASD or the core symptoms of the 
disorder. This may also reflect heterogeneity in our sample of individuals with 
ASD. Furthermore, we were limited by small sample sizes, and it is unclear if 
our lack of group differences in functional connectivity might be related to 
false negative results or type II error.  
Unfortunately, we were unable to investigate the relationship between ADOS 
scores for both imagination and stereotyped behaviours and dACC functional 
connectivity because most participants in our study had a score of zero on 
this section of the ADOS. Previous studies have reported an association 
between resting-state functional connectivity between the caudal ACC and 
insular cortex and repetitive and stereotypical movement scores in individuals 
with ASD 605. In the future, a more sensitive measure for various ASD 
behaviours and symptoms might provide more meaningful associations with 
dACC functional connectivity. 
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As an aside, functional connectivity clusters in participants with ASD were 
smaller and more numerous suggesting greater fracture in brain networks 
associated with the dACC. In individuals with ASD, we reported two or three 
large brain clusters overlapping with salience network and neocortical 
regions, which were similar to those which we reported in NCs. On the other 
hand, we also reported small clusters of brain regions in individuals with 
ASD. For example, for the right dACC region, we reported several clusters 
separately in left and right precuneus, frontal pole/middle frontal gyrus, and 
lateral occipital cortex/middle temporal gyrus.  
There has been evidence of network fracture during executive control tasks 
in individuals with ASD compared to NCs. Just and colleagues (2007) 
investigated the functional connectivity of individuals with ASD compared to 
NCs during the Tower of London task. As a first step in the analysis, 
investigators reported little difference in the BOLD response between low 
executive control compared to high executive control conditions between 
groups. Nevertheless, investigators reported evidence of less 
synchronization between frontal and parietal brain regions in individuals with 
ASD compared to NCs. Firstly, participants with ASD had reduced mean 
functional connectivity between regions in the frontal cortex (DLPFC and 
inferior frontal gyrus) and parietal cortex (precuneus and intraparietal sulcus). 
Secondly, researchers also applied an exploratory factor analysis to thirteen 
predefined ROIs including the frontal and parietal brain regions. Individuals 
with ASD had two independent factors separating parietal and frontal brain 
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regions while these brain regions were incorporated into one factor for NCs 
606. 
Nevertheless, our result of greater network fracture was only speculation. We 
discuss this point to suggest useful future analysis. For example, an 
independent components analysis might better define separate networks of 
brain regions and offer a clearer picture of network fracture in individuals with 
ASD compared to NCs. 
5.4.2 Functional Connectivity Association with Metabolite Concentrations 
In NCs, it is unclear why we did not find a relationship between Glu 
concentrations and functional connectiity. We cannot entirely exclude the 
possibility that our methodology imprecisely quantified Glu concentrations. 
Nevertheless, we argue this was unlikely because our methodology was 
taken from and supported by evidence that Glu concentrations can be 
reliably obtained at 3 T 484. Furthermore, all CRLB scores included in this 
analysis for Glu and Glx concentrations had good validity being below 18%.  
Alternatively, Glu has many other functions besides neurotransmission and is 
stored in large pools in neurons. One of the limitations of 1H-MRS is that it 
cannot differentiate the location of a metabolite in the voxel and the many 
functions of Glu. Following neurotransmission, Glu is rapidly converted to 
Gln. Therefore, Glx concentrations, which includes the Gln signal, might be 
more closely associated with the GGC between neurones and astrocytes 
and, therefore, more closely index excitatory signalling 490,607–609. In NCs, the 
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lack of relationship between Glu and functional connectivity weakly support 
this conclusion.  
In individuals with ASD, increased Glu and Glx concentrations were 
correlated with decreased dACC functional connectivity to temporal, 
paralimbic and subcortical regions (table 5.4; figure 5.5 and 5.6). In contrast, 
for NCs, increased Glx concentrations correlated with increased functional 
connectivity with the insular and opercular cortex (figure 5.7). 
We also reported an interaction between groups in the association between 
Glx and functional connectivity in the salience network. In participants with 
ASD, increased Glx concentrations were associated with reduced functional 
connectivity between the right dACC and a cluster overlapping with the right 
insular cortex, superior temporal lobe and opercular cortex while NCs 
exhibited the opposite relationship. Similarly, increased Glx concentrations in 
individuals with ASD were associated with reduced functional connectivity 
between the left dACC and a cluster overlapping the right insular cortex, 
operculum and superior temporal lobe (figure 5.9 and 5.10), while NCs again 
had the opposite relationship. Finally, increased Glx concentrations were 
associated with reduced functional connectivity between the right dACC and 
a cluster primarily overlapping with the thalamus in individuals with ASD, 
while again NCs have the opposite relationship (figure 5.9). 
The thalamus is a relay station between bottom-up sensory information and 
both the neocortex and the paralimbic cortex 610. Researchers have reported 
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altered volume 611,612, neural integrity 242, glucose metabolism 613, and WM 
integrity near the thalamus of individuals with ASD compared to NCs 614. 
The superior temporal lobe has been associated with social-emotional 
neurocognitive function and multisensory integration 615–617 and also auditory 
processing and language development 618. Several studies have suggested 
an altered functional response in individuals with ASD in this region 619–622. 
Finally, the insular cortex is structural and functionally interconnected with the 
frontal cortex and limbic/subcortical brain regions 302,379,623. The insular cortex 
and dACC are central regions in the salience network 302,306 and closely 
functionally connected in NCs 310. Functional connectivity between the dACC 
and insular cortex have been associated with the integration of emotional and 
body perceptions to guide behaviour 302,383,384,386. Studies have reported an 
altered functional response in the insular cortex 120,620,622,624–627 and altered 
functional connectivity to salience network brain regions in individuals with 
ASD 404,408,628–631. Altered functional connectivity and function in the salience 
network, particularly in association with the insular cortex, could be 
associated with altered sensory and social symptoms associated with ASD 
632,633. 
Nevertheless, or analysis did not provide any clues to indicate if increased 
functional connectivity in the salience network was a benefit or deficit to 
behaviour in individuals with ASD. Based on previous evidence, increased 
functional connectivity in the salience network regions was associated with 
reduced symptom severity in individuals with ASD. Greater resting-state 
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functional connectivity between the salience network, centred on the dACC 
and insular cortex, has been associated with greater long-term improvement 
in adaptive behaviours in children with a diagnosis of ASD 634 and reduced 
stereotyped behaviours and restricted interests in adults with ASD compared 
to NCs 605. Evidence also suggests that increased functional connectivity in 
the salience network was associated with increased attention to emotion and 
internal experience in NCs 302. 
Several investigators have proposed the theory of local overconnectivity in 
association with reduced long-range functional connectivity in participants 
with ASD 635–637. The reason for this disconnect is unclear. Some hypotheses 
include increased excitatory to inhibitory signalling which favour local function 
over long-distance function 637. Alternatively, alterations in cortical 
development such as altered apoptosis, neuronal migration or neurogenesis 
might also lead to incongruency between local and distant brain function 
97,638. Although much more research is required to fully confirm evidence of 
local over-connectivity 639, our data appear to support a general disconnect 
between local Glx and long-distance functional connectivity in individuals with 
ASD compared to NCs. 
In the ACC, there has been evidence of reduced inhibitory influence and 
future studies might wish to further investigate GABA in more detail. A post-
mortem autoradiography study reported a reduction in GABAB receptors in 
both the ACC/MPFC and fusiform gyrus of individuals with ASD compared to 
NCs 640. Although one group did not report a baseline difference in Glu to 
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GABA, they did report that pharmacologically manipulating the proportion of 
GABA concentrations relative to both Glu and GABA concentrations in 
individuals with ASD lead to a more neurotypical functional connectivity in 
association with the dACC 641. If Glx concentrations are not properly 
balanced by inhibition in ASD, extreme Glx might be associated with local 
hyper or hypo excitation in resting-state functional networks leading to 
extreme (increased or decreased) local function and altered long-distance 
functional connectivity 637. 
Interestingly, in NCs, greater Glx concentrations in the dACC were also 
associated with reduced functional connectivity between the left dACC and 
the right supramarginal gyrus located in inferior parietal cortex. This evidence 
likely reflects anticorrelations between the salience network and the default 
mode network 597,642, a network of brain regions having an increased BOLD 
response in association with spontaneous internal thought 643,644. The right 
supramarginal gyrus has been associated with tasks involving proprioception 
645 and empathy in NCs 646. Researchers have demonstrated that the default 
mode network includes the inferior parietal cortex along with the posterior 
cingulate cortex and retrosplenial cortex 268,647,648. 
Kapogiannis and colleagues (2013) reported that in NCs Glu/Cre 
concentrations in the posterior medial cortex, a region associated with the 
default mode network, were positively associated with functional connectivity, 
as measured by independent component analysis, with only other default 
mode network regions. Researchers concluded that Glu/Cre predicted within 
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network functional connectivity but was not associated with functional 
connectivity within other brain networks 291. Our analysis suggests a slightly 
different interpretation in the case of the dACC. In NCs, our data also 
suggest that dACC Glx concentrations were negatively associated with brain 
regions in the default mode network 597,642. Nevertheless, this result requires 
further investigation as other studies have reported that the BOLD activity in 
the dACC was positively correlated with the supramarginal gyrus 381. 
5.4.3 Functional Connectivity Association with Conflict Effect Performance 
Contrary to previous evidence 387, we did not report any association between 
dACC functional connectivity and conflict effect RT in NCs. We assessed 
resting-state functional connectivity in relation to performance of the ANT 
when completed in a laboratory environment at a different time. Therefore, 
functional connectivity between these regions may impact performance while 
an individual completes the ANT, but it does not appear to predict future 
performance in NCs. 
In individuals with ASD, shorter conflict effect RTs were associated with 
increased functional connectivity between the left dACC and the right 
superior LOC. A metanalysis of brain research suggests that LOC is 
functionally associated with sensory visual object recognition tasks in NCs 
649. Much more research is required to investigate this relationship, but this 
result may reflect altered brain function in individual with ASD as the LOC 
was not associated with the conflict effect task in NCs 24,26  
208 
 
In further support of altered function in the LOC in individuals with this 
disorder, one fMRI investigation assessed the BOLD response to an oddball 
task in individuals with ASD and NCs. During the task, circles changed to 
novel shapes, ovals pointed in a deviant direction or ovals pointe in a 
standard direction. Researchers reported an increased BOLD response in 
both the bilateral LOC and dACC in individuals with ASD to both novel and 
deviant shapes compared to NCs. Investigators also applied a 
psychophysiological interaction analysis, which models how a seed region (in 
this study the dACC) influences other regions of the brain in association with 
various experimental conditions 650. Investigators reported that during the 
introduction of deviant shapes the dACC time series correlated with cognitive 
brain regions such as the superior parietal lobule, frontal-pole and middle 
frontal gyrus in NCs while individuals with ASD had increased connectivity to 
sensory regions such as the LOC. 
There were some limitations to our analysis. In addition to a small sample 
size which we previously discussed, we were unable to independently 
quantify extracellular and intracellular Glu concentrations or establish the 
specific function of Glu in a voxel with 1H-MRS 651. Given that Glu has 
various functions in the brain, it is impossible to determine the exact role of 
Glu or Glx concentrations 652. Therefore, it was unclear if metabolite 
concentrations had the same role in each group. 
Furthermore, although we attempted to correct for non-neural artefacts, the 
issue of head motion has been shown to exacerbate group differences in 
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functional connectivity analyses 273. Therefore, as with 1H-MRS, the results of 
our resting-state functional connectivity analysis require follow up and 
confirmation with more direct investigation 264. 
Even with these disadvantages, 1H-MRS is an imaging method which allows 
an investigator to measure metabolite concentrations in human participants 
within the brain both non-invasively and in-vivo. In comparison, other 
methods of measuring Glu concentrations typically rely on post-mortem 
dissection or require invasive contrast agents, as applied in PET imaging. 
Furthermore, a 1H-MRS dataset can be easily acquired during the same 
scanning session because it utilises conventional MRI technology. Therefore, 
it is a good starting point to investigate the relationship between altered Glu 
or Glx concentrations and functional connectivity. 
5.5 CONCLUSION 
 
Our analysis suggested that Glx concentrations in the dACC, rather than Glu, 
predicted resting-state functional connectivity to other functionally associated 
brain regions in NCs. Most strikingly, Glx concentrations in the dACC were 
incongruent with functional connectivity in individuals with ASD but congruent 
in NCs. Researchers have suggested that variations in local excitatory or 
inhibitory signalling mechanisms might be implicated in cortical alterations 
that cause altered long-distance functional connectivity typical of participants 
with ASD 637,653. We support this hypothesis with our data, although we can 
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only speculate about the cause of group interactions. More research is 
required to both replicate and understand the mechanism behind our results. 
Additionally, we were unable to provide further behavioural context to this 
group interaction. We did not report any relationship between salience 
network functional connectivity and symptoms of the disorder in individuals 
with ASD. Previous evidence has suggested that increased salience network 
functional connectivity is beneficial for individuals with ASD 605,634. Therefore 
we speculate that increased Glx concentrations might be maladaptive in 
individuals with ASD. In the future, a more thorough analysis must clarify how 
and if altered Glx mediates behaviour by impacting functional connectivity in 












Glutamate is the primary excitatory neurotransmitter in the brain and 
essential for cortical development, neural communication and plasticity. 
Altered Glu concentrations in the brain will likely have far-reaching 
consequences regarding cerebral health, development and function 132. 
Previous 1H-MRS studies have reported altered Glu and Glx concentrations 
in the brains of individuals with ASD compared to NCs 217,225–234,236–238 while 
other studies reported no differences 240–246. 
This investigation applied a multimodal imaging sequence to investigate 
dACC Glu and Glx concentrations, brain anatomy and resting-state functional 
connectivity in NCs and individuals with ASD. We also investigated the 
relationships between metabolite concentrations and core autistic symptoms, 
demographic characteristics and conflict effect performance. The conflict 
effect task was an inhibition to distraction task which was selected because 
of its functional association with the dACC in NCs. There has also been 
evidence of hypoactivation of the dACC during the conflict effect task in 
individuals with ASD compared to NCs 26. Finally, given evidence that Glu 
and Glx concentrations were associated with functional connectivity to other 
brain regions in NCs 258,290, we also investigated the relationship between 
Glu and Glx concentrations in the dACC and resting-state seed-to-voxel 
functional connectivity. 
The purpose of investigating these relationship was to provide further context 
of Glu and Glx alteration in the brains of individuals with ASD. To our 
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knowledge, we are the first group to investigate Glu concentrations in the 
dACC of adult participants with ASD, although other groups have 
investigated Glx concentrations in the same brain region 245. We are also the 
first group to explore the relationship between Glu or Glx concentrations and 
functional connectivity in participants with ASD.  
The first objective of this chapter is to summarise the primary results (chapter 
6.2). Next, we explain the implications (chapter 6.3), strengths (chapter 6.4) 
and limitations (chapter 6.5) of this research. In conclusion, a discussion of 
worthwhile avenues for future research following on from our analysis is 
presented (chapter 6.6). 
6.2 SUMMARY OF MAIN FINDINGS 
We reported no significant difference in Glu concentrations in individuals with 
ASD compared to NCs both in the full group and when excluding participants 
taking anticonvulsant and antidepressant medications. Age was a significant 
predictor of Glu concentrations for both study groups. We also reported no 
significant differences in both Glx and NAA + NAAG concentrations for 
individuals with ASD compared to NCs.  
Nevertheless, when excluding individuals not taking psychotropic 
medications, there was an interaction between age and group for Glx 
concentrations for individuals. This evidence weakly suggests that individuals 
with ASD had a greater decrease in Glx concentrations with age than NCs. 
Also, Glx concentrations were significantly correlated with NAA + NAAG 
concentrations in individuals with ASD but not NCs. Nevertheless, none of 
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these results survived correction for multiple comparisons. Given our small 
sample size, replication of these uncorrected results is warranted to rule out 
type I error.  
During our second experiment, we reported that the conflict effect inhibition 
task had no relationship to metabolite concentrations in the dACC. 
Furthermore, in contrast to Fan and colleagues 2012 26, our analysis was 
unable to replicate performance deficits on the ANT in individuals with ASD 
compared to NCs. We did report that when participants with ASD had 
decreased conflict effect RT, they also had increased communication deficit 
as measured by the ADOS. Again, this later correlation did not survive 
correction for multiple comparisons and requires replication.   
In NCs, Glx and not Glu concentrations predicted functional connectivity to 
salience network brain regions. We reported that increased Glx 
concentrations in the dACC in individuals with ASD were associated with 
reduced functional connectivity to salience network brain regions, such as the 
insular cortex, while NCs had the opposite relationship. This later result 
suggests incongruency between local compared to long-distance function in 
individuals with ASD. Nevertheless, we did not report group differences in 
functional connectivity or any relationship to functional connectivity and core 
symptoms of the disorder. 
6.3 IMPLICATIONS OF PRESENT RESEARCH 
One of the main findings of this study was a lack of support for altered Glu 
concentrations in individuals with ASD compared to NCs. At least for adult 
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male participants with normal IQ, our data suggest no consistent increase or 
decrease in Glu concentrations in the dACC of individuals with ASD 
compared to NCs. Therefore, evidence of increased Glu concentrations in 
children and adolescents with ASD compared to NCs 217,225,230,231 might only 
occur during development.  
We measured Glx concentrations primarily for comparison to Glu 
measurements in this thesis and other research studies. Our 1H-MRS 
protocol was not optimised for the collection Glx concentrations, but we 
obtained robust Glx measurements with CRLB scores below 17%. For the full 
cohort, we did not report significant differences in Glx concentrations 
between groups.   
We did report greater age-related changes in Glx concentrations in 
individuals with ASD compared to NCs, which may partially explain 
contradictory results in previous studies in adult participants with ASD. Single 
voxel spectroscopy studies of the ACC in younger adults reported no 
difference in Glx concentrations 239,556 while one study in older adults 
reported reductions in both Glu and Glx concentrations 556. Our investigation 
highlights the importance of considering age when interpreting group 
differences in relation to metabolite concentrations in individuals with ASD. 
The neurobiology of the disorder might change with increased age in 
individuals with ASD. 
In addition, our research was not designed to investigate the causal 
relationship between Glx and NAA + NAAG concentrations, but the 
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correlation between these variables suggest that reduced neural integrity as 
indexed by NAA + NAAG concentrations may lead to reductions in Glx in 
individuals with ASD with increased age.  
Local dACC Glx concentrations but not Glu concentrations predicted resting-
state functional connectivity to other brain regions in NCs. This result 
suggests that Glx concentrations might be more closely associated with local 
excitation or the GGC. With greater investigation, the relationship between 
Glx and functional connectivity might be a useful marker of altered brain 
function in individuals with ASD compared to NCs. 
Also, increased Glx concentrations in individuals with ASD were associated 
with reduced long-distance functional connectivity in salience network brain 
regions such as the insular cortex while NCs had the opposite relationship. 
We suggest that this result might be associated with atypical cortical 
development 97,638 or a local imbalance between excitation and inhibition 637. 
Much more research is required to understand and confirm this result, but 
this evidence suggests incongruency between local metabolites and long-
distance function in individuals with ASD. Increased Glx concentrations may 
have a different relationship with long-distance brain function in individuals 
with ASD.  
Unfortunately, we were unable to determine if increased Glx concentrations 
had some benefit to ASD symptoms or behaviours. Based on previous 
evidence that increased salience network functional connectivity was 
associated with reduced symptom severity in individuals with ASD 605,634, we 
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interpreted this relationship to suggest that, unlike NCs, increased Glx 
concentrations were disadvantageous in individuals with ASD. Nevertheless, 
we did not report any association between clinical symptoms and dACC 
functional connectivity. Therefore, these results require further investigation 
in relation to behaviour and disease severity. 
In contrast to Fan et al. (2012) 26, we did not report reduced performance on 
the conflict effect task in individuals with ASD compared to NCs. In fact, 
individuals with increased ASD communication deficits had improved conflict 
effect RTs. We suggest that differences in environment, participant 
motivations or ASD severity between Fan et al. (2012) 26 and the current 
study may have contributed to conflicting performance outcomes.  
6.4 STRENGTHS 
There were several strengths within these experiments. Firstly, the 1H-MRS 
sequence applied in this study was designed and optimised to measure Glu 
concentrations, allowing investigators to make conclusions about Glu 
concentrations rather than having to infer about Glu based on Glx. 
Furthermore, the application of a multimodal imaging sequence was a major 
strength of this study permitting greater exploration of how Glu and Glx might 
be associated with the ASD. Finally, we were able to investigate these 
relationships both non-invasively and in vivo rather than having to rely only 





The primary limitation of this study was a small sample size which limited the 
power of the statistical analysis. For example, we reported trend reductions 
at uncorrected alpha levels in Glx and NAA + NAAG concentrations for 
individuals with ASD compared to NCs. A larger cohort would have likely 
resulted in a more conclusive finding.  Our sample size also limited a more 
detailed exploration of the data. For example, our small cohort did not score 
highly on stereotypical and repetitive movements and we could not 
investigate this symptom in relationship to dACC functional connectivity. 
Nevertheless, the purpose of this study was to explore how Glu or Glx 
concentrations might be associated with behaviour and brain function in 
ASD. Future studies with larger and more diverse cohorts will hopefully build 
on our preliminary findings.  
Additionally, although we could measure metabolite concentrations, we were 
unable to make any conclusions regarding the function of a particular 
metabolite. Glutamate has many functions in the brain, and the grouping of 
intercellular and extracellular Glu concentrations by MRS might not be a 
sensitive enough measure to detect abnormalities in Glu function in 
individuals with ASD compared to NCs (chapter 1.3) 651. Given our current 
technological constraints, more direct investigation of Glu function would be 
beneficial but would require more invasive methods. 
Finally, the decision to investigate the conflict effect task outside of an fMRI 
scanner limited the conclusions that we could make regarding dACC 
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function. We were only able to infer about dACC function based on previous 
BOLD fMRI investigations. Compared to a behavioural performance task, 
neuroimaging is typically a more fine-tuned measure of brain function to an 
external task. In fact, other groups have reported hypofunction of the dACC 
in the absence of behavioural performance differences 407,408. Future 
multimodal studies may wish to incorporate task-based fMRI and 1H-MRS in 
addition to behavioural analysis 407,408. 
6.6 SUGGESTIONS FOR FUTURE STUDIES 
The most exciting outcome of this thesis has been the many additional 
research questions it has raised. Fundamentally, our results require 
replication in other brain regions and in larger, more diverse samples of 
individuals with ASD. It would also be interesting to investigate and compare 
metabolite concentrations and functional connectivity in brain regions 
associated with emotion and social behaviour, such as the pACC 404. Given 
the region-specific nature of the disorder, we anticipate that the results might 
vary between brain regions. 
Furthermore, a longitudinal investigation of metabolites concentrations would 
also be useful in understanding the trajectory of these metabolites across the 
lifespan of individuals with ASD. Our cross-sectional study suggested that 
individuals with ASD have sharper reductions in Glx concentrations with age 
than NCs. As we mentioned previously, this result might also be associated 
with improved interventions for younger generations of individuals with the 
disorder. A longitudinal investigation of these relationships will permit a 
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clearer understanding of the cause of altered metabolites concentrations over 
time. Nevertheless, it is unclear how long participants would need to be 
followed to identify significant reductions with age. A cross-sectional study 
suggested only a 12% reduction in NAA concentrations between the ages of 
20 and 70 years of age in NCs 558. 
Future research might also clarify if altered Glx concentrations are associated 
with behaviour and symptoms of the disorder in individuals with ASD 
compared to NCs. It was unclear if decreased Glx concentrations with age in 
individuals with ASD were adaptive or related to some degenerative 
progression of the disorder.  
Additionally, both NCs and individuals with ASD had excellent performance 
rates on the inhibition to distraction task employed in this study and a more 
difficult task might better index variation in dACC function. Previous evidence 
suggests reduced dACC function and increased ER during this task in 
individuals with ASD compared to NCs 26. Nevertheless, researchers have 
also reported that many other brain regions are also associated with this 
task, such as the DLPFC 26,304. Therefore, future behavioural measures or 
task-based fMRI studies more clearly and singularly associated with dACC 
function might more closely correlate with metabolite concentrations. 
Furthermore, it would be interesting to further investigate Glu, Glx and Gln 
separately in individuals with ASD. One method for doing this might be the 
use of carbon-13 magnetic resonance spectroscopy (13C-MRS) which allows 
for clear differentiation between these metabolites without the requirement for 
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higher magnetic field strengths 132. Nevertheless, this method is not without 
other complications. Carbon-13 exists in low concentrations in the brain and 
requires editing techniques to increase sensitivity during data collection 654. 
Also, it would be useful to further investigate the relationship between local 
excitatory to inhibitory concentrations in association with functional 
connectivity in participants with ASD. Investigators have hypothesised that an 
altered proportion of inhibition to excitation at the local level in individuals 
with ASD compared to NCs might be associated with altered long-distance 
functional connectivity 637,653. These relationships might be more evident 
when also investigating GABA, the primary inhibitory neurotransmitter in the 
brain 655 in relation to Glx, Glu and Gln. 
Finally, our study reliably measured Glu and Glx concentrations in individuals 
with ASD. As improved technology and methodological research for 
measuring metabolite concentrations become more readily available, 
subsequent 1H-MRS studies might benefit from techniques which further 
increase the precision of Glu and Glx measurement. For example, future 
studies may wish to apply increased magnetic field strengths 459,460. 
6.7 CONCLUSION 
In conclusion, this research has prompted many more questions and 
provided opportunities for future studies to better understand the role of Glu 
and Glx in the brain of individuals with ASD. We did not report evidence of 
altered Glu concentrations in adults with ASD compared to NCs. Although we 
did report weak evidence that Glx had greater reductions with age in adults 
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with ASD compared to NCs, this result requires further replication as it did 
not survive correction for multiple comparisons. We reported an altered 
relationship between Glx and long-distance functional connectivity in 
association with salience network regions in individuals with ASD compared 
to NCs. Further replication of these relationships might provide a useful 
marker of altered brain function in individuals with ASD. Our research 
suggests that a more detailed multimodal investigation of Glu and Glx 
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